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ABSTRACT 
 
Laura Paser D’Arcy: The Effect of Geriatric Care on Health Care Use 
(Under the direction of Sally C. Stearns) 
 
Health care for older adults with chronic conditions is costly and often of 
suboptimal quality. The quality of health care for geriatric conditions such as dementia 
and incontinence may be considerably poorer than for chronic disease such as diabetes 
and hypertension. Geriatricians have extensive training in and experience with physical, 
mental, cognitive, and social issues related to aging. Many elders might benefit from 
geriatric care; however, the current and projected future supply of geriatricians is limited. 
An understanding of the use and effects of geriatric care will help to ensure that the 
existing supply of geriatricians is used efficiently and provide information about possible 
benefits of expending supply. The purpose of this dissertation is to describe the use of 
geriatric care, to evaluate whether geriatric care reduces emergency department use, and 
to determine whether geriatric care is typically used in lieu of or in combination with care 
from other types of physicians.  
Using Medicare claims data for a national sample of elders who had a recent 
hospitalization for acute coronary syndromes and subsequent diagnosis of a geriatric 
condition, we found that very few patients received geriatric care. Use of geriatric care 
was closely tied to metropolitan status and nursing home residency. Geriatric care was 
associated with reduced emergency department use for both community and nursing 
home residents. Geriatric consultative care was associated with a reduction in emergency 
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department use that was not statistically different from the reduction associated with 
geriatric primary care. Geriatric care was associated with fewer visits to family and 
internal medicine physicians and in some cases with fewer visits to specialists. 
Although our results suggest that geriatric care reduces emergency department 
use, the total clinical impact of geriatric care is likely to be very small because of the low 
supply of geriatricians. Because of the lack of existing literature on the topic, additional 
studies are needed to elucidate the use and effects of geriatric care in real-world clinical 
settings. However, for geriatric medicine to have a population-level impact on the health 
and health care of older adults, its focus may need to be on teaching, research, and 
advocacy/policymaking. 
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PREFACE 
 
This dissertation is organized in a non-traditional format. The first chapter 
provides an introduction to the aims of the dissertation and a statement of the significance 
of the work. Chapter 2 provides the background, literature review and conceptual 
framework for the dissertation. Chapter 3 describes the data and the methodology used to 
address the three research questions in this dissertation. Chapters 4, 5 and 6 are 
manuscripts for the three studies in this dissertation. These three chapters must stand 
alone as manuscripts to be submitted for publication and have some redundancies with 
the earlier chapters. The three manuscripts in this dissertation are referred to as Study 1 
(Chapter 4), Study 2 (Chapter 5), and Study 3 (Chapter 6). Chapter 7 presents a synthesis 
of the findings, strengths and limitations, and policy implications of the three studies and 
provides directions for future research. 
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1. INTRODUCTION 
 
The growth in the number of elderly Americans, especially those aged 85 years or 
older, is increasing pressure on the health care system in the United States. Health care 
for older adults with chronic conditions is costly and often of suboptimal quality [1]. 
Nearly a quarter of elderly Medicare beneficiaries have four or more chronic conditions, 
and average Medicare expenditures per capita for this group are more than eight times 
higher than for beneficiaries with three or fewer chronic conditions [2]. The quality of 
health care for geriatric conditions such as dementia and incontinence may be 
considerably poorer than for chronic diseases such as diabetes and hypertension [3]. The 
term “geriatric condition” is defined precisely in Chapter 2; it refers to conditions that 
increase in prevalence with age (e.g., stroke, hearing impairment) as well as geriatric 
syndromes, which are clinical conditions that do not fit into distinct clinical categories 
(e.g., falls, weight loss/malnutrition) [4]. 
Comprehensive primary care programs may be beneficial for elders with multiple 
chronic  diseases, geriatric conditions, or other complex health care needs, but these 
programs are not widely available [5]. Most elders receive primary care from family 
medicine/general practice or general internal medicine (FM/IM) physicians. About 15% 
of elders replace traditional primary care with health care from specialists [6]. Very few 
elders receive primary or specialty care from geriatricians. Geriatricians are FM/IM 
physicians who are certified in geriatric medicine (GM). While geriatrician supply has 
declined from 8,824 to 6,756 in the last fifteen years, the number of elders is projected to  
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increase 90% from nearly 37 million to 70 million between 2005 and 2030 [7, 8]. In the 
literature, the term “geriatric care” is used in two contexts: to refer to care provided to 
elders by any type of provider, and to refer to care provided by geriatricians. We use the 
term “geriatric care” to refer to care provided by geriatricians.  
Given the small number of board-certified geriatricians and the large number of 
older patients, health care for elders is a shared responsibility of primary care physicians, 
specialists and geriatricians. However, training for FM/IM physicians and specialists may 
be inadequate for several competencies related to elderly patients, including recognition 
and management of geriatric conditions, transitional care, assessment of caregiver and 
family needs, and coordination of care [9-12]. Geriatricians’ training targets these and 
other related skills, and geriatricians often work in collaboration with other disciplines 
including nursing, pharmacy, physical and occupational therapy, and social work [13].  
1.1. Specific aims 
 
 This dissertation includes three studies. The aims for the three studies were as 
follows: 
Aim 1: Describe the frequency of geriatric care, patient characteristics associated with 
geriatric care, and trends in the use of geriatric care. 
Study 1 provides novel data on the use of geriatric care by a broad sample of Medicare 
beneficiaries. Using the beneficiary as the unit of observation, we described the 
frequency of geriatric care in hospital and non-hospital settings. Bivariate and 
multivariate models indicated whether demographic characteristics and comorbidities 
were related to the use of geriatric care. Patterns of the use of geriatric care over time 
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were assessed.  
Aim 2: Analyze the effect of geriatric care on ED use. 
Study 2 was based on the hypothesis that the knowledge, skills, and experience of a 
geriatrician may enable him or her to provide care to a beneficiary that reduces the 
likelihood of ED use compared to people who receive care from other types of 
physicians. We examined whether geriatric care provided during a six month period was 
associated with reduced ED use in the following month. Several measures of geriatric 
care were used to provide a multi-dimensional picture of the association of geriatric care 
with ED use. Fixed effects (FE) were used to account for unobservable factors that may 
have affected both geriatric care and ED use. Separate analyses were conducted for 
community residents and long-term NH residents, because NH residence is an indicator 
of frailty and complex health care issues that are difficult to measure in claims data. We 
also conducted a supplementary analysis examining the association between geriatric care 
and in-hospital death. 
Aim 3: Assess whether geriatric care is associated with the use of FM/IM physicians and 
specialists. 
Geriatricians may function in practice as primary care physicians or as specialists who 
provide consultative (i.e., intermittent) care. In Study 3, we assessed whether geriatric 
care acts as a substitute or complement for other types of care by estimating the 
association of geriatric care in a six month period with visits to FM/IM physicians and 
visits to specialists in the following six months. As in Study 2, we used FE to account for 
unobservable factors that may have affected both geriatric care and visits to other 
physicians, and separate analyses were conducted for community residents and NH 
4 
 
residents. 
1.2. Summary of significance 
 
Limitations in the current supply and a projected future shortage of geriatricians 
in the United States have been well-documented [4, 14]. In light of these supply 
constraints, understanding to whom, how frequently, and in what settings geriatric care is 
provided as well as whether geriatric care tends to be a substitute or complement for 
other types of physician care is critical to ensuring that geriatric care is used efficiently. 
However, patient-level data on the use of geriatric care are not available in the literature. 
Further, the effects of geriatric care provided in real-world settings are unknown. A 
number of interdisciplinary geriatric interventions have been tested in randomized 
controlled trials in the past two decades. Evidence from these interventions suggests that 
highly coordinated, comprehensive, ongoing care in outpatient and in-home settings has 
favorable effects on some measures of health and health care use [15-20]. Evidence 
demonstrating the efficacy of interventions without ongoing care (i.e., consultative care 
only) in outpatient and home settings is scarce [21-23]. No studies were found that 
assessed geriatric interventions in NHs. Drawing conclusions about the effects of 
geriatric care in real-world settings from trials of geriatric interventions is challenging 
because of differences among trials and differences between geriatric care provided as 
part of trials versus outside of these interventions. Whether the favorable outcomes found 
in trials translate to improvements in outcomes in real-world settings is not known. The 
effect of geriatric care on ED use is of interest since ED use has increased in recent years, 
and reductions in ED use are desirable from the perspectives of patients, providers, 
payers, and society. Reliable evidence about the use and effects of geriatric care is 
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required in order to help policymakers, health professionals, and researchers develop 
strategies to distribute this scarce resource more efficiently and to inform broader 
discussion about effective models of care for elders with geriatric conditions.  
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2. BACKGROUND 
 
Primary care has been defined as first-contact care that is longitudinal, 
comprehensive, and coordinated [24]. Adult primary care specialties traditionally include 
FM, IM, and general practice physicians without further subspecialty training. FM 
physicians are trained to care for all patients of all ages, while IM physicians typically 
treat adults only; according to the American Boards of Family Medicine (ABFM, 
formerly the American Board of Family Practice) and Internal Medicine (ABIM), 
however, the differences between these specialties are “not sharply defined” [25]. In this 
paper, we use the term “IM” to refer to general internists (i.e., excluding internal 
medicine subspecialists such as cardiologists) and the term “specialist” to refer to 
physicians other than FM/IM generalists and geriatricians.  
2.1. Geriatrician training and supply 
 
Three allopathic medicine specialties offer a certification in geriatrics: FM, IM, 
and psychiatry. Osteopathic physicians can also pursue a certification in geriatrics. The 
focus of the following discussion about geriatrician training refers to allopathic 
physicians, since by 2003, less than 5% of certifications in GM had been earned by 
osteopathic physicians [26]. Several major events related to the training and certification 
of geriatricians have occurred in the last four decades [26]. Training in GM began in the  
early 1970s with six fellowship programs. In 1988, the boards established a Certification 
of Added Qualification in GM; this certification is valid for ten years. Until 1994, 
physicians could qualify for the exam on the basis of substantial clinical experience 
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instead of a geriatrics fellowship. Geriatrics fellowships were initially required to last two 
years; in 1995, the boards changed the requirement for length of fellowships to one year. 
Although physicians can choose additional years of GM fellowship training, this practice 
is uncommon. Since 2003-2004, geriatrics fellows in the second year and beyond have 
accounted for no more than 18% of all geriatrics fellows [27]. 
Since July 1, 2006, the American Board of Internal Medicine has considered GM 
to be a subspecialty, while the American Board of Family Medicine continues to 
recognize GM with a certification [28]. The difference between a certification and a 
subspecialty is a difference in name only. FM-trained geriatricians are required to 
maintain their primary certification in FM, whereas IM-trained geriatricians can have 
their primary certification in IM or GM. The majority of geriatricians are trained in IM; 
from 1998 to 2008, approximately 80% of GM certifications were awarded to internists 
[29].  
Although nearly all FM/IM residency programs require geriatric clinical 
experience, most require less than one month of clinical time devoted to geriatric training 
during the three year residency [11, 12]. This level of training stands in stark contrast to a 
recommendation from the Institute of Medicine that FM/IM residents receive nine 
months of geriatric experience [30]. Training requirements typically do not include 
geriatrics-related foci such as recognition and treatment of geriatric syndromes, 
transitional care, and use of inappropriate medications [10]. FM/IM residents encounter 
elderly patients outside of the structured geriatric training period; however, exposure 
without structured training may be insufficient to prepare residents to address the 
complex and varied problems commonly faced by elderly patients, including not only 
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physical and mental health problems but also issues related to independence, caregivers, 
and social support. Because of their additional training and experience, geriatricians have 
a number of skills that distinguish them from FM/IM physicians (see Table 2.1).  
Small-scale studies have provided some limited evidence about the processes of geriatric 
care. Noting the lack of empirical work examining whether fellowship-trained 
geriatricians deliver higher-quality care to older adults for geriatric conditions than 
providers without formal geriatric training, Phelan and colleagues [31] used data on 140 
elderly patients receiving primary care at a medical center in the Pacific Northwest to 
study processes of care. Geriatricians were likely to have fewer instances of potentially 
inappropriate prescribing and more assessments of geriatrician syndromes than FM/IM 
physicians. A study at five clinics in Israel suggests that geriatricians may be particularly 
likely to recommend prescription drug modification and physical or occupational therapy 
[32]. In general, however, a paucity of data exist on whether the quality of medical care 
differs between geriatricians and other physicians [33]. 
Geriatrician supply in the United States has been a concern for years [4, 14]. The 
number of geriatricians in the US decreased from 9,256 in 1998 to 7,128 in 2007 [27, 34]. 
Because of the growth of the elderly population, an estimated  36,000 geriatricians will 
be needed to achieve the same geriatrician to elderly population ratio in 2030 as existed 
in 2002 [35]. Yet current graduation rates from geriatrics fellowship programs suggest 
that there will be only 7,750 geriatricians [36]. In recent years, a majority of GM fellows 
have been international medical graduates. Since the change to the one year fellowship 
requirement in 1995, the share of GM fellows who are international medical graduates 
has ranged from 51.6% (2002-2003) to 68.5% (2007-2008) [37].   
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One factor affecting geriatrician supply is reimbursement for geriatric services, 
which is the same or lower than reimbursement to FM/IM physicians despite the higher 
amount of uncompensated care that may be required for a geriatric patient population 
(e.g., interdisciplinary team care, case management occurring outside of a visit with a 
patient) [14]. The recent Institute of Medicine report titled “Retooling for an Aging 
America: Building the Health Care Workforce” made two recommendations applicable to 
both geriatricians and other health care professionals (e.g., geriatric nurse practitioners): 
increasing reimbursement for clinical services delivered to elders by practitioners with a 
certification in geriatrics, and instituting programs for loan forgiveness, scholarships, and 
direct financial incentives [4]. As a result of the passage of the Patient Protection and 
Affordable Care Act, steps are being taken to increase reimbursement for geriatric care 
and support the development of geriatricians as well as non-physician providers of care to 
the elderly, although the effect of these policy changes on geriatrician supply will not be 
known for quite some time [38].  
2.2. Provision of geriatric care 
 
The proper role of geriatricians in the health care system has been widely debated. 
Callahan and colleagues [39] discuss three approaches to GM: focus on persons most in 
need, consultative care, and health system design. In the first approach, geriatricians 
provide comprehensive primary care for elders who generally have a high need for 
geriatric care defined by disability, geriatric syndrome, or site of care (e.g., nursing home 
(NH)). In the second approach, geriatricians provide consultation to a broader range of 
elders, affecting health care through the care provided by other primary care providers. In 
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the third approach, geriatricians contribute to health care administration and health 
system design to improve health care for older adults.  
Few data are available which address whether one of these approaches is a more 
common and/or more effective use of geriatricians’ services than the other approaches. 
About 44% of respondents to a survey of geriatricians whose fellowships occurred in the 
1990s reported that the focus of their current position is essentially all geriatrics [40]. 
Other respondents said their primary focus was geriatrics with a secondary focus in IM 
(19%), FM (6%), or another specialty (6%). About one-quarter of respondents reported 
that geriatrics was the secondary focus of their current practice. Unlike FM/IM 
physicians who typically provide primary care, geriatricians commonly provide both 
primary and consultative care. Among respondents to a survey of geriatricians whose 
fellowships occurred in the 1990s, 64% reported that they engage in outpatient primary 
care, and 60% reported conducting outpatient comprehensive assessment [40]. 
Site of care differs among specialties. Claims data from 1998 for a nationally 
representative sample of Medicare beneficiaries show that geriatricians are substantially 
more likely to provide care in a NH and less likely to provide care in an office than 
family medicine and general internal medicine (FM/IM) physicians [41]. In that study, 
nearly 27% of GM claims originated in NHs compared to 7% for FM/IM claims. The 
reverse was found for office visits: 72% for FM/IM compared to 47% for geriatricians. 
Although NH care comprises a larger share of geriatricians’ practices than it does for 
FM/IM physicians, the small number of geriatricians compared to FM/IM physicians 
means that most physicians who provide NH care have no specialized geriatric training 
[42]. Further, although most NH medical directors serve as attending physicians for at 
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least some of the residents in their NHs [33], only 30% of NH medical directors are 
certified in GM [43].  
2.3. Evidence on the effect of geriatric care 
 
Interventions that aim to improve health care outcomes for older adults have been 
implemented in a host of settings. Many interventions have had no geriatrician 
involvement, and some have no physician involvement (the primary interventionist is 
typically a nurse practitioner, nurse, or social worker). The following discussion focuses 
largely on interventions that have included geriatricians. Existing evidence on the effect 
of geriatric care comes largely from randomized controlled trials (RCTs) of 
comprehensive geriatric assessment (CGA). CGA is a multidimensional, interdisciplinary 
process that determines an individual’s medical, psychosocial, functional, and 
environmental resources and problems, aims to improve diagnostic accuracy and 
optimize drug prescribing, and develops a coordinated plan for treatment and follow-up 
[44-46]. CGAs that provide continuing care are frequently referred to as geriatric 
evaluation and management (GEM). In contrast to GEM, other CGAs provide 
consultative care only (i.e., little or no follow-up after the initial assessment). In this case, 
an individual’s primary care physician, who is usually not directly involved in the CGA, 
determines to what extent the plan of care developed during the CGA is followed. A 
literature review on adherence to recommendations of eight outpatient and home-based 
consultative CGA found that physician adherence ranged from 49% to 79% [47].  
The interdisciplinary teams involved in CGA typically include geriatricians, nurse 
practitioners or nurses, and social workers; less commonly, pharmacists, physical 
therapists, or occupational therapists are included. The role of geriatricians in these 
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programs varies and is sometimes unclear. A geriatrician may play the leading role in the 
intervention team, work closely with the primary interventionist (typically a nurse 
practitioner or nurse), or participate in a less intensive way.  
2.3.1. RCTs: Inpatient 
A number of RCTs have examined the effects of GEM and consultative CGA in 
hospitals. The majority of these studies occurred prior to the year 2000 and were in 
Veterans Administration medical centers; most hospitals have not adopted or considered 
adopting inpatient GEM [48, 49]. A meta-analysis of GEM by Stuck et al. found 
favorable changes in mortality at six months, living at home at six and twelve months 
(alive and not hospitalized), physical function, and cognitive function [44].  Results for 
consultative CGA were less positive; cognitive function increased, but there was no 
effect on mortality, living at home, or physical function.  
Ellis and Langhorne used the same meta-analysis methodology as Stuck et al. and 
concluded that results of more recent GEMs were less favorable than results from earlier 
interventions [45]. The rate of living at home was substantially higher among GEM 
participants, but no effect was seen on mortality. Neither recent GEMs nor recent 
consultative CGAs have provided strong evidence of a favorable effect on physical and 
cognitive function, although the authors did not conduct a formal meta-analysis of 
consultative CGA results. In sum, evidence of the effectiveness of hospital-based GEM 
and consultative CGA programs is weak. No studies were found that assessed the effect 
of GEM or consultative CGA in NHs. 
2.3.2. RCTs: Outpatient and in-home 
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Because of the high cost of hospital care, many of the more recent CGAs have 
been implemented in outpatient or home settings [15]. Like inpatient interventions, 
outpatient and in-home GEMs and consultative CGAs have produced results that are 
mixed; however, their results are more positive than results from hospital-based 
programs. Older trials of GEM and consultative CGA did not produce promising results 
in either setting. A meta-analysis of ten in-home programs (eight GEM and two 
consultative CGA) and four outpatient programs (three GEM and 1 consultative CGA) 
found few significant effects of those programs on morality, living at home, and physical 
and cognitive function [44].  
More recent evidence demonstrating the effectiveness of outpatient and in-home 
consultative CGA is also scarce. One intervention reported no effects on physical or 
cognitive function, NH admission, ED use, or mortality [21]. Another found improved 
mental health after twelve months but no effects on mortality or a variety of measures of 
physical and mental function [17]. Consultative CGA for patients discharged home after 
an ED visit produced a decrease in NH admissions at thirty and 120 days for high-risk 
patients [22]. No effects were found for low-risk patients or for subsequent ED use, 
hospitalization, or costs at thirty or 120 days. No effects were seen for elective 
hospitalizations, NH admission, or mortality. A more recent trial of outpatient 
consultative CGA coupled with an intervention to increase adherence to 
recommendations showed an increase in the prevention of functional decline [23]. A trial 
of in-home consultative CGA lasting four weeks after discharge from the emergency 
department (ED) resulted in reductions in the total number of hospitalizations as well as 
ED use alone; favorable effects were also seen for physical and cognitive function [50].  
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Compared to hospital-based GEM and consultative CGA in any setting, evidence 
on the effectiveness of outpatient and in-home GEM is much more favorable. Outpatient 
GEM has shown favorable effects on physical functioning [15, 16] and mental or 
cognitive health [15, 17, 18]. Some outpatient GEMs have produced either cost 
reductions or no increase in costs [15-17, 51]. Yet these programs have failed to reduce 
NH use and hospitalizations [15, 17, 18]. A meta-analysis of nine outpatient CGAs (six 
GEM and three consultative) found no effect on survival [20].  
In a meta-analysis of eighteen in-home interventions, only two included a 
geriatrician [52]. One of those two interventions showed a reduction in the risks of NH 
admission and functional status decline but no effect on mortality; the other intervention 
produced no significant effects on any of the three measures. Participants in an in-home 
GEM intervention not included in that meta-analysis had a reduced rate of decline in 
physical and cognitive function and lower likelihoods of hospital admission and ED use 
[19]. The Geriatric Resources for Assessment and Care of Elders (GRACE) trial of in-
home GEM for low-income elders reported lower ED use and hospital admissions among 
the subsample at high risk of hospitalization [53]. Among the full sample, no 
improvements in mortality or physical function were found but other measures including 
general and mental health improved. This RCT was the only one located which compared 
process measures in addition to outcome measures. Receipt of information about urinary 
incontinence and falls for those reporting the condition at baseline, presence of health 
care representative or living will, and presence of a medication list were higher among 
intervention participants. In sum, evidence of the effectiveness of outpatient and in-home 
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GEM, and to a less extent outpatient and in-home consultative CGA, is mixed but 
promising.  
2.3.3. Analyses using observational data 
Although GEM has features similar to primary care by geriatricians and 
consultative CGA has features similar to consultative care by geriatricians, they differ in 
important ways from primary care and consultative care by geriatricians in the 
community. The high degree of coordinated, interdisciplinary care found in most GEM 
and consultative CGA interventions does not represent the experience of most patients 
seeing geriatricians. Additionally, since the level of geriatrician involvement in 
interventions varies widely, it is difficult to characterize how the geriatrician impacts 
outcomes. In order to assess the effects of geriatric care more broadly than studies of 
CGA, we located a handful of analyses that explicitly measured the effect of geriatric 
care using observational data. Some observational studies have also examined the effect 
of geriatric care for particular subpopulations such as hip fracture patients [54, 55], but a 
review of that literature is outside the scope of this dissertation. 
At a clinic in Washington, 146 elders participated in an intervention which 
consisted of two visits with a geriatrician [56]. One visit was a systematic assessment, 
screening, and examination, and the other visit was a problem-solving session aimed at 
reducing threats to functional independence and promoting chronic disease self-
management. Participants were matched 1:3 with controls at other clinics based on sex 
and a propensity score computed using demographic, clinical, and health care utilization 
data. Hospitalization rate and total health care costs were lower among intervention 
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participants; no effects were found for mortality, NH admission, outpatient or specialty 
visits, or high-risk prescriptions.  
In a study of 512 patients at five clinics in central Israel who were referred to a 
geriatrician from June 2003 through October 2006, the only outcome measure examined 
was the difference in the number of visits to the primary care provider in the six months 
before and after the geriatrician consultation [32]. No control group was used. The 
difference was small but statistically significant (mean of 10.9 visits before and 10.2 
visits after). Although the authors reported that visit reduction did not differ by group 
(e.g., age, cognitive function), no multivariable model was estimated.  
Another paper examined potentially inappropriate prescribing among elderly VA 
patients with at least one outpatient clinic visit and one medication during the study 
period [57]. The study included one individual and one facility measure of geriatric care. 
Potentially inappropriate prescribing was significantly less likely among patients who had 
at least one inpatient or outpatient geriatric visit. In contrast, whether the patient was in a 
facility where the proportion of patients with at least one geriatric visit exceeded the 
median of all facilities in the sample had no association with potentially inappropriate 
prescribing.  
Each of these three studies offers some information about how geriatricians may 
have different effects than FM/IM physicians, but their limitations are substantial. The 
studies had substantially different samples, measures of geriatric care, and outcomes; 
therefore, a comparison of their results is difficult. The studies had limited external 
validity. None of the study populations was nationwide; two were restricted to a single 
geographic location, and the third was restricted to the Veteran’s Affairs system. Finally, 
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an important limitation common to all three studies is that they failed to address 
unobserved variables that may affect both the use of a geriatrician and the outcome 
measure. An inability to observe factors such as functional status, longevity expectations, 
and health-care seeking behavior that could plausibly affect both geriatrician use and 
health outcomes makes estimating a causal effect of geriatrician visits on outcomes 
challenging. 
2.4. Who should visit a geriatrician? 
 
The published literature does not provide formal evidence or consensus on 
conditions for which geriatric care is most likely to be beneficial. Information about 
which groups are expected to benefit can be gathered from two sources: sample selection 
criteria used in RCTs of CGA and a 2008 survey of directors of geriatrics academic 
programs which asked to what degree elders would be likely to benefit from geriatric care 
(Table 2.2) [28]. Most trials have had lengthy sample selection criteria. These include 
criteria that must be met by every patient (e.g., geographic location, demographic 
characteristics) and a list of additional criteria of which one or two must be met by each 
patient (e.g., particular health conditions). The criteria are designed to select individuals 
who are most likely to respond to intervention.  
Health conditions used as sample selection criteria for RCTs of geriatric 
interventions fall into three categories: physical health, mental and neurological health, 
and geriatric syndromes. Interventions that use indicators of poor physical health to 
define the sample typically include chronic diagnoses such as diabetes and heart disease 
[15, 18, 53, 58]. The most commonly used indicators of mental and neurological health 
used by RCTs of geriatric interventions are dementia and delirium/confusion [17, 58-60] 
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as well as depression [58, 59, 61]. Mental and neurological health indicators are used 
more frequently than physical health indicators. Stroke may be considered a measure of 
physical health or neurological health [17, 59]. Other conditions used to select samples 
for trials fall under the broad category of geriatric syndromes, which are health conditions 
that are strongly associated with advanced chronologic age. Functional status is a strong 
predictor of health outcomes and is probably the most widely used characteristic for 
recruitment into RCTs of geriatric interventions [17, 18, 51, 58-64]. Four other conditions 
are used less frequently than functional status but are still common: (1) bed 
rest/immobility [17, 59]; (2) falls or impaired gait and balance [17, 58, 59, 61]; (3) 
incontinence [17, 59-61], and (4) weight loss/malnutrition/failure to thrive [17, 59].  
 In addition to health conditions, RCT investigators have used demographic factors 
and measures of health care use as indicators of which elders might benefit from geriatric 
care. Trials are typically conducted using only patients in a particular setting (e.g., 
hospital, community). Nearly all studies have a minimum age for sample inclusion; the 
minimum age is usually 65. Some studies use 70 or 75 as the minimum age [15, 58, 62]. 
Trials have occasionally targeted populations on the basis of socioeconomic status or 
social/family problems [53, 59]. Finally, measures of health care use including hospital 
readmission, number of outpatient visits, and number of medications are used as sample 
selection criteria in a number of trials [15, 17, 51, 53, 56].  
 The idea that a multitude of conditions or characteristics may be indicative of the 
potential to benefit from geriatric care is supported by the results of a 2008 survey of 
directors of geriatrics academic programs [28]. Respondents were asked whether elders 
would be likely to benefit from geriatric care greatly, to some extent, to a small extent, or 
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not at all relative to primary, consultative, and hospital care from FM/IM physicians. 
Questions were posed about groups of elders by age, functional state, medical 
complexity, and geriatric syndromes (Table 2.2). The results of the survey are consistent 
with the sample selection criteria commonly used by RCTs of geriatric interventions. 
Based on both RCT criteria and the survey, old age alone appears to be an insufficient 
marker for potential to benefit from geriatric care. Only one-third of survey respondents 
reported that an individual aged 75 to 85 would greatly benefit from geriatric care. Most 
survey respondents indicated that elders with moderate to severe functional impairment 
would greatly benefit from geriatric primary care. This finding mirrors the high 
frequency with which activity of daily living restrictions appears in sample selection 
criteria for RCTs.  
In addition to agreement on advanced age and functional impairment, three other 
characteristics that were most often reported to be indicative of greatly benefiting from 
geriatric care are closely tied to sample selection criteria used in RCTs: complex 
psychomedical problems (e.g., depression and dementia); complex biomedical problems 
(e.g., multiple comorbidities and immobility); and geriatric syndromes. In most cases, the 
share of respondents indicating that consultative or hospital geriatric care would provide 
a great benefit was similar to but slightly lower than the share indicating that primary 
geriatric care would provide a great benefit. In general, most of the conditions for which 
at least 80% of respondents reported the potential for a great benefit from geriatric care 
have been used frequently in RCT sample selection criteria. One case in which this is not 
true is frailty/vulnerability. A high proportion of respondents reported that 
frailty/vulnerability were indicative of the potential to substantially benefit from geriatric 
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care. These terms are not often used in sample selection for RCTs of geriatric 
interventions, perhaps because of the lack of clarity about how to measure these complex 
constructs.  
2.5. Conceptual framework 
 
This analysis examines the relationship between physician specialty and selected 
measures of health care use with a focus on the effects of geriatric care. From an 
economic perspective, a beneficiary maximizes his or her expected utility by making 
decisions intended to maintain or increase one’s health capital. The choice of physician 
type may affect a beneficiary’s health outcomes. For example, some health crises that 
lead to ED use may be able to be prevented by care by physicians trained in the spectrum 
of issues affecting elderly patients. Health status and several other factors internal and 
external to the beneficiary, described below, affect the specialty of the physician from 
which the beneficiary seeks care (Figure 2.1). Subsequently, the effect of physician type 
on health outcomes such as ED use arises via the knowledge, skills and experience of the 
physician in conjunction with beneficiary compliance with physician recommendations.  
A beneficiary chooses the physician(s) whose care leads to the highest expected 
utility net of costs. Geriatricians are unique, because they are trained as both a primary 
care physician and a subspecialist. They can participate in a patient’s care as the primary 
care physician or as a consultant. Since geriatric care may have heterogeneous treatment 
effects, an individual assesses the benefits and costs of geriatric care given their personal 
characteristics and expectations. The benefits and costs of geriatric care are applicable to 
both primary and consultative care from a geriatrician. In Study 2, we test whether the 
benefits are larger for primary geriatric care than for consultative geriatric care. 
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Health status may be the most important factor that affects whether a person 
chooses geriatric care. Patients who have poor or declining functional and cognitive 
status or geriatric syndromes are particularly well-suited to geriatric care; unlike FM/IM 
physicians and specialists, geriatricians have extensive training and experience caring for 
people with these conditions. In contrast, elders who are relatively healthy and those 
whose health conditions are less closely related to the aging process or have little effect 
on their functional and cognitive status (e.g., hypertension, diabetes) may be less likely to 
benefit from geriatric care relative to other types of care. Therefore, healthier elders and 
those with common chronic conditions may be less likely to choose geriatric care. 
A beneficiary may be referred to geriatric care by a physician from whom they 
have previously received inpatient or outpatient care. For a NH resident, nursing home 
staff or the medical director may recommend geriatric care. In the case of referral, a 
beneficiary may value the expected benefit from geriatric care in part based on trust in 
the existing provider. Referral to geriatric care is more likely than self-referral, since 
anecdotal evidence suggests a general lack of knowledge about geriatric care. The ability 
of a beneficiary whose health is poor to identify and select alternatives to the existing 
patient-provider relationship may depend in large part on family and social support. 
Socioeconomic status (e.g., supplemental health insurance) may also affect the 
aggressiveness with which the beneficiary seeks options for health care. 
Personal preferences such as time preference and longevity expectations may 
affect whether a person chooses geriatric care. Geriatricians’ unique skill set enhances 
their ability to manage both medical and non-medical aspects of patients’ care (e.g., 
providing support for caregiver and family decision-making, identifying available social 
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services). These types of non-medical care are likely to improve quality of life, but their 
impact on longevity is less clear. Therefore, a person who values present quality of life 
more than longevity may gain more utility from geriatric care than someone who pursues 
aggressive medical care with the intention of extending longevity at all costs. In other 
words, the effect of geriatric care on utility for a beneficiary who has a high discount rate 
may be larger than the effect of geriatric care for a beneficiary with a low discount rate.  
The total individual costs of geriatric care are determined in part by 
socioeconomic status (e.g., supplemental health insurance), health status, physician 
referral, patient preferences, and geriatrician availability and location. A geriatrician may 
provide or recommend different types or amounts of care than a FM/IM physician or 
specialist for a patient with a particular health status. Care recommendations affect the 
out-of-pocket cost of physician care, since beneficiaries in fee-for-service Medicare have 
an annual deductible and 20% coinsurance (unless other insurance covers these costs). 
The nature of geriatric care may be such that more services or more expensive services 
are incurred initially, but the beneficiary consumes less health care over time than if he or 
she visited another type of physician. For example, a geriatrician may be more likely than 
other physicians to refer a patient who has functional status limitations to physical or 
occupational therapy. Although higher short-term costs would be incurred under geriatric 
care in this case, physical or occupational therapy may reduce the risk of falls; it follows 
that there may be a reduced risk of health care use that would be associated with the 
occurrence of a fall (e.g., ED use). Similarly, the short-term cost of geriatrician visits for 
medication management may be outweighed by a reduction in the longer-term risk of ED 
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use for adverse drug events. In either event, the cost of geriatric care over multiple 
periods may be lower than the cost of care from another type of physician.  
In addition to socioeconomic status and health status, several other factors play a 
role in the non-monetary costs of geriatric care. Search costs are lower for beneficiaries 
whose provider refers them to geriatric care. Non-monetary costs are also affected by 
patient preference; some patients incur higher costs as a result of changing providers than 
other patients. These may include time costs due to filling out paperwork on one’s 
medical history as well as the psychological cost of uncertainty. In most cases, a 
beneficiary has far less information than a physician about the options and likely 
outcomes of treatment [65]. Beneficiaries who are especially uncomfortable with this 
information asymmetry may incur a higher transaction cost from switching to geriatric 
care than beneficiaries who are less affected by uncertainty. For example, a beneficiary 
who has received care from the same physician for several years may experience higher 
transaction costs due to uncertainty than a beneficiary who does not have a long-standing 
relationship with a physician. Existing data suggest that most Americans prefer to have a 
long-term relationship with a single primary care provider, which implies that non-
monetary costs associated with changing providers may have a substantial impact on 
whether a patient receives geriatric care [66-68]. Finally, the costs of geriatric care are 
not determined only by factors such as health status and preferences that are internal to 
the beneficiary. Physician location and availability are external to the beneficiary but also 
affect the cost of geriatric care. Conditional on local demand, low geriatrician supply 
implies more time required to wait for an appointment and to travel to appointments. This 
corresponds to higher costs for the beneficiary due to deteriorating health and travel.  
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 Once a beneficiary has chosen care from a geriatrician or another type of 
physician, the physician’s knowledge, skills, and experience determine the contribution 
of the physician to the beneficiary’s health care use. In the case of consultative geriatric 
care, the degree to which the primary care physician complies with recommendations 
from the geriatrician also plays an important role in whether the geriatric consultation 
affects subsequent health care use. As described in Table 2.1, the marginal product of 
GM relative to other specialties is driven by skills such as diagnosis and management of 
acute and chronic conditions as well as involvement with other providers, social services, 
and caregivers. These features of geriatric care may allow beneficiaries who receive care 
from geriatricians to have a lower likelihood of health care services such as ED use and 
in-hospital death that are typically considered to be undesirable (compared to similarly ill 
beneficiaries who receive care from other types of physicians). In other words, because 
geriatricians have knowledge, skills, and experience that distinguish them from other 
types of physicians, geriatric care plausibly leads to better health outcomes than non-
geriatric care for certain patients.  
This conceptual framework identified internal and external factors that affect use 
of geriatric care and the pathways of the effect of geriatric care on health outcomes. The 
discussion focused on health status as a key factor affecting the benefits and costs of 
geriatric care. The reason health status is intrinsically linked to the expected utility from 
geriatric care is that the marginal product of GM is not likely to be the same for all elders. 
Both the sample selection criteria and the empirical models used in this dissertation 
reflect these effects of health status and other factors internal and external to the 
beneficiary on geriatrician use and the effect of geriatric care on health care use. 
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2.6. New contributions 
This is an opportune time to examine the effects of geriatric care; in the short-run, 
the number of elders in the US will grow substantially, while geriatrician supply is 
predicted to continue to stagnate due to low recertification rates and failure to fill 
geriatrics fellowship positions. Using a large, geographically diverse sample of elderly 
Medicare beneficiaries, we assessed patient-level patterns of geriatrician use and the 
association of geriatric care with ED use and other physician visits. This study 
complements the literature on RCTs of multidisciplinary geriatric interventions and 
makes a substantial contribution to the limited number of existing studies that used 
observational data to examine the effect of visits to geriatricians. The effects of both the 
number of visits to a geriatrician as well as geriatric care as a share of the beneficiary’s 
total physician visits were examined. Using multiple measures of geriatric care provided 
depth to the analysis and expanded the policy implications of the results.  
The results of this study are not definitive; additional studies are needed to 
examine the effect of geriatrician use on other important outcomes (e.g., quality of life, 
functional status) and to determine whether the results of this study can be replicated 
using other samples. However, by focusing on physician choice and health care use, this 
study provides vital information about the effects of geriatric care at a time of marked 
increase in the elderly population and recent policy changes designed to increase support 
for geriatric care and education. 
.   
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Figure 2.1. Conceptual framework
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Table 2.1. Key features of geriatric care 
• Expertise in managing common conditions that affect older persons including 
dementia, falls, urinary incontinence, malnutrition, osteoporosis, sensory 
impairment, and depression 
• Understanding the interaction between aging and other conditions and diseases 
• Recognizing the effects of aging and other conditions on clinical health, physical 
and mental function and independence 
• Understanding the appropriate use of medications to avoid the potential hazards and 
unintended consequences of multiple medications 
• Coordinating care among other providers to help patients maintain functional 
independence and improve their overall quality of life 
• Evaluating and organizing health care and social services to preserve the 
independence and productivity of older persons 
• Assisting families and other caregivers as they face decisions about declining 
capacity, independence, availability of support services, and end-of-life decision-
making 
Source: American Geriatrics Society [13] 
 
 
  
 
28
Table 2.2. Characteristics/conditions indicative of potential to benefit from geriatric care 
Randomized controlled trials 
Survey of directors of geriatric academic 
programs [5] 
Conditions used in this dissertation Characteristic/condition 
Frequency of 
use Characteristic/condition 
% responding 
greatly benefit^ 
Physical health     
Diabetes, heart disease, 
stroke Moderate 
Complex biomedical 
problems 79%-82% Stroke 
Mental/neurological 
health     
Dementia, depression High 
Psychomedical 
complexity 81%-87% Dementia, depression 
Delirium/confusion Low 
Psychomedical 
complexity 81%-87% Delirium 
Geriatric syndromes     
Functional status, 
falls/impaired gait 
and balance High 
Moderate to severe 
functional impairment 59%-82% 
Pressure ulcer, fractures, dislocations, 
lacerations, osteoporosis, syncope, 
hearing impairment,  
vision impairment 
Incontinence Moderate Geriatric syndromes 75%-82% Urinary incontinence 
Bed rest/immobility, 
weight loss/malnutrition Low 
Unexplained health 
decline 68%-73% 
Weight loss/malnutrition, failure to 
thrive, dehydration, pressure ulcer 
Advanced age     
65+ High 75-85 33%-40% 66+ 
70+ or 75+ Moderate >85 68%-82% None 
Demographic characteristics    
Socioeconomic status, 
social/family problems Low 
Socioeconomic, family, or 
ethical problems 67%-69% ZIP code level income (control only) 
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Randomized controlled trials 
Survey of directors of geriatric academic 
programs [5] 
Conditions used in this dissertation Characteristic/condition 
Frequency of 
use Characteristic/condition 
% responding 
greatly benefit^ 
Measures of health care use    
Hospital readmission, 
number of outpatient 
visits, number of 
medications Moderate End-of-life/palliative care 72%-75% None 
^ “Greatly benefit” refers to the percent of respondents who said that someone with a given characteristic/condition would greatly benefit from primary, 
consultative or hospital care from geriatricians, compared to the benefit of care from FM/IM physicians. 
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3. METHODS 
 
 This chapter provides an overview of the methodologies used for the three 
studies. Much of the information contained here is in also included in the methods 
sections for the individual studies. The methodologies for the three studies were the same 
when possible; in some cases, samples, measures, or estimations varied because of the 
nature each of the studies. 
3.1. Research design 
 
This dissertation used a retrospective cohort design. Data analysis began on the 
date when the beneficiary was included in the sample on the basis of a diagnosis of a 
qualifying geriatric syndrome/condition (discussed in more detail below). Beneficiaries 
were followed from this date until date of death, study end (12/31/2007), or admission to 
a long-stay hospital. In Study 1, we examined the association of geriatric care with 
contemporaneous demographic characteristics and comorbidities. In Studies 2 and 3 we 
used lagged measures of geriatrician visits to examine the relationship between geriatric 
care and health care use.  
3.2. Data sources 
The main data source for this dissertation was Medicare claims. Data from 
Medicare Provider Analysis and Review (MedPAR), Outpatient, Carrier, and 
Denominator files were available for 2002 through 2007. Medicare claims data were 
supplemented with ZIP code-level data from the 2000 Census and Rural-Urban 
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Commuting Areas Codes [69, 70]. Data for the instruments were from an analysis file 
constructed using aggregated data from the American Medical Association (AMA) 
Physician Masterfile and the American Board of Medical Specialties (ABMS). Since 
AMA and ABMS data for 2007 were unavailable, data for 2003-2006 and 2009 were 
used to interpolate the values of the instrumental variables in 2007. 
3.3. Sample 
 
We used 2002-2007 Medicare claims data for beneficiaries who met the following 
criteria (Figure 3.1): an acute care hospital stay with a diagnosis of acute coronary 
syndromes (ACS) (ICD-9 codes 410.xx, 411.1x, and 413.9x) from January 2003 through 
October 2004; age > 66 years at the time of the hospital stay; and continuously enrolled 
in Medicare Parts A and B until death or 12/31/2007 (the last date for which data were 
available) (n=965,087). The initial sample of nearly one million beneficiaries was 
identified for a separate study [71].  
The data used in this dissertation were advantageous because of the large initial 
sample size; since geriatric care is rare, having a large sample was critical. Yet the 
presence of ACS alone is unlikely to suggest a potential to benefit from geriatric care in 
excess of the benefits that would be expected from FM/IM or specialty care. In order to 
ensure a sample with the most potential to benefit from geriatric care and sufficient 
statistical power, we used two additional sample selection criteria: diagnosis of a geriatric 
syndrome/condition in a setting other than a long-stay hospital at least one year after the 
hospitalization for ACS and before the date of death or 12/31/2007 (n=452,985), and no 
diagnosis of the same syndrome/condition in the two prior years (n=340,848).  
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Requiring a diagnosis of one of the geriatric syndromes/conditions (Table 2.2) 
created a buffer between measurement of physician visits for this dissertation and use of 
cardiac care around the time of the hospitalization. Further, in the case of acute 
conditions such as stroke and fracture, requiring beneficiaries to have a look-back period 
of two years maximizes the likelihood that the diagnosis represents the onset of the 
condition. The rationale for this criterion was identification of a point in time at which a 
beneficiary’s health status may have recently changed, since physician care may have 
particularly important effects on health care use following a health shock. Taken together, 
requiring a diagnosis of a geriatric syndrome/condition and a look-back period of two 
years for that diagnosis restricted the sample to beneficiaries who were most likely to 
benefit from geriatric care. Geriatrician use was substantially higher among beneficiaries 
in the final sample than among beneficiaries who did not meet these two sample selection 
criteria relating to diagnosis of the geriatric syndrome/condition, which suggests that the 
conditions we chose may in fact have indicated a high likelihood of benefiting from 
geriatric care.  
Diagnoses occurring during long-stay hospital records were not used for sample 
selection, since patterns of health care use are markedly different for long-stay hospital 
patients. The mean (median) stay in a long-stay hospital in our claims data was 580 (595) 
days. During that period of time, beneficiaries would not have been at risk for the 
outcomes in Studies 2 and 3. An additional sample selection criterion was used in Study 
1: a minimum of one year of follow-up data after diagnosis of the geriatric condition (n = 
214,375). Of the beneficiaries who met all criteria except a minimum of one year of 
follow-up data after diagnosis of the geriatric condition, 55% died within the first year 
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following diagnosis. The remaining 45% had less than one year of data available between 
the date of diagnosis and 12/31/2007. In addition to the full sample, analyses for Study 1 
were conducted using subsamples defined by the presence of dementia and congestive 
heart failure (CHF).  
Studies 2 and 3 had the same number of beneficiaries. Both had 287,259 
community dwellers and 66,551 NH dwellers. Study 2 used person-month observations. 
The sample sizes were 5,277,762 (community) and 1,005,122 observations (NH). Some 
beneficiaries (n=26,875) had observations in both the community and NH samples. Study 
2 used person-six month observations. The sample sizes were 1,006,879 (community) 
and 195,433 observations (NH). 
3.4. Measurement 
 
3.4.1. Physician visits 
Data in the Carrier files are divided into claims, and each claim can have up to 
thirteen line items. Each line item has its own “from date” and “to date” as well as its 
own Unique Physician Identification Number (UPIN). We defined a physician visit as all 
line items provided to a single beneficiary on a given date by a single physician [6]. We 
used the line item date rather than the claim date because, in some cases, these two dates 
differed. For example, 22.9% of claims with two or more line items had at least one line 
item from date that did not match the claim from date.  
A visit in the claims data was included in this analysis if it met one or more of the 
following criteria: 1) associated with a physician-related performing provider Unique 
Physician Identification Number (UPIN) [72, 73]; 2) for 2007 claims data only, UPIN 
was missing but a National Provider Identifier (NPI) was present (unlike UPIN, NPI data 
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do not have any inherent information about whether the provider is a physician); or 3) the 
performing provider specialty indicated that the provider was a physician assistant or 
nurse practitioner. Visits were identified using Berenson-Eggers Type of Service 
(BETOS) codes for evaluation and management services provided during office, home, 
and NH visits as well as consultations [72]. All line items with BETOS codes M1A, 
M1B, M4A, M4B, and M6 were included unless one of the following Healthcare 
Common Procedure Coding System (HCPCS) codes was present: 99221-99239, 99251-
99255, 99261-99263, 99271-99275, 99411-99412, 95115-95117, or G0175.  
Physician visits were measured by specialty group, not by individual physician. 
Three specialty groups were used: geriatricians, FM/IM physicians, and specialists. For 
example, one visit to each of two geriatricians were treated the same as two visits to a 
single geriatrician. Visits to general practitioners, preventive medicine physicians, nurse 
practitioners, and physician assistants were included with FM/IM physicians. NAs and 
PAs can bill Medicare directly, and in non-hospital settings, they can bill incident to a 
physician service. They receive 85% of the physician fee schedule when they bill 
Medicare directly and 100% when they bill incident to physician service (i.e., there is no 
record of NP or PA involvement) [74]. About 35% of NPs and PAs are in FM, while 
more NPs than PAs are in IM or GM (17.8% and 5.9% of NPs are in IM and GM 
respectively, compared to 8.5% and 0.8% of PAs) [75]. Elderly patients are less likely 
than younger patients to see a NP or PA only [76]. Medicare claims data do not identify 
PAs and NPs by their specialty, and no data were located on practice patterns of 
gerontological NPs. Therefore, it is not possible in this dissertation to identify or infer the 
use of gerontological NPs. 
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In the specialist group, we included all specialties that could possibly be 
considered as providing the bulk of care to a beneficiary. The following specialties were 
included in the specialist group: addiction medicine, allergy and immunology, 
cardiology, dermatology, endocrinology, gastroenterology, gynecological oncology, 
hematology, hematology-oncology, infectious diseases, interventional radiology, medical 
oncology, nephrology, neurology, neuropsychiatry, obstetrics/gynecology, osteopathic 
manipulative treatment, physical medicine and rehabilitation, psychiatry, pulmonary 
disease, radiation oncology, rheumatology, surgical oncology, and urology.  
Physicians self-designate specialty when they apply to become a Medicare 
provider; this specialty appears in the Carrier file. Since specialty is self-designated, 
geriatrician specialty does not necessary imply that a physician has ever been or is 
currently certified in GM. If a physician lists multiple specialties on their application, 
they identify the specialty they want listed first in claims data. In some cases the first 
specialty may not be listed if a claim merits using another specialty on the basis of the 
services provided (Research Data Assistance Center, personal communication, January 
13, 2010). Medicare updates the records only when the physician or his/her institution 
sends an update to the Centers for Medicare and Medicaid Services.  
3.4.2. Geriatric care 
Compared to non-geriatricians, a much larger share of geriatricians were listed as 
having multiple specialties in the claims data for a single year (e.g. a physician whose 
specialty is listed as GM for some visits and FM for others). Using a dataset with one 
observation per physician per year, we found that 20.7% of physician-year observations 
that had at least two GM visits also had non-GM visits. The corresponding figures for 
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physician-year observations that had at least two FM/IM visits and also had non-FM/IM 
visits were much smaller: 5.1% (FM) and 9.9% (IM).  
Because geriatricians had multiple specialties more often than other physicians, 
using the specialty listed for a given visit likely would have undercounted geriatrician 
visits. We assumed that physicians who are trained in GM apply their geriatric 
knowledge and experience in the care of all older patients regardless of which specialty is 
listed for a particular visit. We considered physicians with at least two visits in a year 
coded as GM to be a geriatrician for all visits by all beneficiaries in that year. All visits 
by all beneficiaries for whom data were available (n = 965,087) were used to identify 
physicians with at least two GM claims. We used two or more visits to minimize the 
possibility that the geriatrician designation was an error. Of the visits labeled as GM by 
the two or more visit measure, 90.2% were labeled as GM by the original claims data 
(i.e., the two or more visit measure did not substantially over count GM visits). In 
contrast to measurement of GM visits, FM/IM and specialist visits were classified based 
on the physician specialty listed on the Carrier claim. 
Group practices may bill under a single UPIN. Group UPINs typically have a first 
digit of W – Z [73]. However, in some cases, multiple providers may bill under a single 
physician-related UPIN. If this practice was widespread, then assigning GM to all visits 
for physicians who have two or more visits coded as GM could have introduced 
substantial measurement error (i.e., GM would have  been assigned to visits provided by 
a non-geriatrician who billed under the same UPIN as a geriatrician). A comparison of 
UPINs and NPIs in the 2007 data suggested that multiple providers billing under a single 
physician-related UPIN is not a widespread issue. Of the physician-related UPINs that 
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appeared on one or more claims in 2007 on which NPI is also listed, 96.3% were 
associated with only one NPI. Only 0.3% of UPINs were associated with more than two 
NPIs. Practice-level NPIs also exist and may be listed for the billing provider, but 
individual NPI is listed for the performing provider. 
We used several measures of geriatric care in the three studies (Table 3.1). For 
Study 1, we measured any geriatric care (≥1 visit) in six months and one year as well as 
an ordered measure of geriatric care in one year: 0, 1, 2 to 3, 4 to 6, and ≥7 visits. For 
Study 2, we used three measures of geriatric care in six months. Two measures indicated 
the dose of geriatric care: any geriatric care and 1, 2, or ≥3 visits. These measures were 
used for Study 3. A third measure indicated geriatric care as a share of all physician visits 
[72, 77]. The reference category was beneficiaries for whom FM/IM visits accounted for 
the largest number of total visits (“FM/IM plurality”). Three groups were compared to 
FM/IM plurality: (1) beneficiaries for whom geriatrician visits accounted for the largest 
number of total visits (“GM plurality”); (2) beneficiaries who had at least one geriatrician 
visit but for whom geriatrician visits was not the largest number (“GM consultation”); 
and (3) beneficiaries for whom specialist visits was the largest number (“specialist 
plurality”). 
Studies 2 and 3 measured geriatric care using a six month lag. We chose to use a 
lagged measure of visits to ensure that the geriatric care occurred prior to outcomes. The 
data showed that among those who had any geriatric care, a sizeable share of 
beneficiaries had a single visit only. We chose to use a six month window because using 
a shorter measure of geriatric care (e.g., three months) would have failed to capture many 
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of the beneficiaries who had a single geriatrician visit, while using a longer measure (e.g., 
nine months) could have hidden a true effect of geriatric care if it diminished over time.  
It is possible that six months may be too long or too brief a period of time for 
geriatric care to affect outcomes. A shorter measure of geriatric care may be more 
appropriate if one hypothesizes that the effect of physician care diminishes substantially 
over time. On the other hand, when measuring geriatrician visits as a share of total visits 
(i.e., GM plurality care and GM consultative care), having a longer time period over 
which to categorize physician use may provide a truer picture of which physician 
specialty is really driving the beneficiary’s care. We conducted sensitivity analyses for 
Study 2 regarding the measurement of geriatric care. Using the three month measures, 
sample sizes were the same as the six month measures. Using the nine month measures, 
sample sizes decreased because additional data were needed for each observation. The 
community sample size decreased from 287,259 to 249,486, while the NH sample size 
decreased from 66,551 to 61,526.  
3.4.3. Dependent variables 
 The dependent variable in Study 2 was ED use. ED use was measured using 
MedPAR claims for beneficiaries who were admitted to the hospital after the ED visit; 
for those who were not admitted to the hospital, ED use was measured in from Outpatient 
claims. In MedPAR claims, a positive ED charge indicated ED use in MedPAR claims, 
while a claim for revenue centers 0450-0459 or 0981 indicated ED use in Outpatient 
claims [78]. In Study 3, FM/IM physician visits and specialist visits were measured as the 
number of visits in six months. These visits were measured the same way as visits to 
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geriatricians (Chapter 3.4.1) were measured, except specialty for FM/IM visits and 
specialist visits was taken directly from the line item in the Carrier claim. 
3.4.4. Comorbidities 
Several options exist for measuring comorbidities in analyses of observational 
data; comorbidity measures developed by Charlson and Elixhauser are the two most 
widely used methods [79, 80]. The Elixhauser method creates individual binary 
indicators for 30 comorbid conditions, while the Charlson method creates a single 
indicator generated by 17 comorbidities. Several studies have compared the performance 
of the two methods. Studies which use inpatient data to predict mortality have concluded 
that the Elixhauser method has better predictive power than the Charlson method [81, 
82]. Additional evidence suggests when using outpatient and/or physician claims in 
addition to inpatient claims, the Elixhauser method may be a superior predictor of 
mortality, hospitalization, and physician visits [83, 84]. Another comparison of the two 
methods found that they produce similarly predictions of health care expenditures [85]. 
Based on the existing evidence, we concluded that the Elixhauser method is at least as 
good as (and likely better than) the Charlson method for predicting health care use.    
MedPAR, Outpatient, and Carrier claims were used to create indicators of the 
Elixhauser comorbidities and the geriatric comorbidities listed in Chapter 3.3. Indicators 
for the Elixhauser comorbidities were generated using software from the Healthcare Cost 
and Utilization Program [86]. This software normally includes only diagnoses that are 
unrelated to a claim’s principal diagnosis; this assumption was relaxed to allow for the 
inclusion of all comorbidities in order to capture as full a picture as possible about a 
beneficiary’s comorbidity burden. In order to prevent overestimation of geriatric 
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condition prevalence and to avoid “rule out” diagnoses, comorbidities were identified 
only if they were found in one MedPAR or two or more Outpatient or Carrier claims 
occurring more than thirty days apart [87, 88]. 
Relying only on comorbidities indicated in the claims data in a given month 
would likely undercount comorbidities that are not likely to be reversible (i.e., likely to 
still be present even when not indicated in claims data).  Our files had only up to five 
additional diagnosis codes (Medicare claims can have up to ten diagnosis codes in 
addition to the principal diagnosis), and evidence suggests that diagnoses may be 
underreported in claims data [89, 90]. In an effort to identify all comorbidities likely to 
have been present in a given month, we differentiated between comorbidities that may 
have been reversible and those that were unlikely to be reversible (e.g., depression may 
be reversible, but dementia is not). We indicated comorbidities that may have been 
reversible only in the months during which the diagnoses appeared in the claims data. 
Comorbidities that were not likely to be reversible were indicated in the month of the first 
diagnosis and for the remainder of the study period. The following comorbidities were 
treated as non-reversible: stroke, osteoporosis, dementia, urinary incontinence, hearing 
impairment, vision impairment, hypertension, diabetes, CHF, deficiency anemia, chronic 
obstructive pulmonary disease, peripheral vascular disease, hypothyroidism, valvular 
disease, diabetes with complications, tumor without metastasis, renal failure, other 
neurological disorder, rheumatoid arthritis, obesity, metastatic cancer, paralysis, 
lymphoma, liver disease, and alcohol abuse. All other comorbidities were treated as 
reversible (depression, dehydration, syncope, fracture, pressure ulcer, weight loss, failure 
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to thrive, laceration, delirium, dislocation, hypertension with complications, psychoses, 
coagulation deficiency, pulmonary circulation disorder, and blood loss anemia).  
3.4.5. Control variables 
In all three studies, metropolitan status was obtained by linking ZIP code to 
Rural-Urban Commuting Area Code [69]. Median household income was measured at the 
ZIP code level using data from the 2000 Census. ZIP code was generally derived from 
the claims files; for beneficiaries with no physician visits in a year and all beneficiaries in 
2007, ZIP code came from the Denominator file. Dual eligibility measured whether the 
beneficiary had some or all of their Medicare costs paid by the state Medicaid program 
[91]. In Studies 2 and 3, binary indicators identifying the month (for Study 3, the first 
month of the six month period) captured seasonal variation in the outcome measures and 
linear and non-linear time trends captured any changes in the outcome measures that 
occurred during the study period. 
3.4.6. Instrumental variables 
The first instrument for geriatric care measured geriatrician supply: a count of the 
number of geriatricians in the beneficiary’s home county per 10,000 residents aged 65 
and older. The second instrument measured differential distance to geriatric care: the 
difference between the distance from the beneficiary’s home ZIP code to the ZIP code of 
the nearest geriatrician and the distance from home ZIP code to the ZIP code nearest 
FM/IM physician or specialist. Physicians were eligible to be included in the data 
generating the instruments if they were clinically active, non-resident, and non-federal. 
Clinically active physicians exclude physicians with one or more of the following 
characteristics: (1) dead; (2) older than 80 years; (3) major professional activity is listed 
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as administration, medical teaching, research, inactive, temporary foreign, or other; (4) 
type of practice is listed as administration, medical teaching, research, retired, other 
medical activities, temporarily not in practice, or not active for other reasons; or (5) 
primary present employment is listed as non-patient care. Resident physicians were 
excluded since they have not finished graduate medical education, and federal physicians 
were excluded care because from those physicians is not available to the general public. 
More specifically, although the Department of Veterans Affairs employs a number of 
geriatricians, we excluded those physicians from the instruments because visits to 
physicians in a Veterans Affairs facility typically are not billed to Medicare (i.e., do not 
appear in Medicare claims data).  
FM/IM physicians and specialists were identified by primary specialty from the 
AMA data and the first current certification from the ABMS data. Geriatricians were 
identified by primary and secondary specialty from the AMA data and up to three current 
certifications from the ABMS data. We identified geriatricians differently than FM/IM 
physicians and specialists in order to be consistent with the differences in how we 
measured geriatrician visits and visits to other physicians in the claims data.  
Multiple ZIP codes are reported for most physicians in the AMA data. The ZIP 
code and corresponding county code we used for each physician were from the address 
that was most likely to be the place where the physician practices most of the time. If the 
preferred mailing address was used for all physicians, 55-60% of addresses would be 
home addresses. The “max office” procedure creates an address that is most likely to be 
the place where the physician practices most of the time (e.g., screens for cases where the 
preferred mailing address is a home and an alternate mailing address is an office). Using 
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this procedure, 86% of addresses for office-based physicians are office addresses. 
Distance was measured as the number of miles between the centroid of the beneficiary’s 
home ZIP code and the centroid of the physician ZIP code using the zipcitydistance 
function in SAS 9.1.3. 
3.4.7. NH residence 
Long-term NH dwellers are likely to have different unobservable characteristics 
than community dwellers or beneficiaries who have a brief stay in a skilled nursing 
facility (SNF) (e.g., poorer functional and cognitive status). By separating beneficiaries 
into two groups based on setting, we hoped to minimize within-group variation in 
unobserved characteristics. A beneficiary was classified as a long-term NH resident if he 
or she met the following criteria: (1) three consecutive months with at least one nursing 
NH claim; and (2) at least one of these months had no skilled nursing NH (SNF) claims. 
Place of Service codes 31 and 32, HCPCS codes 99301-99318, 99379-99380, and G0066, 
and BETOS code M4B indicated long-term nursing NH use in Carrier claims. SNF stays 
were identified using the SNF indicator code in MedPAR claims. A beneficiary was in 
the community sample until the date of death, end of study, or the first month in which he 
or she was identified as a NH resident.   
We used an alternative, less restrictive measure of NH residence for sensitivity 
analyses to determine whether the results reported in Studies 2 and 3 were sensitive to 
changes in how NH use was identified. Under the alternative definition, NH residency 
was measured on the basis of two consecutive months with at least one NH claim; there 
was no requirement about whether either or both of these months took place in a SNF or 
other NH. The number of beneficiaries in the community sample decreased by 15,177 
  
44 
 
 
(5.3%), while the number of beneficiaries in the NH sample increased by 28,762 (43.2%). 
The NH sample increased by more than the community sample decreased because many 
more beneficiaries had observations in both samples under the alternative measure of NH 
residence than under the original measure.  
3.5. Overview of data analysis 
 
The starting date for the study period of all three studies was the same (Figure 
3.2). This date was determined by the setting in which the beneficiary was diagnosed 
with the qualifying geriatric condition. If the beneficiary was in a hospital, the discharge 
date from the MedPAR record was used as the starting date. Hospital discharge date was 
used rather than admission date since the beneficiary was not at risk for the outcomes 
used in Studies 2 and 3 during the hospitalization. If the beneficiary was in a SNF, the 
starting date was the admission date in the MedPAR record for the SNF stay. If the 
beneficiary was in neither a hospital nor a SNF, the starting date was the claim “from 
date” on the Carrier or Outpatient record. In other words, the date in the Carrier record 
was used as the starting date only when it did not occur between the admission and 
discharge dates of any of the beneficiary’s MedPAR records. 
3.5.1. Use of geriatric care in non-hospital settings 
To examine the frequency and location of geriatric care as well as characteristics 
associated with the use of geriatric care, we used data from the twelve months following 
the date of diagnosis of the geriatric condition. To examine the use of geriatric care over 
time, we used data for six month periods beginning with the date of diagnosis of the 
geriatric condition and ending on the date of death or 12/31/2007. We chose six month 
periods because we felt that three months was too short a time to infer a pattern of 
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physician use, while nine months would have substantially reduced our ability to look 
across time. On average, we followed beneficiaries for four periods of six months (two 
years); for 23% of the sample, we had data for only two periods of six months (the first 
year following the geriatric diagnosis). Between diagnosis and date of death or 
12/31/2007, the 214,375 beneficiaries had 813,631 complete six month periods of data.  
3.5.2. Association of geriatric care and emergency department use  
 The unit of analysis for this study was the beneficiary-month (30 day period) 
beginning with the date of diagnosis of the geriatric condition. ED use was estimated as a 
function of geriatric care during the previous six months. Using a lagged measure ensured 
that the geriatric care occurred prior to the ED use. As discussed in Chapter 2.5, a host of 
factors may play a role in whether people choose geriatric care including health status, 
family support, referral from one’s existing provider or NH, and the costs of geriatric 
care. Since some of these factors may also affect ED use and were unobservable in 
Medicare claims data, we used linear probability models (LPMs) with individual fixed 
effects (FE) to control for time-invariant unobserved variables. 
When unobservable variables vary at or below the level of the FE, the preferred 
approach is IV regression if a valid instrument can be identified. We do not present 
results from IV regression as the preferred approach for either Study 2 or Study 3 because 
of questions regarding the validity of our instruments and the highly implausible effect 
sizes estimated by the IV models for some measures of geriatric care in Study 2. Our 
instruments are described in Chapter 3.4.6, and our IV methodology is described in 
Chapter 3.6. 
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Six months may be too long or too brief a period of time for geriatric care to 
affect outcomes, so we also measured geriatric care over three months and nine months. 
To test whether our measure of long-term NH use was overly restrictive, we used an 
alternative measure: two consecutive months with at least one NH claim. We also 
conducted the analyses for beneficiaries who had a diagnosis of dementia in the first 
month. 
3.5.3. Association between visits to geriatricians and visits to other physicians 
In Study 3, we examined visits to FM/IM physicians and specialists as a function 
of geriatric care in the previous six months. The unit of analysis was beneficiary-six 
months. We chose six months in order to balance our desire for a long follow-up period 
with the need to minimize the impact of censoring and maintain a sufficient sample size. 
We estimated ordinary least squares (OLS) models using individual FE. FE was the 
preferred specification because of our concerns about bias from self-selection of geriatric 
care and difficulties locating valid instrumental variables. For all outcomes and both 
samples, F tests of joint insignificance of the FE were rejected (p<0.000), and Hausman 
tests indicated that estimates from OLS models were inconsistent (p<0.000).  
Results from Poisson models with FE were very similar to results from OLS 
models with FE; we chose OLS as the preferred specification for ease of interpretation. 
Ideally we would have used a negative binomial model with FE, since specification tests 
suggested the presence of overdispersion (p<0.000). However, the FE negative binomial 
model in Stata did not appear to be analogous to the concept of FE that we used in the 
OLS models (i.e., FE that that uses only within-individual variation to estimate 
parameters and then averages the estimates across individuals). 
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To assess whether the relationship between geriatric care and specialist visits was 
moderated by FM/IM care, we included FM/IM visits in the previous six months as an 
explanatory variable in the model estimating specialist visits and vice versa. We 
measured physician visits during three months as an alternative to six months because of 
our concerns about censoring due to death or end of study. We used binary dependent 
variables (any FM/IM visits and any specialist visits in six months) to allow for the 
possibility that geriatric care may have affected the likelihood of having any physician 
visits rather than the number of physician visits. To test whether results were sensitive to 
measurement of geriatric care as 1, 2, or ≥3 visits, we estimated models measuring 
geriatric care as 1, 2, 3, and ≥4 visits. To test whether our measure of long-term NH use 
was overly restrictive, we used samples defined by an alternative measure: two 
consecutive months with at least one NH claim. We explored IV as an alternative to FE 
since FE do not eliminate bias if time-varying unobserved variables are related to both 
geriatric care and physician visits. We estimated IV models using two-stage residual 
inclusion (2SRI). 
3.6. Instrumental variables 
 
3.6.1. Rationale 
The theoretical justification for using measures of geriatrician supply and location 
is that geriatrician availability impacts the likelihood of using geriatric care but is 
uncorrelated with unobservable variables that affect visits to other physicians, ED use, or 
in-hospital death. Geriatrician supply is likely to be positively associated with use of 
geriatric care. A beneficiary who lives in an area with a relatively high geriatrician to 
elderly population ratio is more likely to be aware of the availability of geriatric care than 
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one who lives in an area with lower geriatrician supply. Further, higher geriatrician 
supply may lead to reduced costs for waiting to obtain an appointment. Because of their 
medical history, beneficiaries in our sample may have more physician visits and more 
problems finding transportation than elders with better health status or younger adults. 
Since their transportation costs may be higher, differential distance may negatively 
impact a beneficiary’s likelihood of using geriatric care. Having two instruments is 
helpful in a statistical sense because multiple instruments allow for a test of 
overidentification. Further, although the differential distance measure is likely to be 
correlated with geriatrician supply, differential distance is a more flexible measure 
because it ignores geographic boundaries. This is important in light of existing evidence 
that, for example, the health benefits of access to medical care in urban counties spillover 
into rural counties with close proximity to urban counties [92, 93]. 
The instruments were valid only if there is was no direct effect of geriatrician 
supply and differential distance to geriatric care on outcomes and the instruments were 
uncorrelated with unobservable variables that affect those outcomes. Physician supply 
and differential distance have been used as instruments for the receipt of cardiac care [94, 
95]. Some research suggests that primary care provider supply is correlated with area-
level health outcomes and that physician density is endogenous in models of area-level 
health [96-99]. A recent paper found a connection between area-level primary care 
physician supply and individual-level outcomes [100]. To address concerns about the 
supply instrument, we used an alternative measure of supply that measured the 
availability of geriatricians relative to other types of physicians rather than indicating the 
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actual availability of geriatricians: the ratio of county geriatrician supply to county 
FM/IM and specialist supply.  
Despite using an alternative instrument, geriatrician supply (and therefore 
distance) is highly correlated with the presence of academic medical centers, and it 
seemed implausible to us that there would be no unobserved, area-level differences in ED 
use and physician visits related to the presence of an academic medical center. To explore 
the validity of excluding the instruments from the equation of ED use, we compared two 
groups: community dwellers who lived in an area where geriatrician supply was at or 
above the median for all community dwellers, and those who lived in an area where 
supply was below the median (we did a similar comparison for the NH sample) [101]. 
This comparison suggested that the distribution of observable variables was not 
independent of geriatrician supply. For example, beneficiaries who lived in an area with 
high geriatrician supply had much higher median ZIP code income and were less likely to 
be dual eligible than beneficiaries who lived in an area with low geriatrician supply. 
Differences in observed socioeconomic status are problematic, because unobserved 
socioeconomic status may be associated with both geriatrician supply and ED use and in-
hospital death. In short, differences in observable variables between groups that were 
defined by values of the instruments suggested that the instruments were not functioning 
well as a natural experiment for geriatric care.   
3.6.2. IV estimation 
The description of IV estimation provided in the remainder of this chapter refers 
to Study 2 (we conducted a similar IV estimation for Study 3). Two-stage least squares is 
not an ideal IV estimation technique for a binary dependent variable because of well-
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known shortcomings in LPMs (e.g., assumption of constant marginal effects and 
predicted probabilities outside the 0 to 1 interval). Our main IV results for the effect of 
any GM use were generated using a recursive bivariate probit model [102]. In a recursive 
bivariate probit model, the dependent variable of one equation appears on the right-hand 
side of the other equation. The error terms from the two equations are allowed to be 
correlated. In order to compare IV estimates for the effect of any GM use with other 
measures of geriatric care, we used two-stage residual inclusion (2SRI) in which both the 
observed value of the endogenous variable and the predicted residual from the first stage 
equation are included in the second stage equation. The 2SRI approach has been used for 
several specific nonlinear models [103-105]. Terza, Basu, and Rathouz [106] show more 
generally that 2SRI is a theoretically consistent implementation of IV in non-linear  
models.  
The predicted residual was calculated as the difference between the actual value 
of the dependent variable and the predicted probability. The first stage logit model had 
one residual, while the first stage ordered logit model had three residuals because there 
were four levels of geriatric care in the ordered measure. The categorical measure of 
geriatric care was estimated via a multinomial logit, and three predicted residuals were 
calculated as differences between mutually exclusive binary variables and predicted 
probabilities. For example, the residual for GM consultative care was generated by a 
dummy variable indicating whether a beneficiary was actually in the GM consultative 
care group minus the predicted probability of being in the GM consultative care group. 
Evidence from Hausman tests of the assumption of independence of irrelevant 
alternatives in the multinomial logit model suggested that this assumption was supported 
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(p<0.05). Bias-corrected confidence intervals for changes in the predicted probability of 
the dependent variable were generated by bootstrapping 250 random samples drawn at 
the beneficiary level with replacement. Bias-corrected confidence intervals for odds 
ratios were generated using bootstrapping 250 random samples drawn at the beneficiary 
level with replacement.  
Depending on whether the measure of geriatric care was binary, ordered, or 
categorical, the first stage equation that predicted geriatric care in a six month period was 
estimated using a logit, ordered logit, or multinomial logit model with standard errors 
clustered at the beneficiary level. If a comorbidity was present in at least one month 
during the six month period, then the comorbidity was indicated for the entire six month 
period. The same procedure was used for state buy-in due to Medicaid eligibility. The 
values for the instruments and the other control variables reflect the beneficiary’s 
characteristics during the last month of the six month period. In other words, if the 
beneficiary moved during a six month period, geriatrician supply and distance, income, 
and metropolitan status would reflect the beneficiary’s location in the sixth month. About 
11.0% of beneficiaries move at least once, but only 2.6% of observations are affected 
because most people do not move multiple times. 
3.6.3. Specification tests  
The first specification test was a Hausman test of the assumption of independence 
of irrelevant alternatives that is inherent in multinomial logit models. In Study 2, one of 
the measures of geriatric care was a categorical variable, which means that one of the first 
stage models for IV was a multinomial logit. The null hypothesis of the Hausman test is 
that the odds of two outcomes are independent of ot
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results suggested that the independence of irrelevant alternatives assumption was 
supported for both the community and NH samples. When estimating ED use, the p 
values for whether each of the three outcome categories can be omitted exceed 0.05 in all 
cases for both the community and NH samples except one (specialist as the modal visit 
type, NH sample).  
Tests to assess the exogeneity of geriatrician use and the strength of the 
instrumental variables were conducted in a two-stage least squares model where both 
stages were estimated using LPMs. The predicted values of any GM use from the first 
stage was significant when included with the actual value of any GM use in the second 
stage (p<0.01 for both outcomes and both samples) This indicated that the variable any 
GM use was endogenous [107].  
A test statistic greater than 10 from an F-test to determine whether the estimated 
coefficients for the instruments in a linear model are jointly different from zero is an 
indicator that the instruments are not weak [108]. Using a LPM for the first stage 
equation predicting any GM use, the test statistics for the F-test of the two instruments 
are 116.97 (NH) and 241.58 (community), indicating that these variables are strong 
instruments. Lagrange multiplier tests of overidentification rejected the null hypothesis 
that the instruments are validly excluded from the second stage model for both samples, 
although this test does not provide information about which instrument(s) may be 
invalidly excluded from the second stage model [109].  
3.7. Alternative methodologies 
 
We considered using propensity score methods to estimate the models in Studies 
2 and 3. Propensity scores are often used as an alternative to multivariate regression 
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[110]. Several propensity score methods exist, including many variations of weighting 
and matching. The main advantage of propensity scores compared to multivariate 
regression is their non-parametric nature. However, using propensity scores does not 
address the problem of unobserved heterogeneity. Since we believe strongly that use of 
geriatric care is related to unobservable variables that also affect outcomes, we could not 
argue in favor of the assumption of ignorability and thus focused on FE and IV models. 
Propensity score methods have occasionally been combined with IV, but we did not 
pursue that route because of the concerns we had with the assumption that our 
instruments were validly excluded from the outcome models in Studies 2 and 3. 
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Figure 3.1. Sample selection criteria 
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Figure 3.2. Analysis timeline 
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Table 3.1. Study variables 
Variable Time period Study Source Type 
Dependent variables 
Any ED use 1 month 2 Claims Binary 
Number of FM/IM visits 6 months 3 Claims Count 
Number of specialist visits 6 months 3 Claims Count 
Geriatric care 
Any geriatric care 1 year, 6 months 1 Claims Binary 
1, 2-3, 4-6, ≥7 geriatrician visits 1 year 1 Claims Ordered 
Any geriatric care Prior 6 months 2 & 3 Claims Binary 
1, 2, ≥3 geriatrician visits Prior 6 months 2 & 3 Claims Ordered 
GM plurality care, GM consultative care Prior 6 months 2 Claims Categorical 
Explanatory/control variables 
Comorbidities 
1 year (Study 1),  
1 month (Study 2), and 
6 months (Study 3) 1, 2, & 3 Claims Binary 
Age 1 month 1, 2, & 3 Claims Categorical 
Gender 1 month 1, 2, & 3 Claims Binary 
Race 1 month 1, 2, & 3 Claims Binary 
Medicaid state buy-in 1 month 1, 2, & 3 Claims Binary 
ZIP code median income 1 month 1, 2, & 3 US Census  Categorical 
Metropolitan status 1 month 1, 2, & 3 Claims Categorical 
Calendar month 1 month 2 & 3 Claims Binary 
Linear and non-linear time trends 1 month 2 & 3 Claims Binary 
Instrumental variables 
Geriatrician supply in county Prior 6 months 2 & 3 AMA/ABMS Continuous 
Differential distance to geriatric care Prior 6 months 2 & 3 AMA/AMBS Continuous 
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4. STUDY 1: USE OF GERIATRIC CARE IN THE UNITED STATES 
 
4.1. Abstract 
 
Objectives: To describe the frequency and location of geriatric care; examine patient 
characteristics associated with use of geriatric care; and describe trends in the use of 
geriatric care over time. 
Design: Retrospective cohort study. 
Setting: Medicare claims data for a national sample of elderly beneficiaries with a history 
of acute coronary syndromes (ACS). 
Participants: 214,375 elderly Medicare beneficiaries who had a diagnosis of a geriatric 
syndrome or condition at least one year after hospitalization for ACS. 
Measurements: Geriatrician visits for evaluation and management services in the first 
year following diagnosis of the geriatric condition and in all six month periods following 
diagnosis until date of death or end of study period.  
Results: Geriatric care reached only 3.5% of these patients. The use of geriatric care was 
approximately evenly split between heavy users (4 or more visits in one year) and light 
users (1 to 3 visits in one year). Beneficiaries living in a metropolitan area, those with 
dementia or depression, and those who had any nursing home physician visits were 
substantially more likely to use geriatric care than other beneficiaries. Most beneficiaries 
with at least one geriatrician visit in a nursing home had the majority of their nursing 
home physician visits provided by geriatricians.  
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Conclusion: Few Medicare beneficiaries with geriatric conditions receive geriatric care. 
The potential for geriatric medicine to have a significant clinical impact on the elderly 
population is very small. Other avenues including research, teaching, and policymaking 
may be more effective uses of the limited supply of geriatricians.  
Key words: geriatrician visits, geriatric syndromes, nursing home, primary care, geriatric 
consultation 
4.2. Introduction 
The growth in the number of elderly Americans, especially those aged 85 years or 
older, is increasing pressure on the health care system in the United States. Health care 
for older adults with chronic conditions is costly and often of suboptimal quality [1]. The 
quality of health care for geriatric conditions may be considerably poorer than for other 
conditions such as diabetes or hypertension [3]. Several outpatient geriatric evaluation 
and management programs have shown favorable effects on outcomes including physical 
functioning and mental or cognitive health [15-18]. In some cases, these interventions 
have produced either cost reductions or no increase in costs [15-17, 51]. Comprehensive 
interdisciplinary geriatric care programs may be beneficial for elders with multiple 
chronic conditions, geriatric conditions, or other complex health care needs, but these 
programs are not widely available [5]. Although many elders might benefit from geriatric 
care, the current and projected future supply of geriatricians is limited [4, 35, 36]. In light 
of these supply constraints, an understanding of to whom, how frequently, and in what 
settings geriatric specialty care is provided is critical if evidence from these randomized 
controlled trials is to be translated into population-based geriatric care.  
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Although the appropriate role of geriatric care has been widely discussed in the 
literature, little is known about the actual use of geriatric care in the US population [39, 
111-115]. Existing evidence uses the geriatrician as the unit of observation; no studies 
that describe visits to geriatricians using the patient as the unit of observation were 
located. Claims data from 1998 for a nationally representative sample of Medicare 
beneficiaries show that geriatricians are substantially more likely to provide care in a 
nursing home and less likely to provide care in an office than family medicine and 
general internal medicine (FM/IM) physicians [41]. In that study, nearly 27% of geriatric 
medicine claims originated in nursing homes compared to 7% for FM/IM claims. The 
reverse was found for office visits: 72% for FM/IM compared to 47% for geriatricians. 
Unlike FM/IM physicians, geriatricians commonly provide both primary and consultative 
care. Among respondents to a survey of geriatricians whose fellowships occurred in the 
1990s, 64% reported that they engage in outpatient primary care, and 60% reported 
conducting outpatient comprehensive assessment [40]. No published study has examined 
the extent to which geriatric specialty care reaches the older patient population or in what 
settings the care is provided. 
 Using a large, longitudinal Medicare dataset of older adults who had a prior 
hospitalization for acute coronary syndromes (ACS) and subsequent diagnosis of a 
geriatric condition, our study objectives were to: 1) describe the frequency and location 
of geriatric care; 2) examine patient characteristics associated with use of geriatric care; 
and 3) describe trends in the use of geriatric care over time. In addition to the full sample, 
we conducted the analysis for two disease-specific subsamples. We chose one condition 
for which geriatricians may have substantially more training and relevant experience 
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(dementia) and one condition for which geriatric care may not necessarily be expected to 
be substantially different than care from FM/IM physicians (congestive heart failure 
(CHF)).  
4.3. Methods 
4.3.1. Sample 
We used Medicare claims data for nearly one million fee-for-service beneficiaries 
who met the following criteria (Figure 4.1): an acute care hospital stay with a diagnosis 
of ACS (ICD-9-CM codes 410.xx, 411.1x, and 413.9x) from January 2003 through 
October 2004; age > 66 years at the time of the hospital stay; and continuously enrolled 
in Medicare Parts A and B until death or 12/31/2007 (n=965,087). The initial sample of 
nearly one million beneficiaries was identified for a separate study [71]. Data from 
Medicare Provider Analysis and Review (MedPAR) (inpatient), Outpatient, Carrier 
(physician), and Denominator files were available for 2002 through 2007.  
Since geriatric care is rare, the data we used were advantageous because of the 
large initial sample size. Although ACS is not a condition for which geriatric care would 
be expected to confer benefits relative to care from other physicians, beneficiaries who 
have had ACS may have poorer functional status and overall health status than the 
general elderly population. In combination with the diagnosis of a geriatric condition, 
these people may have been particularly good candidates for geriatric care. The sample 
selection criteria were: (1) diagnosis of a geriatric condition in a setting other than a long-
stay hospital at least one year after the hospitalization for ACS (n=452,985); (2) no 
diagnosis of the same geriatric condition in the two prior years (n=340,848); and (3) a 
minimum of one year of follow-up data after diagnosis of the geriatric condition 
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(n=223,126). Of the 117,722 patients who met all criteria except a minimum of one year 
of follow-up data, 55% died within the first year following diagnosis of the geriatric 
condition. A small number of beneficiaries were lost due to missing data (most had 
missing income data because their ZIP code did not match a ZIP code tabulation area in 
the 2000 Census).  The final sample size was 214,375. The sample sizes for the disease-
specific subsamples were 44,169 (dementia) and 92,955 (CHF). 
Geriatric conditions included stroke, dementia, depression, delirium, pressure 
ulcer, fracture, dislocation, laceration, osteoporosis, syncope, hearing impairment, vision 
impairment, urinary incontinence, weight loss/failure to thrive, and dehydration (Table 
4.1). We created this list of geriatric conditions based on diagnoses used for inclusion in 
randomized controlled trials of geriatric interventions and a 2008 survey of directors of 
geriatrics academic programs which asked to what degree elders with a variety of health 
conditions or other characteristics would be likely to benefit from geriatric care [28].  
To examine the frequency and location of geriatric care as well as characteristics 
associated with the use of geriatric care, we used data from the twelve months following 
the date of diagnosis of the geriatric condition. To examine the use of geriatric care over 
time, we used data for six month periods beginning with the date of diagnosis of the 
geriatric condition and ending on the date of death or 12/31/2007. We chose six month 
periods because we felt that three months was too short a time to infer a pattern of 
physician use, while nine months would have substantially reduced our ability to look 
across time. On average, we followed beneficiaries for four periods of six months (two 
years); for 23% of the sample, we had data for only two periods of six months (the first 
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year following the geriatric diagnosis). Between diagnosis and date of death or 
12/31/2007, the 214,375 beneficiaries had 813,631 complete six month periods of data.  
4.3.2. Measures 
We measured a physician visit as all claim line items provided to an individual 
beneficiary on a given date by a single physician [6]. We used Berenson-Eggers Type of 
Service (BETOS) codes for evaluation and management services to determine location of 
the visit (Table 4.2). For evaluation and management visits with a BETOS code 
indicating a consultation rather than a specific location (M6), we used Healthcare 
Common Procedure Coding System codes to identify location.  
Physician specialty was indicated for each visit in the Carrier claims data. 
Compared to non-geriatricians, a much larger share of geriatricians were listed as having 
multiple specialties in the claims data for a single year (e.g. a physician whose specialty 
was listed as geriatric medicine for some visits and FM for others). As a result, using the 
specialty listed for a given visit would likely have undercounted geriatrician visits. We 
assume that physicians who are trained in geriatric medicine apply their knowledge and 
experience in the care of all older patients regardless of which specialty is listed for a 
particular visit. We considered physicians with at least two visits in a year coded as 
geriatric medicine to be a geriatrician for all visits by all beneficiaries in that year. 
Geriatrician specialty was identified using all available claims data (n = 965,087 
persons).  
 MedPAR, Outpatient, and Carrier claims were used to create two sets of 
comorbidities: the standard set of comorbidities created by Elixhauser and the geriatric 
conditions listed above [80]. We included comorbidities diagnosed at any time during the 
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first year after diagnosis of the geriatric condition. To prevent overestimation of 
comorbidity prevalence and to avoid “rule out” diagnoses, comorbidities were included 
only if they were found in one MedPAR claim or two or more Outpatient or Carrier 
claims more than 30 days apart [87, 88]. Gender, race, dual eligible status, and age were 
extracted from the Denominator file. Dual eligibility measured whether the beneficiary 
had some or all of their Medicare costs paid by the state Medicaid program [91]. Income 
and metropolitan status were measured using the beneficiary’s home ZIP code [69, 70]. 
ZIP codes were derived from the claims files; for beneficiaries with zero physician visits, 
ZIP code came from the Denominator file.  
4.3.3. Analytical approach 
 To examine frequency of use and location of geriatric care (objective 1), we set 
the levels of geriatrician visits a priori as 0, 1, 2 to 3, 4 to 6, and 7 or more visits in the 
year following diagnosis of the geriatric condition. We examined use of geriatric care in 
any setting as well as separately for hospital and non-hospital settings. We used Kruskal-
Wallis tests to examine how often people had geriatric care in more than one setting.  
We examined the bivariate associations of demographic variables and comorbidities with 
geriatric care using Chi-square tests for categorical variables and Mann-Whitney 
(Wilcoxon rank-sum) tests for ordinal and interval variables (objective 2). We also 
estimated a multivariate logistic regression model. To examine the use of geriatric care 
over time (objective 3), we examined summary statistics on the number of beneficiaries 
and number of periods with any geriatric care. To compare and contrast the use of 
geriatric care over time by location, we examined data beginning with the period in 
which the initial visit occurred in order to focus on the periods during which the 
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beneficiary was likely to have knowledge of and access to geriatric care. For example, if 
a beneficiary had 5 periods of data and the first geriatrician nursing home visit occurred 
during period 2, we examined geriatrician nursing home visits in periods 2 through 5. All 
analyses were performed for the full sample as well as dementia and CHF subsamples. 
All statistical analyses were performed using Stata 11.1 (StataCorp LP, College Station, 
TX). This study was approved by the institutional review board at the University of North 
Carolina at Chapel Hill.  
4.4. Results  
4.4.1. Frequency and location of geriatric care  
The vast majority (96.5%) of the 214,375 elderly Medicare enrollees included in 
the sample had no geriatrician visits in any setting during the year following diagnosis of 
the geriatric condition (Table 4.3). Approximately as many people had 1-3 geriatrician 
visits (3,784) as had 4 or more visits (3,631). More people in the study sample received 
geriatric care in non-hospital settings (2.8%) than in hospital settings (1.2%).  
The most common clinical settings of geriatric care were nursing home and 
office/outpatient. Among the 7,415 of beneficiaries with at least one geriatrician visit in 
the year, 43.3% had at least 1 visit in a nursing home, 41.2% had at least 1 visit in an 
office/outpatient setting and 33.4% had at least 1 visit in a hospital. The figures for other 
settings were substantially smaller: 2.9% (home) and 0.7% (emergency department). 
Most people (81.1%) received geriatric care in a single setting only.  
Nursing home residents (i.e., people who had at least one nursing home visit by 
any specialty) had substantially higher rates of geriatric care than persons living in 
community settings. Of the 48,449 beneficiaries who had at least one nursing home visit, 
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8.2% had geriatric care in any setting. In contrast, of the 165,926 beneficiaries who had 
zero nursing home visits, only 1.9% had geriatric care in any setting.  
People who had at least one geriatrician visit in a nursing home tended to get 
mostly geriatric care in the nursing home. Among the 3,211 people who had at least one 
geriatrician visit in a nursing home, 44.5% had geriatric care for all physician visits in the 
nursing home. An additional 25.3% had geriatric care for at least half of their nursing 
home visits. In contrast, people who had at least one geriatrician visit in an outpatient or 
hospital setting tended to get geriatric care for a minority of their physician visits in those 
settings. 
4.4.2. Patient characteristics associated with geriatric care 
Bivariate comparisons showed that geriatric care users were likely to be age 86 or 
older (OR 1.65, CI 1.57 to 1.73) and live in a ZIP code in the highest income quartile 
(OR 1.64, CI 1.56 to1.72) and less likely to reside in a rural area (OR 0.33, CI 0.28 to 
0.38) (Table 4.4). Beneficiaries who received geriatric care had more comorbidities 
(median of 8 vs. 6, p<0.01). Most comorbidities were positively associated with the use 
of geriatric care, including 12 of the 15 geriatric conditions used for sample selection.  
Gender and dual eligibility were no longer significant after adjusting for age and 
other factors, and the association between geriatric care and living in a ZIP code in the 
highest income quartile was smaller. After adjustment, all geriatric conditions used for 
sample selection were positively associated with geriatric care except hearing 
impairment, vision impairment, and dislocation. With the exception of AIDS (which was 
very rare in this sample), dementia was the variable that had the largest positive 
association with geriatric care in both the bivariate and multivariate models. 
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4.4.3. Use of geriatric care over time 
 More than half of people who used geriatric care had geriatrician visits in a single 
six month period only. Using data for all complete 6 month periods after the diagnosis of 
the geriatric condition (two to eight observations per person), 4.7% (10,076) of the 
214,375 beneficiaries had at least one geriatrician visit. Among these 10,076 
beneficiaries, close to one quarter (23.0%) had only a single geriatrician visit. An 
additional 31.5% had multiple geriatrician visits in a single six month period but no 
geriatric care in any other periods. Still, some people were heavy users of geriatric care. 
Among the 4,585 beneficiaries who had geriatric care in multiple periods, the median 
share of periods with at least one geriatrician visit was 80%. 
Geriatrician visits played a much larger role in nursing home care than in care 
delivered in other settings. Among the 4,561 beneficiaries who had at least one 
geriatrician nursing home visit, the median share of nursing home visits that were 
geriatrician visits over all periods starting with the first period that had geriatric nursing 
home care was 78.9%. Among the 3,915 beneficiaries who had at least one geriatrician 
office/outpatient visit, the median share of office/outpatient visits that were geriatrician 
visits over all periods starting with the first period that had geriatric office/outpatient care 
was 33.3%.  
4.4.4. Results from dementia and CHF subsamples  
Geriatrician use in any setting in the first year following diagnosis of the geriatric 
condition was higher among the dementia (6.7%) and CHF (4.4%) subsamples than in the 
full sample (3.5%) (Appendix Table 1). The differences in geriatrician use largely applied 
to beneficiaries who had zero nursing home visits from any specialty. In general, we 
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found only minor differences in the frequency and location of geriatric care as well as 
characteristics of geriatric care users when comparing the dementia and CHF subsamples 
to the full sample (Appendix Tables 2 and 3).  
4.5. Discussion 
Using Medicare claims data for a national sample of elderly beneficiaries with a 
prior hospitalization for ACS, this study described the frequency and location of geriatric 
care and characteristics of geriatric care users based on visits for evaluation and 
management services during one year following diagnosis of a geriatric condition. We 
found that geriatric care reached a very small share (3.5%) of Medicare beneficiaries who 
had at least one diagnosis that indicated the potential to benefit from geriatric care. The 
use of geriatric care was relatively evenly split between heavy users (4 or more visits in 
one year) and light users (1 to 3 visits in one year). More than two-thirds of people who 
had at least one geriatrician visit in a nursing home had geriatric care for the majority of 
their nursing home visits in the year. This suggests that geriatricians were largely 
functioning as primary care providers for nursing home residents while they functioned 
as both primary care and consultative care providers for patients in community settings. 
Beneficiaries with either dementia or CHF were more likely to have geriatric care than 
the full sample. An assessment of trends in the use of geriatric care over time also 
indicated a split in the use of geriatric care between heavy and light users and 
concentration of heavy use in nursing homes. Assuming beneficiaries did not have visits 
to multiple individual geriatricians, this suggests that people who received geriatric care 
in the nursing home tended to receive most of their care from a single provider while in a 
nursing home.  
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Although the use of geriatric care was rare among all people regardless of 
geographic location, our data indicate that the use of geriatric care was largely restricted 
to people who had geographic access. The reduction in odds of geriatric care associated 
with living in a rural area was equivalent to the increase in odds associated with being 
aged 86 or older. Generally speaking, geriatrician supply is concentrated in areas with 
academic medical centers which are typically located in metropolitan areas [40]. We 
repeated the analyses described in this paper to compare beneficiaries who lived in a 
county with at least one geriatrician with those who lived in a county with zero 
geriatricians and found that people with geographic access were substantially more likely 
to receive geriatric care in both hospital and non-hospital settings. Beneficiaries with 
geographic access had a higher number of geriatrician visits and were more likely to use 
geriatric care repeatedly over time than those who had at least some geriatric care but 
lacked geographic access. Policies which encourage the availability of geriatric care in 
non-metropolitan areas could help to correct this imbalance (e.g., linking academic 
medical centers that have several geriatricians on staff with physicians in other areas). 
Using claims data for elderly fee-for-service Medicare beneficiaries who survived 
at least one year after a hospitalization for ACS limits the external generalizability of our 
results. Given the potentially life-threatening nature of ACS, it is possible that cardiac 
care could have “crowded out” geriatric care. To mitigate this issue, we required a 
diagnosis of a geriatric condition at least one year after the ACS hospitalization. Further, 
use of geriatric care in the year following diagnosis of the geriatric condition was more 
common among people whose condition was diagnosed one to two years after the ACS 
hospitalization than among those whose condition was diagnosed at least two years later. 
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Higher use of geriatric care by the group whose diagnosis occurred closer in time to the 
ACS hospitalization suggests that cardiac care did not crowd out geriatric care in our 
sample; this improves confidence in the generalizability of our results. A second 
limitation is that we could not identify visits to gerontological nurse practitioners. Finally, 
it is possible that some diagnoses may have been correlated with physician specialty. 
Geriatricians may diagnose conditions such as dementia or depression more often or at an 
earlier stage than other types of physician; different diagnosis patterns could account for 
some of the differences in comorbidity prevalence between users and non-users of 
geriatric care [21].  
This investigation used patient-level data to describe the use of geriatric care in 
the United States. Our findings are consistent with existing knowledge about the limited 
use of geriatric care in the United States, particularly in non-metropolitan areas. Geriatric 
care was used by very few beneficiaries, even though everyone in the sample had 
experienced at least one condition for which geriatricians have advanced knowledge and 
training. The 96.5% of beneficiaries who had no geriatric care rely on traditional primary 
care providers and specialists. Although some physicians may have extensive experience 
dealing with geriatric conditions and other issues related to aging, many physicians do 
not. Training for FM/IM physicians and specialists may be inadequate for several 
competencies related to elderly patients, including recognition and management of 
geriatric conditions, transitional care, assessment of caregiver and family needs, and 
coordination of care [9-12]. Further, physician residencies often lack exposure to settings 
of care outside of the hospital, including nursing homes [4].  
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The rarity of geriatric care is largely due to the low supply of geriatricians, an 
issue which has been a concern for years [4, 14]. This study did not address the effects of 
geriatric care, but even if geriatric care does improve health outcomes, our results suggest 
that the impact of clinical practice at the population level is very minimal. For clinical 
geriatric care to have a sizeable effect would require an enormous increase in the supply 
of geriatricians. Recent policy changes such as a provision in the Affordable Care Act 
that temporarily increases reimbursement for primary care services provided by 
geriatricians (in addition to other primary care physicians) are unlikely to achieve this 
goal [38]. The low supply of geriatricians implies that not clinical practice but instead 
teaching, research, and advocacy/policymaking are the pathways through which geriatric 
medicine may be able to have a broad impact on the health of older adults. Therefore, 
despite the fact that the population who can receive geriatric care directly is 
geographically limited, concentration of geriatricians in academic medical centers may be 
beneficial for the purposes of advancing the field of geriatric medicine via teaching, 
research, and advocacy/policymaking. 
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Figure 4.1. Sample selection criteria 
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Table 4.1. ICD-9-CM codes used to identify geriatric conditions 
Geriatric condition ICD-9-CM codes 
Stroke 430.xx-432.xx, 434.xx-437.1x, 437.3x-438.xx 
Dementia 290.0-290.43, 294.0-294.8, 331.0-331.2, 331.7, 797 
Depression 300.4, 301.12, 309.0, 309.1, 311 
Delirium 293.0x, 293.1x 
Pressure ulcer 707.0x, 707.2x-707.9x 
Fracture 800.xx--829.xx 
Dislocation 830.xx-839.xx 
Laceration 870.xx-879.xx, 880.xx-884.xx, 890.xx-894.xx 
Osteoporosis 733.0 
Syncope 780.2 
Hearing impairment 389.xx 
Vision impairment 369.xx 
Urinary incontinence 596.51-596.52, 596.54-596.59, 599.8x, 625.6x,  
788.3, 788.30-788.34, 788.37-788.39 
Weight loss/failure to thrive 260-263.9, 783.21-783.22, 783.7x 
Dehydration 276.5 
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Table 4.2. BETOS and HCPCS codes used to identify location of physician visits 
Location BETOS HCPCS 
Office, nursing home, home M1A, M1B, M4A, M4B, 
M5A, M5B, M5C, M5D 
90652, 99201-99205, 99211-99215, 
99241-99245, 99271-99275, 99301-99318, 
99341-99350, 99379, 99380, G0066, 
G0175, G0375, G0376 
Hospital, emergency department M2A, M2B, M2C, M3 99217-99239, 99251-99255, 
99261-99263, 99281-99288 
BETOS = Berenson-Eggers Type of Service, HCPCS = Healthcare Common Procedure Coding System 
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Table 4.3. Frequency and location of geriatric care 
 during first year following diagnosis of geriatric  
condition 
Geriatrician visits People % 
All settings 
0 206,960 96.5 
1 1,833 0.9 
2-3 1,951 0.9 
4-6 1,541 0.7 
≥7 2,090 1.0 
≥1 7,415 3.5 
Office, nursing home, home 
0 208,312 97.2 
1 1,464 0.7 
2-3 1,640 0.8 
4-6 1,372 0.6 
≥7 1,587 0.7 
≥1 6,063 2.8 
Hospital, emergency department 
0 211,850 98.8 
1 816 0.4 
2-3 724 0.3 
4-6 479 0.2 
≥7 506 0.2 
≥1 2,525 1.2 
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Table 4.4. Factors associated with geriatric care in first year following diagnosis of geriatric condition 
  0 visits, % ≥1 visits, % 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
Sample 206,960 7,415   
Female 64.9 70.2 1.27** (1.21,1.34) 1.06 (1.00,1.12) 
Nonwhite 10.2 13.6 1.39** (1.30,1.48) 1.27** (1.18,1.38) 
Dual eligible 19.2 21.7 1.16** (1.10,1.23) 0.95 (0.89,1.01) 
Age   
   75 or younger 28.8 18.9 Reference  Reference  
   76-80 24.4 21.7 0.86** (0.81,0.91) 1.23** (1.14,1.32) 
   81-85 23.7 26.4 1.15** (1.09,1.21) 1.40** (1.30,1.51) 
   86 or older 23.1 33.1 1.65** (1.57,1.73) 1.65** (1.53,1.78) 
Income   
   1st quartile 25.1 18.7 Reference  Reference  
   2nd quartile 25.1 19.2 0.71** (0.67,0.75) 0.98 (0.90,1.06) 
   3rd quartile 25 27 1.11** (1.05,1.17) 1.14** (1.05,1.23) 
   4th quartile 24.8 35.1 1.64** (1.56,1.72) 1.32** (1.22,1.42) 
Metropolitan status   
   Metropolitan area 69.1 87.1 Reference  Reference  
   Micropolitan area 15.1 7.3 0.44** (0.41,0.48) 0.46** (0.42,0.51) 
   Small town 9.1 3.3 0.34** (0.30,0.39) 0.36** (0.31,0.41) 
   Rural area 6.7 2.3 0.33** (0.28,0.38) 0.35** (0.29,0.41) 
Geriatric conditions   
   Stroke 26.2 32.3 1.34** (1.28,1.41) 1.15** (1.09,1.21) 
   Dementia 19.9 39.8 2.66** (2.53,2.79) 1.95** (1.85,2.07) 
   Osteoporosis 22 25.6 1.22** (1.16,1.29) 1.32** (1.25,1.40) 
   Urinary incontinence 10.3 12.8 1.28** (1.19,1.37) 1.36** (1.27,1.46) 
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  0 visits, % ≥1 visits, % 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
   Depression 19.4 32.3 1.99** (1.89,2.09) 1.76** (1.67,1.86) 
   Dehydration 17.8 22.7 1.36** (1.28,1.44) 1.11** (1.05,1.18) 
   Hearing impairment 7.7 6.8 0.88** (0.80,0.96) 1.06 (0.96,1.16) 
   Syncope 16.9 17.6 1.05 (0.99,1.12) 1.10** (1.03,1.17) 
   Fracture 17.5 23.6 1.45** (1.38,1.54) 1.42** (1.34,1.50) 
   Pressure 4 8.6 2.26** (2.08,2.46) 1.51** (1.38,1.65) 
   Weight loss/failure to thrive 9.3 15.9 1.84** (1.73,1.96) 1.56** (1.45,1.67) 
   Vision impairment 1.7 2 1.20* (1.02,1.42) 1.17 (0.99,1.39) 
   Laceration 5.1 6.7 1.33** (1.21,1.46) 1.20** (1.09,1.32) 
   Delirium 1.6 4.1 2.60** (2.31,2.93) 1.50** (1.31,1.70) 
   Dislocation 2.6 1.6 0.59** (0.49,0.71) 0.92 (0.77,1.12) 
Comorbidities   
   Hypertension 89.3 93.1 1.63** (1.49,1.78) 1.35** (1.23,1.48) 
   CHF 42.9 55.1 1.63** (1.56,1.71) 1.26** (1.19,1.33) 
   Diabetes 39.4 41.4 1.09** (1.04,1.14) 0.97 (0.91,1.03) 
   Deficiency anemia 39.3 52.6 1.72** (1.64,1.80) 1.19** (1.13,1.26) 
   Chronic obstructive pulmonary  
   disease 34 36.4 1.11** (1.06,1.17) 1.00 (0.95,1.05) 
   Peripheral vascular disease 28.8 36.7 1.44** (1.37,1.51) 1.06* (1.01,1.12) 
   Hypothyroidism 26 29.9 1.21** (1.15,1.28) 1.03 (0.98,1.08) 
   Valvular disease 22.8 24.7 1.11** (1.05,1.17) 0.97 (0.92,1.03) 
   Other neurological 11.4 18.1 1.72** (1.62,1.83) 1.17** (1.09,1.25) 
   Diabetes, with complications 15.7 19.5 1.29** (1.22,1.37) 1.17** (1.09,1.26) 
   Renal failure 14.2 18.5 1.37** (1.29,1.45) 1.19** (1.11,1.27) 
   Tumor, no metastasis 12.4 12.4 1.00 (0.93,1.07) 1.05 (0.98,1.14) 
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  0 visits, % ≥1 visits, % 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
   Electrolyte disorder 16.3 23 1.54** (1.46,1.63) 1.12** (1.06,1.19) 
   Hypertension, with complications 20.4 21.7 1.08** (1.02,1.14) 0.85** (0.80,0.90) 
   Paralysis 1.9 3.3 1.77** (1.56,2.02) 1.33** (1.16,1.53) 
   Psychoses 7.9 15.9 2.20** (2.06,2.34) 1.21** (1.12,1.30) 
   Coagulation deficiency 5.4 6.8 1.27** (1.16,1.39) 1.04 (0.95,1.15) 
   Rheumatoid arthritis 6.3 7 1.13** (1.03,1.24) 1.08 (0.98,1.19) 
   Obesity 3.6 4 1.10 (0.98,1.24) 1.19** (1.05,1.35) 
   Pulmonary circulation disorder 3.6 4.6 1.32** (1.18,1.47) 1.15* (1.02,1.29) 
   Blood loss anemia 3.1 4 1.30** (1.16,1.47) 1.01 (0.90,1.15) 
   Metastatic cancer 1.5 1.6 1.09 (0.91,1.31) 1.08 (0.89,1.32) 
   Lymphoma 1.2 1.4 1.19 (0.98,1.45) 1.15 (0.94,1.41) 
   Liver disease 1.1 1.5 1.31** (1.08,1.59) 1.21 (1.00,1.48) 
   Alcohol abuse 0.8 1.1 1.37** (1.10,1.71) 1.22 (0.97,1.53) 
   Drug abuse 0.3 0.7 2.29** (1.71,3.07) 1.73** (1.28,2.34) 
   AIDS 0 0.1 3.18** (1.60,6.34) 2.43* (1.15,5.13) 
   Ulcer 0.2 0.2 1.31 (0.78,2.20) 1.08 (0.63,1.84) 
Constant         0.01** (0.01,0.01) 
**p<0.01, *p<0.05 
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5. STUDY 2: THE ASSOCIATION OF GERIATRIC CARE AND  
EMERGENCY DEPARTMENT USE  
 
5.1. Abstract 
 
Objective: To determine the effect of geriatric care on emergency department (ED) use. 
Data Sources: 2002-2007 Medicare claims data for a national sample of elderly 
beneficiaries with a hospitalization for acute coronary syndromes. 
Study Design: Individuals diagnosed with a geriatric condition were followed up to three 
years. Fixed effects were used to control for unobserved heterogeneity.  
Data Collection: We examined the likelihood of ED use each month. Geriatric care was 
measured with a six month lag as number of visits and share of total visits to 
geriatricians. Samples were stratified by community and long-term nursing home 
residence. 
Principal Findings: Geriatric care was associated with reductions in monthly ED use of 
7.5% to 18.8%. Reductions associated with geriatric consultative care were not 
statistically different from reductions associated with geriatric primary care. Results for 
the two samples were similar.  
Conclusions: Geriatric care appears to have protective effects on ED use among at-risk 
elders. Geriatric consultative care may be as effective at reducing ED use as geriatric 
primary care. Results are evidence of associations; causality is still uncertain. Additional 
studies are needed to examine the effect of geriatric care on additional outcomes in other 
samples and to assess whether differences exist in the effects of geriatric primary and 
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consultative care.  
Key words: geriatric care, primary care, nursing home, emergency department 
5.2. Introduction 
 
Health care for older adults with chronic conditions is costly and often of 
suboptimal quality [1, 2]. The quality of health care for geriatric conditions (e.g., 
dementia, incontinence) may be considerably poorer than for other conditions such as 
diabetes and hypertension [3]. Geriatricians may be better able to address the complex 
physical, cognitive, mental, and social issues faced by older adults who have geriatric 
conditions. Geriatricians are family medicine or general internal medicine (FM/IM) 
physicians who are certified in geriatric medicine (GM). In this paper, the term “geriatric 
care” refers to care provided by geriatricians. Processes of geriatric care include 
prevention and early recognition of acute illness, management of chronic disease and 
medications, coordination of care among multiple providers, and communication with 
caregivers [13].  
Compared to other physicians, geriatricians’ training and experience may enable 
them to provide higher quality of care for elders who have geriatric conditions. Higher 
quality of care may lead to reductions in some types of health care use such as emergency 
department (ED) use. Reductions in ED use are desirable from the perspectives of 
patients, providers, payers, and society. ED use among elders has increased substantially 
in recent years [116]. This trend is problematic in part because ED use and 
hospitalizations are linked to adverse outcomes including inappropriate medication use, 
hospital-acquired infections, and declines in functional and cognitive status [117-121].  
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Evidence related to the effects of geriatric care has been generated by randomized 
controlled trials of comprehensive geriatric assessment (CGA). CGA is a 
multidimensional, interdisciplinary process that assesses an individual’s physical, 
cognitive, mental, and social problems, aims to improve diagnostic accuracy and 
optimize drug prescribing, and develops a coordinated plan for treatment and follow-up 
[44-46]. CGAs that provide ongoing care in outpatient and in-home settings have shown 
favorable effects on physical functioning, mental, and cognitive health, although they 
may not reduce nursing home (NH) use and hospitalizations or improve survival [15-20]. 
Evidence demonstrating the efficacy of CGA without ongoing care (i.e., consultation) in 
outpatient and home settings is scarce [21-23]. No studies were found that assessed CGA 
in NHs.  
Inferring the effect of geriatric care on health care use in real-world settings is 
difficult because the level of geriatrician involvement in CGA varies widely and CGA is 
not commonly available outside of trials. A handful of analyses have tried to explicitly 
measure the effect of geriatric care using observational data [32, 56, 57]. Those studies 
used dissimilar measures of geriatric care and had limited external validity. In addition, 
they failed to control for unobservable factors that may have affected both the use of 
geriatric care and other types of health care use (e.g., marital status, health-care seeking 
behavior). When these factors cannot be measured well in secondary data, they have 
important implications for estimating the effects of geriatric care. 
This paper contributes to the literature on the effects of geriatric care by using 
data from a large national sample to examine whether geriatric care is associated with a 
reduced likelihood of ED use. We used Medicare claims data for elders who had a prior 
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hospitalization for acute coronary syndromes (ACS). Because geriatric care is rare, 
having a sample identified by ACS was advantageous because of the large initial sample 
size. Since the presence of ACS alone is unlikely to require geriatric care, we used data 
from beneficiaries with a geriatric condition which suggested that they may have been 
particularly likely to benefit from geriatric care. We hypothesized that care from 
geriatricians would lead to a reduced likelihood of ED use compared to care from FM/IM 
physicians and specialists. 
5.3. Methods 
 
5.3.1. Data and sample 
We used Medicare claims data for beneficiaries who met the following criteria: an 
acute care hospital stay with a diagnosis of ACS (ICD-9 codes 410.xx, 411.1x, and 
413.9x) from January 2003 through October 2004; age > 66 years at the time of the 
hospital stay; and continuously enrolled in Medicare Parts A and B until death or 
12/31/2007 (n=965,087). The initial sample of nearly one million beneficiaries was 
identified for a separate study [71]. Data from Medicare Provider Analysis and Review 
(MedPAR), Outpatient, Carrier, and Denominator files were available for 2002 through 
2007.  
Although ACS is not a condition for which geriatric care would be expected to 
confer benefits relative to care from other physicians, beneficiaries who have had ACS 
may have poorer functional status and overall health status than the general elderly 
population. In combination with the diagnosis of a geriatric condition, these people may 
have been particularly good candidates for geriatric care. The sample selection criteria 
were: (1) diagnosis of a geriatric condition in a setting other than a long-stay hospital at 
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least one year after the hospitalization for ACS (n=452,985), and (2) no diagnosis of the 
same condition in the two prior years (n=340,848). These criteria created a buffer 
between measurement of geriatric care and use of cardiac care around the time of the 
hospitalization and maximized the likelihood that the diagnosis represented the onset of 
the geriatric condition.  
We generated the following list of geriatric conditions from randomized 
controlled trials of CGA and a survey of directors of geriatrics academic programs which 
asked to what degree elders would be likely to benefit from geriatric care: stroke, 
dementia, depression, delirium, pressure ulcer, fractures, dislocations, lacerations, 
osteoporosis, syncope, hearing impairment, vision impairment, urinary incontinence, 
weight loss/malnutrition, dehydration, and failure to thrive [28].1 
5.3.2. Measures 
NH Residence  
Long-term NH dwellers are likely to have different unobservable characteristics 
than community dwellers or beneficiaries who have a brief stay in a skilled nursing 
facility (SNF) (e.g., poorer functional and cognitive status). By separating beneficiaries 
into two groups based on setting, we hoped to minimize within-group variation in 
unobserved characteristics. Separate analyses also allowed the effects of geriatric care to 
differ by setting. NH dwellers were identified by two criteria: three consecutive months 
with at least one NH claim per month, and at least one of those months had no SNF 
claims. Once a beneficiary met these two criteria, he/she remained in the NH sample 
                                                 
1ICD-9 codes used to identify geriatric comorbidities: 430.xx-432.xx, 434.xx-437.1x, 437.3x-438.xx, 
290.0-290.43, 294.0-294.8, 331.0-331.2, 331.7, 797, 300.4, 301.12, 309.0, 309.1, 311, 293.0x, 293.1x, 
707.0x, 707.2x-707.9x, 800.xx--829.xx, 830.xx-839.xx, 870.xx-879.xx, 880.xx-884.xx, 890.xx-894.xx, 
733.0, 780.2, 389.xx, 369.xx, 596.51-596.52, 596.54-596.59, 599.8x, 625.6x,  
788.3, 788.30-788.34, 788.37-788.39, 260-263.9, 783.21-783.22, 783.7x, and 276.5. 
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permanently. Place of Service codes 31 and 32, Healthcare Common Procedure Coding 
System (HCPCS) codes 99301-99318, 99379-99380, and G0066, and Berenson-Eggers 
Type of Service (BETOS) code M4B indicated NH residence in Carrier claims [122]. 
SNF stays were identified using the SNF indicator code in MedPAR claims.  
ED use 
We used a binary measure indicating whether the beneficiary had any ED use in a 
month. We used monthly measures of ED use to minimize bias from censoring. Revenue 
centers 0450-0459 or 0981 indicated ED use in Outpatient claims [78]. A positive ED 
charge indicated ED use in MedPAR claims. 
Geriatric care 
Using Carrier data, a physician visit was defined as all line items provided to a 
single beneficiary on a given date by a single physician [6]. Visits were identified by 
BETOS codes for evaluation and management services provided during office, home, and 
NH visits or during consultations provided in one of those settings [72]. All line items 
with BETOS codes M1A, M1B, M4A, M4B, and M6 were included unless one of the 
following HCPCS codes was present: 99221-99239, 99251-99255, 99261-99263, 99271-
99275, 99411-99412, 95115-95117, or G0175.  
Physicians were identified by a physician-related Unique Provider Identification 
Number [72, 73]. Three physician specialty groups were used: geriatricians, FM/IM 
physicians, and specialists. Visits to FM/IM physicians and specialists were classified 
based on the physician specialty listed on the Carrier claim.2 Visits to general 
                                                 
2The following specialties were included in the specialist group: addiction medicine, allergy and 
immunology, cardiology, dermatology, endocrinology, gastroenterology, gynecological oncology, 
hematology, hematology-oncology, infectious diseases, interventional radiology, medical oncology, 
nephrology, neurology, neuropsychiatry, obstetrics/gynecology, osteopathic manipulative treatment, 
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practitioners, preventive medicine physicians, nurse practitioners (NPs), and physician 
assistants (PAs) were included with FM/IM physicians. The data did not indicate NP and 
PA specialty, whether an NP or PA billed incident to a physician, or whether a NH 
resident received care from the NH medical director.  
A much larger share of geriatricians than non-geriatricians were listed as having 
multiple specialties in the claims data for a single year (e.g. a physician listed as GM for 
some visits and IM for others). Therefore, using the specialty listed for a given visit 
would likely have undercounted geriatrician visits. We considered physicians with at 
least two visits in a year coded as GM to be a geriatrician for all visits by all beneficiaries 
in that year. Since physicians self-identify their specialty when they apply to become a 
Medicare provider, geriatrician specialty does not necessary imply that a physician has 
ever been or is currently certified in GM.  
We measured geriatric care during six month periods. A shorter measure of 
geriatric care (e.g., three months) would have failed to capture many beneficiaries who 
used geriatric care very infrequently, while a longer measure (e.g., nine months) may 
have hidden a true effect of geriatric care if it diminished over time. Two measures 
indicated the dose of geriatric care: any geriatric care (“any GM”) and 1, 2, or ≥3 visits 
(“number of GM visits”). A third measure indicated geriatric care as a share of all 
physician visits. The reference category was beneficiaries for whom FM/IM visits 
accounted for the largest number of total visits (“FM/IM plurality”). Three groups were 
compared to FM/IM plurality: (1) beneficiaries for whom geriatrician visits accounted for 
the largest number of total visits (“GM plurality”); (2) beneficiaries who had at least one 
                                                                                                                                                 
physical medicine and rehabilitation, psychiatry, pulmonary disease, radiation oncology, rheumatology, 
surgical oncology, and urology. 
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geriatrician visit but for whom geriatrician visits was not the largest number (“GM 
consultation”); and (3) beneficiaries for whom specialist visits was the largest number 
(“specialist plurality”). 
Control variables 
Metropolitan status was obtained by linking ZIP code to Rural-Urban Commuting 
Area Codes [69]. Median household income was measured at the ZIP code level using 
data from the 2000 Census [70]. ZIP code was derived from claims files; for beneficiaries 
with no physician visits in a year and all beneficiaries in 2007, ZIP code came from the 
Denominator file. Dual eligibility measured whether the beneficiary had some or all of 
their Medicare costs paid by the state Medicaid program [91]. Dichotomous month 
variables captured seasonal variation in ED use, and non-linear time trends captured any 
changes in ED use that occurred during the study period. 
MedPAR, Outpatient, and Carrier claims were used to create two sets of 
comorbidities: the standard set of comorbidities introduced by Elixhauser, and the set of 
geriatric conditions listed above [80, 86]. Comorbidities were included only if they were 
found in one MedPAR or two or more Outpatient or Carrier claims occurring more than 
thirty days apart [87, 88]. Evidence suggests that diagnoses may be underreported in 
claims data [89, 90]. Therefore, comorbidities that were likely to be present even when 
not indicated in claims data were indicated in the period of the first diagnosis and for all 
subsequent periods; these were stroke, osteoporosis, dementia, urinary incontinence, 
hearing impairment, vision impairment, hypertension, diabetes, congestive heart failure, 
deficiency anemia, chronic obstructive pulmonary disease, peripheral vascular disease, 
hypothyroidism, valvular disease, diabetes with complications, tumor without metastasis, 
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renal failure, other neurological disorder, rheumatoid arthritis, obesity, metastatic cancer, 
paralysis, lymphoma, liver disease, and alcohol abuse.  
5.3.3. Statistical analysis 
 The unit of analysis for this study was the beneficiary-month (30 day period) 
beginning with the date of diagnosis of the geriatric condition. ED use was estimated as a 
function of geriatric care during the previous six months. Using a lagged measure ensured 
that the geriatric care occurred prior to the ED use. A beneficiary was in the community 
sample until death, end of study, or the first month he or she was identified as a NH 
resident. Upon entering a long-stay hospital, a beneficiary was permanently excluded 
from both samples. Sample sizes were 287,259 community dwellers (5,277,762 
observations) and 66,551 NH dwellers (1,005,122 observations). Some beneficiaries 
(n=26,875) had observations in both samples.  
A host of factors may play a role in whether people choose geriatric care 
including health status, family support, referral from one’s existing provider or NH, and 
the costs of geriatric care. Since some of these factors may also affect ED use and were 
unobservable in Medicare claims data, we used linear probability models (LPMs) with 
individual fixed effects (FE) to control for time-invariant unobserved variables. F tests of 
joint insignificance of the FE were rejected for both samples (p<0.000), and Hausman 
tests indicated that estimates from OLS models were inconsistent (p<0.000). We used 
LPMs rather than logit models because of the issue of perfect prediction. In the naïve 
(i.e., multivariate regression) models, ED use was estimated with standard errors 
clustered at the beneficiary level.  
5.3.4. Alternative specifications 
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Six months may be too long or too brief a period of time for geriatric care to 
affect outcomes, so we also measured geriatric care over three months and nine months. 
To test whether our measure of long-term NH use was overly restrictive, we used an 
alternative measure: two consecutive months with at least one NH claim. We also 
conducted the analyses for beneficiaries who had a diagnosis of dementia in the first 
month. 
We tried instrumental variable (IV) regression, since it is plausible that time-
varying unobserved variables may affect both geriatric care and ED use (e.g., functional 
status).We used a recursive bivariate probit model to estimate the effects of any geriatric 
care using IV [102]. In a recursive bivariate probit model, the dependent variable of one 
equation appears on the right-hand side of the other equation. The error terms from the 
two equations are allowed to be correlated. The instruments were county geriatrician 
supply and differential distance to geriatric care (distance from beneficiary home ZIP 
code to nearest geriatrician minus distance from home ZIP to nearest FM/IM physician or 
specialist). The data for the instruments were from an analytic file created using data 
from the American Medical Association Physician Masterfile and the American Board of 
Medical Specialties. Tests of exogeneity suggested that any geriatric care was not 
exogenous in either sample (p<0.05) [107]. F-tests indicated that the instruments were 
strong (F test statistic>10) [108]. However, we do not present IV results as the preferred 
approach because of questions regarding the validity of the instruments. Lagrange 
Multiplier tests of overidentification rejected the null hypothesis that the instruments 
were jointly validly excluded from models of ED use. Correlation between control 
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variables and instruments also suggested that the instruments may not have been validly 
excluded.  
5.4. Results 
 
5.4.1. Descriptive statistics  
ED use was observed for a median of seventeen months for beneficiaries in the 
community sample and fourteen months for those in the NH sample. The majorities of 
both samples were female, white, and at least 80 years old in the first month of 
observation (Table 5.1). NH dwellers had a median of six comorbidities compared to four 
for community dwellers. The comorbidity with the largest difference in prevalence 
between the two samples was dementia: 44.3% (NH) compared to 13.2% (community) 
(Appendix Table 4).   
Geriatric care was uncommon in either sample, although it was much more 
frequent in the NH sample (5.2% of NH observations vs. 1.4% of community 
observations). Nearly 60% of observations with geriatric care for NH dwellers were for 
≥3 visits compared to 42.9% for community dwellers. GM plurality and GM consultation 
were approximately equal in both samples. More beneficiaries in the NH sample had any 
geriatric care during at least one observation in the study period than in the community 
sample (8.4% vs. 2.7%).  
The monthly rate of ED use was somewhat lower among community dwellers 
(8.0% community vs. 9.6% NH). The majority of each sample had at least one ED visit 
during the study period (60.2% community vs. 65.8% NH).  
5.4.2. Main results 
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Results from the naïve models showed that geriatric care was associated with 
reductions in the predicted probability of monthly ED use for both samples (Table 5.2). 
In naïve models, measures of geriatric care that indicated heavier use (2 visits, ≥3 visits, 
GM plurality) were generally more often statistically significant than measures that 
indicated lighter use (any geriatric care, 1 visit, GM consultation).  
FE models suggest that geriatric care had a significant negative association with 
ED use for both samples. The reductions in ED use associated with the various measures 
of geriatric care were similar across the two samples. Compared to results from the naïve 
models, FE results showed a larger favorable association for any geriatric care. For 
community residents, the reduction in ED use of 0.9 percentage points associated with 
any geriatric care represented an 11.3% decrease from the average monthly ED use of 
0.080 (Figure 5.1). The naïve model predicted a 5.0% decrease (0.4 percentage points). 
For NH residents, the reduction in ED use of 1.1 percentage points associated with any 
geriatric care represented an 11.5% decrease from the average monthly ED use of 0.096, 
compared to 8.3% for the naïve model. The largest reduction in the likelihood of ED use 
was associated with ≥3 visits, but those effects were not significantly different from the 
effects of 2 visits for either sample.  
GM plurality was significantly associated with a reduction in ED use compared to 
FM/IM plurality. The effect sizes were reductions of 10.0% (0.8 percentage points) for 
community dwellers and 9.4% (0.9 percentage points) for NH dwellers. The effects of 
GM consultative care were slightly larger than but not statistically different from GM 
plurality in both samples.  
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For both samples, the associations of geriatric care with ED use were at least as 
large (absolute value) as the coefficient estimates of many of the demographic 
characteristics such as age and metropolitan status (Appendix Table 5). Several of the 
comorbidities had larger associations with ED use than did geriatric care.  
5.4.3. Alternative specifications 
Results from three (nine) month measures of geriatric care suggested slightly 
smaller (larger) reductions in ED use compared to results from six month measures; 
interpretation of those results was the same as above. Using samples defined by the 
alternative measure of NH residence led to estimates that were very similar to the original 
estimates. Results for beneficiaries with dementia were also very similar in magnitude to 
the original estimates, although in some cases they were not statistically significant 
(likely due to a lack of statistical power, since the dementia subsamples were 
substantially smaller than the full samples). 
Reductions in the predicted probability of ED use from any geriatric care 
estimated by IV models were statistically significant and were several times larger than 
reductions in ED use estimated by FE models: 7.4 (IV) versus 0.9 (FE) percentage points 
for community dwellers and 11.7 (IV) versus 1.1 (FE) percentage points for NH dwellers. 
IV results apply to the marginal subpopulation only (i.e., the local average treatment 
effect) [123]. This group was beneficiaries who would have received geriatric care solely 
because it is plentiful in their local area; they may not be generalizable to those who 
intentionally seek geriatric care. If ED use for the marginal subpopulation was anything 
close to the rates for the full samples (8.0% community, 9.6% NH), then the estimated 
effects of 7.4 (community) and 11.7 percentage points (NH) would be implausibly large. 
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IV and FE models estimated using data for beneficiaries who were living in county with 
at least one geriatrician produced results that were very similar to those from the full 
sample. Because we found evidence that the instruments were not validly excluded from 
the model of ED use, we chose FE as the preferred specification. 
5.5. Discussion 
 
Using claims data for elderly Medicare beneficiaries who had a history of ACS 
and a subsequent diagnosis of a geriatric condition, we found that geriatric care was used 
rarely but occurred much more often among NH dwellers than community dwellers. 
Reductions in ED use were seen for a variety of measures of geriatric care for both 
samples. Predicted reductions in monthly ED use were small in an absolute sense (0.6 to 
1.8 percentage points) but large in a relative sense (7.5% to 18.8%). GM consultation was 
found to be as effective as GM plurality for both samples.  
Particular contributions of this study to the literature on the effects of geriatric 
care are threefold: (1) a large, geographically diverse sample; (2) a variety of measures of 
geriatric care in community and NH settings; and (3) reduction in bias from unobservable 
variables that may have affected both ED use and selection into geriatric care. However, 
the present study has some limitations. The results of this analysis cannot be generalized 
to beneficiaries without a history of ACS and geriatric conditions nor to those enrolled in 
Medicare managed care. The claims data lacked a number of variables that would have 
been useful (e.g., family support, detailed measures of functional and cognitive status). It 
is possible that time-varying unobserved variables were related to the use of geriatric care 
as well as ED use, so our results must be interpreted as evidence of an association rather 
than evidence of a causal link.  
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Measurement of physician specialty is a key issue in this analysis. Physician 
specialty was self-designated, and we considered physicians with at least two visits in a 
year coded as GM to be a geriatrician for all visits in that year. As a result, we many have 
misclassified some visits to non-geriatricians as geriatric care and vice versa. In addition, 
some FM/IM physicians have extensive experience working with elders with geriatric 
conditions. If we could compare only geriatricians with active certification in GM to 
physicians without extensive experience working with patients with geriatric conditions, 
we might find an even larger reduction in ED use associated with geriatric care (i.e., the 
results we present may be a lower bound of the association of geriatric care with ED use). 
More generally, the mechanisms by which geriatric care may reduce ED use are not clear. 
Existing evidence on the processes of geriatric care is very limited [32, 53]. We could not 
discern which aspect(s) of geriatric care were responsible for the negative association 
with ED use. 
Differences in estimates between naïve and FE models suggested the presence of 
unobserved variables affecting both the use of geriatric care and ED use. One key 
variable is health status. If declining health status leads to use of geriatric care, then 
patients who use geriatric care may be less healthy in ways that are unobservable in 
claims data than patients who do not (e.g., difficulty with activities of daily living). On 
the other hand, geriatricians may be more likely than other physicians to diagnose 
geriatric conditions such as dementia [21]. If geriatricians make a diagnosis at an earlier 
stage in the progression of a condition than non-geriatricians, patients who use geriatric 
care may be healthier in unobservable ways than those who do not. Therefore, the 
expected direction of the bias from unobservable variables in the estimation of the effect 
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of geriatric care on ED use was unclear. We found that decreases in ED use associated 
with geriatric care were generally substantially larger when estimated by FE models than 
when estimated by naïve models. In other words, the naïve estimates were biased upward 
(toward zero) by time-invariant unobservable variables. It may be that the FE effects 
were larger in part because beneficiaries who visited geriatricians had poorer unmeasured 
health status than other beneficiaries (assuming that poorer unmeasured health status was 
also related to higher ED use). Although FE could not control for changes in health status 
during the study period, FE accounted for unmeasured health status at baseline.  
In this study, we found that although geriatric care is rarely used, it may be 
effective in reducing ED use. This suggests that increasing the supply of geriatricians 
may lead to improved health outcomes for elderly Medicare beneficiaries with geriatric 
conditions. Low geriatrician supply in the United States has been a concern for years [4, 
14]. An estimated 36,000 geriatricians will be needed to maintain the current geriatrician 
to elderly population ratio in 2030, yet current graduation rates from geriatrics fellowship 
programs suggest that there will be 7,750 geriatricians in 2030 [35, 36]. One factor 
affecting geriatrician supply is remuneration. Geriatricians train at least one additional 
year but are typically paid less than FM/IM physicians [124, 125].  
In the Patient Protection and Affordable Care Act, geriatricians were included in 
the list of primary care providers who are eligible for a 10% incentive payment from 
Medicare for primary care services provided from 2011 to 2015 [38]. However, this 
short-term change in reimbursement is not likely to have a meaningful effect on the 
supply of geriatricians. Further, Medicare reimbursement for physician visits is based on 
the time and effort it takes to see an “average” patient, yet geriatricians’ patients tend to 
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face disproportionately complex physical, cognitive, mental, and social health issues [4, 
126]. Permanently increasing reimbursement for visits by patients with complex issues 
could induce more FM/IM physicians to pursue a certification in GM. Specific options 
might include expanding reimbursement for case management and coordination of care 
outside of the face-to-face visit. Expanding the role of midlevel providers (e.g., 
gerontological NPs) may help to address the shortage of geriatricians [4]. Incentive 
payments could be broadened to include NPs and PAs specializing in geriatrics and 
primary care. 
Effects of policy changes on the supply of geriatricians are not likely to occur in 
the short-term (if they occur at all). Therefore, the leading policy implication of this study 
may not be increasing the number of geriatricians but rather impacting the use of the 
existing supply of geriatricians. Results from naïve models suggested that compared to 
FM/IM plurality, GM plurality reduced the predicted probability of ED use by both 
samples, while GM consultation had no effect. These findings support conclusions from 
existing literature which suggest that geriatric interventions that provide primary care are 
substantially more effective than those that provide consultative care. FE results did not 
support the same conclusions. The reduction in ED use associated with GM consultation 
was not different from the reduction in ED use associated with GM plurality (which in 
some cases may suggest the provision of primary care by geriatricians).  
Approximately half of observations in both of our samples had geriatric care for a 
plurality of visits and half had geriatric consultative care. Most geriatricians report 
regularly providing both primary and consultative care [40]. If geriatric care is as 
effective in a consultative role as in a primary care role, then more patients could benefit 
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from the existing supply of geriatricians by increasing the amount of geriatric care 
provided on a consultative basis. Increasing reimbursement for consultations, for 
interdisciplinary teams, or for activities related to consultations (e.g., communication 
between the geriatrician providing the consultation and the primary care physician) might 
encourage geriatricians to increase their role as consultative care providers. Among the 
list of payment and delivery reform models to be given priority by the Center for 
Medicare and Medicaid Innovation at the Centers for Medicare and Medicaid Services is 
the use of geriatric assessments [127]. 
In our study, geriatric care was provided much more commonly to NH residents 
than to community residents. Most FM/IM physicians provide little or no NH care, while 
geriatricians often provide NH care [40, 41, 128]. FM/IM physicians who provide care to 
NH patients may have more experience treating patients with geriatric conditions and 
related issues than other FM/IM physicians. Therefore, one might expect that any 
differences in outcomes as a function of FM/IM physician care versus geriatric care in the 
community sample would be larger than differences in outcomes between FM/IM 
physician care and geriatric care in the NH sample. Yet our results suggest that the 
reduction in ED use associated with geriatric care was very similar for the two samples 
(after taking into account the slightly higher rate of ED use in the NH sample). Further 
examination of whether outcomes differ for NH residents on the basis of physician 
specialty is warranted, especially because the issue has not been addressed by 
randomized controlled trials. Low reimbursement may play a role in the difficulty of 
attracting FM/IM physicians to NH care [129]. Increases in reimbursement for NH care 
may induce more FM/IM physicians to “follow” their patients into NHs (a practice which 
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is uncommon now) [33]. The provision of NH care by more FM/IM physicians might 
allow geriatricians more time to provide consultative care for both NH and community 
residents.  
This paper complements the literature on geriatric interventions by assessing the 
effect of geriatric care on ED use among community and NH residents. The results of this 
analysis offer an important contribution to a larger assessment of the role of geriatricians 
and effective models of care for elders with geriatric conditions and suggest directions for 
future research. Studies should continue to examine whether differences exist in the 
effects of geriatric primary and consultative care as well as whether the effects of 
geriatric care vary based on setting of care. More generally, researchers need to analyze 
the effect of geriatric care in other samples and on other outcomes such as quality of life, 
functional status, and health care expenditures. Given the increased constraints on 
geriatrician supply in the near term as the elderly population continues to grow, 
additional research is needed to ensure that elders with geriatric conditions receive high 
quality care.  
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Figure 5.1. Percent change in likelihood of ED use in one month associated with geriatric care 
95% confidence intervals shown.  
Percent change calculated as change in predicted probability of ED use (Table 5.2) divided by the sample mean of  ED use (Table 5
for the community sample, 11.3% for any geriatric care reflects a decrease of 0.9 percentage points relative to the sample av
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Table 5.1. Descriptive statistics 
  
Comm.      
First month  
NH**             
First month      
Comm.      
All months  
NH**             
All months 
Observations 287,259 66,551 Observations 5,277,762 1,005,122 
   
Demographic characteristics Geriatric care during previous 6 months  
Age Any geriatric care 0.014 0.052 
   66-74 0.231 0.108   
   75-79 0.235 0.156 Number of geriatrician visits   
   80-84 0.245 0.242     0 visits 0.986 0.948 
   85-89 0.178 0.255     1 visit 0.005 0.012 
   90+ 0.111 0.238     2 visits 0.003 0.009 
Male 0.378 0.286     ≥3 visits 0.006 0.031 
Nonwhite 0.103 0.116   
Dual eligible 0.171 0.350 Physician use   
ZIP median income $42,704  $43,987      GM plurality 0.007 0.025 
Metropolitan status     GM consultation 0.007 0.027 
   Metropolitan area 0.686 0.731     Specialist plurality 0.304 0.100 
   Micropolitan area 0.153 0.130     FM/IM plurality 0.682 0.848 
   Small town 0.092 0.083   
   Rural area 0.069 0.056 Dependent variable   
Comorbidities, median 4 6 Any ED use in 1 month 0.080 0.096 
**Differences between samples are statistically significant at p<0.01 for all variables. 
Month indicators, time trends, and comorbidities omitted. 
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Table 5.2. Change in predicted probability of ED use in one month  
Sample Comm. Comm. NH NH 
Model Logit LPM Logit LPM 
FE? No Yes No Yes 
Geriatric care in previous 6 months 
Any geriatric care 
(reference: 0 visits) -0.004** -0.009** -0.008** -0.011** 
(-0.006, -0.001) (-0.012,-0.006) (-0.011, -0.004) (-0.016,-0.007) 
 
Number of geriatrician visits 
(reference: 0 visits) 
   1 visit 0.000 -0.006** 0.002 -0.004 
(-0.004, 0.004) (-0.010,-0.001) (-0.005, 0.008) (-0.010,0.003) 
   2 visits -0.008** -0.012** -0.004 -0.012** 
(-0.013, -0.004) (-0.017,-0.007) (-0.011, 0.003) (-0.019,-0.005) 
   ≥3 visits -0.004** -0.013** -0.012** -0.018** 
(-0.008, -0.001) (-0.018,-0.008) (-0.016, -0.009) (-0.024,-0.012) 
   
Physician use 
(reference: FM/IM plurality) 
   GM plurality -0.009** -0.008** -0.011** -0.009** 
(-0.012, -0.005) (-0.012,-0.003) (-0.015, -0.007) (-0.015, -0.002) 
   GM consultation -0.001 -0.009** -0.003 -0.009** 
(-0.004, 0.002) (-0.013,-0.006) (-0.008, 0.001) (-0.006, -0.011) 
   Specialist plurality -0.003** 0.001 0.007** -0.010** 
(-0.004, -0.002) (-0.000,0.001) (0.005, 0.009) (-0.015, -0.005) 
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Sample Comm. Comm. NH NH 
Model Logit LPM Logit LPM 
FE? No Yes No Yes 
Control variables 
Age (omitted: 66-74) 
    75-79 -0.001* -0.001 -0.006** -0.003 
(-0.001, -0.000) (-0.003,0.000) (-0.008, -0.003) (-0.010,0.003) 
    80-84 0.002** 0.000 -0.008** -0.006 
(0.001, 0.003) (-0.003,0.002) (-0.009, -0.004) (-0.014,0.002) 
    85-89 0.005** 0.001 -0.009** -0.004 
(0.004, 0.006) (-0.002,0.004) (-0.010, -0.007) (-0.013,0.006) 
    90+ 0.010** 0.007** -0.010** 0.002 
(0.008, 0.011) (0.003,0.011) (-0.011, -0.006) (-0.009,0.013) 
Male -0.002** N/A 0.008** N/A 
(-0.003, -0.002) (0.007, 0.010) 
Nonwhite 0.003** N/A -0.004* N/A 
(0.002, 0.004) (-0.007, -0.002) 
Dual eligible 0.016** -0.003* -0.005** -0.010** 
(0.014, 0.016) (-0.006,-0.001) (-0.006, -0.004) (-0.014,-0.007) 
ZIP income quartile (omitted: First quartile) 
    Second 0.001 -0.007** -0.003 -0.014** 
(0.000, 0.001) (-0.011,-0.003) (-0.005, -0.001) (-0.022,-0.006) 
    Third -0.001 -0.011** -0.006** -0.019** 
(-0.002, -0.000) (-0.015,-0.007) (-0.007, -0.005) (-0.027,-0.011) 
    Fourth -0.005** -0.020** -0.010** -0.039** 
(-0.006, -0.005) (-0.024,-0.015) (-0.012, -0.009) (-0.048,-0.030) 
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Sample Comm. Comm. NH NH 
Model Logit LPM Logit LPM 
FE? No Yes No Yes 
Metropolitan status (omitted: Metropolitan area) 
    Micropolitan area 0.014** 0.001 0.010** -0.003 
(0.014, 0.015) (-0.003,0.006) (0.009, 0.012) (-0.015,0.009) 
    Small town 0.022** 0.007* 0.022** -0.001 
(0.021, 0.024) (0.001,0.012) (0.019, 0.023) (-0.014,0.013) 
    Rural area 0.018** 0.008* 0.019** 0.002 
(0.017, 0.019) (0.001,0.014) (0.017, 0.023) (-0.014,0.017) 
Observations 5,277,762 5,277,762 1,005,122 1,005,122 
** p<0.01, * p<0.05 
95% confidence intervals in parentheses.  
Month indicators, time trends, and comorbidities omitted. 
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6. STUDY 3: IS GERIATRIC CARE A SUBSTITUTE OR COMPLEMENT  
FOR OTHER PHYSICIAN CARE?  
 
6.1. Abstract 
 
Background: Whether geriatric care is typically used in conjunction with or in lieu of 
visits to family medicine/general internal medicine (FM/IM) physicians or specialists is 
unknown. 
Objectives: Using data on physician visits for evaluation and management services 
provided in non-hospital settings, we examined the relationship between visits to 
geriatricians and visits to FM/IM physicians or specialists. 
Research Design: We conducted a retrospective cohort analysis using 2002-2007 
Medicare claims data for elderly beneficiaries who had a hospitalization for acute 
coronary syndromes and subsequent diagnosis of a geriatric condition. Analyses were 
stratified by community and long-term nursing home (NH) residence.  
Measures: We measured any geriatric care and number of geriatrician visits during six 
month periods and FM/IM and specialist visits in the following six months.  
Results: Measures of geriatric care were associated with reductions in FM/IM care of 
8.8% to 19.4%. The relative magnitude of the reduction in specialist visits associated 
with geriatric care was smaller than the reduction in FM/IM visits. Relative reductions in 
specialist visits were larger at lower levels of geriatric care for community dwellers and 
at higher levels of geriatric care for NH dwellers.  
Conclusions: Geriatric care was associated with reduced FM/IM care and in some cases 
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with reduced specialty care. Results are evidence of associations; causality is still 
uncertain. In light of increased constraints on geriatrician supply in the near term due to 
the substantial increase in the elderly population, future studies should determine the 
circumstances under which substitution of geriatric care for FM/IM care or specialty care 
is most effective. 
Key words: geriatric care, primary care, specialty care 
6.2. Introduction 
 
In a traditional arrangement, a family medicine/general practice or general 
internal medicine (FM/IM) physician provides the majority of a patient’s care, and 
specialists play a complementary role. About 15% of older adults replace traditional 
primary care with care from specialists [6]. People who develop geriatric syndromes 
(e.g., dementia, falls), functional limitations, or other geriatric conditions that reduce their 
quality of life may seek geriatric care or may be referred to geriatric care by an existing 
provider. Geriatricians are FM/IM physicians who are certified in geriatric medicine. 
Geriatricians have extensive training in and experience with physical, mental, and 
social issues related to aging [13]. FM/IM and other physicians (e.g., geriatric 
psychiatrists and neurologists) may have extensive experience working with elders. 
However, these physicians are not likely to be equipped to assess and address the full 
range of issues related to aging that elders with geriatric conditions may face. 
Geriatricians can replace a traditional primary care provider, or they can provide 
consultation for a host of specific issues (e.g., cognitive impairment) that are 
complementary to primary care from FM/IM physicians. Some evidence suggests that 
primary care and specialty care are substitutes [130, 131]. However, because most 
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geriatricians regularly provide both primary and consultative care, geriatric medicine is 
unique [40]. The relationship between geriatric care and visits to FM/IM physicians and 
specialists has not been addressed in the literature. In light of the substantial increase in 
the elderly population in the near-term combined with stagnant geriatrician supply, 
understanding how geriatric care is presently being used is important [4]. We 
hypothesized that geriatric care is a substitute for FM/IM care but had no a priori 
hypothesis about the relationship between visits to geriatricians and specialists.  
We used Medicare claims data for elders who had a hospitalization for acute 
coronary syndromes (ACS). Because geriatric care is rare, having a sample identified by 
ACS was advantageous because of the large initial sample size. Yet since the presence of 
ACS alone is unlikely to require geriatric care, we selected a sample that had a geriatric 
condition. We conducted separate analyses for community and long-term nursing home 
(NH) dwellers. NH residence is a signal of functional dependence and other complex 
issues that cannot be measured well using claims data. Patterns of physician use may be 
different in the two settings because of physician visit regulations for NH residents. The 
Centers for Medicare and Medicare Services (CMS) requires a physician visit for an 
initial assessment followed by routine evaluations for every 30 days for the first 90 days 
and every 60 days thereafter; every other visit can be provided by a physician extender 
(e.g., nurse practitioner) [33]. Reassessments are required promptly after a significant 
change in the resident’s condition.  
Limited existing data describe physician care for NH residents. A majority of NH 
residents are treated by a physician other than the physician who provided their primary 
care prior to NH entry; in some cases, this physician is the NH medical director [33, 129, 
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132]. No existing data describe the use of specialty or consultative care in NHs. Based on 
the assumption that NH residents and their families prefer to have a single physician 
provide as much of the patient’s care as possible, we hypothesized that geriatric care is 
negatively associated with both FM/IM care and specialist care for NH residents. 
6.3. Methods 
 
6.3.1. Data and sample 
We used Medicare claims data for beneficiaries who met the following criteria: 
(1) an acute care hospital stay with a diagnosis of ACS from January 2003 through 
October 2004 (Table 6.1); (2) age > 66 years at the time of the hospital stay; and (3) 
continuously enrolled in Medicare Parts A and B until death or 12/31/2007 (n=965,087) 
[71]. Data from Medicare Provider Analysis and Review (MedPAR), Outpatient, Carrier, 
and Denominator files were available for 2002 through 2007.  
Since the presence of ACS alone is unlikely to suggest a potential to benefit from 
geriatric care, we used two additional sample selection criteria: (4) diagnosis of a 
geriatric condition in a setting other than a long-stay hospital at least one year after the 
hospitalization for ACS (n=452,985), and (5) no diagnosis of the same condition in the 
two prior years (n=340,848). These criteria created a buffer between measurement of 
geriatric care and use of cardiac care around the time of the hospitalization and 
maximized the likelihood that the diagnosis represented the onset of the condition. 
Geriatric conditions included stroke, dementia, depression, delirium, pressure 
ulcer, fracture, dislocation, laceration, osteoporosis, syncope, hearing impairment, vision 
impairment, urinary incontinence, weight loss/failure to thrive, and dehydration. We 
created this list of geriatric conditions based on diagnoses used for inclusion in 
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randomized controlled trials of geriatric interventions and a 2008 survey of directors of 
geriatrics academic programs which asked to what degree elders with a variety of health 
conditions or other characteristics would be likely to benefit from geriatric care [28]. 
6.3.2. Measures 
NH residence 
We measured long-term NH residence by two criteria: (1) three consecutive 
months with at least one nursing NH claim; and (2) at least one of these months had no 
skilled nursing NH (SNF) claims. Once a beneficiary met these two criteria, he/she 
remained in the NH sample permanently.  
Physician visits 
Using data from the Carrier files, a physician visit was defined as all line items 
provided to a single beneficiary on a given date by a single physician [6]. Physicians 
were identified using the Unique Provider Identification Number. Visits were identified 
using Berenson-Eggers Type of Service codes for evaluation and management services 
provided during office, home, and NH visits as well as consultations [72]. Three specialty 
groups were used: geriatricians, FM/IM physicians, and specialists. 
FM/IM and specialist visits 
The dependent variables in this study were visits to FM/IM physicians and 
specialists in six months (we refer to the two dependent variables jointly as “physician 
visits”). Physician visits were categorized based on the physician specialty listed on the 
Carrier claim.  
Geriatric care 
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We used two measures of geriatrician visits during a six month period: any 
geriatric care and 1, 2, or ≥3 visits. A much larger share of geriatricians than non-
geriatricians were listed as having multiple specialties in the claims data for a single year 
(e.g. a physician listed as geriatric medicine for some visits and FM for others). As a 
result, using the specialty listed for a given visit would likely have undercounted 
geriatrician visits. We considered physicians with at least two visits in a year coded as 
geriatric medicine to be a geriatrician for all visits by all beneficiaries in that year.  
Control variables 
Metropolitan status was obtained by linking ZIP code to Rural-Urban Commuting 
Areas [69]. Median household income was measured at the ZIP code level using data 
from the 2000 Census [70]. ZIP code was derived from claims files; for beneficiaries 
with no physician visits in a year and all beneficiaries in 2007, ZIP code came from the 
Denominator file. Dual eligibility measured whether the beneficiary had some or all of 
their Medicare costs paid by the state Medicaid program [91]. Dichotomous month 
variables captured seasonal variation in physician use, and non-linear time trends 
captured any changes in physician use that occurred during the study period. 
We created two sets of comorbidities: comorbidities defined by Elixhauser, and 
geriatric conditions listed above [80, 86-88]. Diagnoses may be underreported in claims 
data [89, 90]. Therefore, comorbidities that were likely to be present even when not 
indicated in claims data were indicated in the period of the first diagnosis and for all 
subsequent periods; these were stroke, osteoporosis, dementia, urinary incontinence, 
hearing impairment, vision impairment, hypertension, diabetes, congestive heart failure, 
deficiency anemia, chronic obstructive pulmonary disease, peripheral vascular disease, 
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hypothyroidism, valvular disease, diabetes with complications, tumor without metastasis, 
renal failure, other neurological disorder, rheumatoid arthritis, obesity, metastatic cancer, 
paralysis, lymphoma, liver disease, and alcohol abuse.  
6.3.3. Statistical analysis 
The unit of analysis for this study was beneficiary-six months beginning with the 
date of diagnosis of the geriatric condition. We chose six months in order to balance our 
desire for a long follow-up period with the need to minimize the impact of censoring and 
maintain a sufficient sample size. Physician visits were estimated as a function of 
geriatric care during the previous six months. Using a lagged measure ensured that the 
geriatric care occurred prior to the physician visits. A beneficiary was in the community 
sample until the date of death, end of study, or the first month in which he or she was 
identified as a NH resident. Upon entering a long-stay hospital, a beneficiary was 
excluded from both samples for the remainder of the study. The sample sizes were 
287,259 community dwellers (1,006,879 observations) and 66,551 NH dwellers (195,433 
observations).  
We estimated ordinary least squares (OLS) models using fixed effects (FE) at the 
individual level and compare those results to results from multivariate logistic regression 
models. We chose FE because unobserved variables may affect both use of geriatric care 
and other physician care (e.g., social support), and we had difficulties locating valid 
instrumental variables (IVs). We found evidence in favor of FE for both outcomes and 
both samples: F tests of joint insignificance of the FE were rejected (p<0.000), and 
Hausman tests indicated that estimates from OLS models were inconsistent (p<0.000) 
[133]. Since results from Poisson models with FE were very similar to results from OLS 
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models with FE, we chose OLS as the preferred specification for ease of interpretation 
(Appendix Tables 10 and 11).  
6.3.4. Alternative specifications 
To assess whether the relationship between geriatric care and specialist visits was 
moderated by FM/IM care, we included FM/IM visits in the previous six months as an 
explanatory variable in the model estimating specialist visits and vice versa. We 
measured physician visits during six months because of our concerns about censoring due 
to death or end of study. We used binary dependent variables (any FM/IM visits and any 
specialist visits in six months) to allow for the possibility that geriatric care may have 
affected the likelihood of having any physician visits rather than the number of physician 
visits. To test whether results were sensitive to measurement of geriatric care as 1, 2, or 
≥3 visits, we estimated models measuring geriatric care as 1, 2, 3, and ≥4 visits. To test 
whether our measure of long-term NH use was overly restrictive, we used samples 
defined by an alternative measure: two consecutive months with at least one NH claim.  
We explored IV as an alternative to FE since FE do not eliminate bias if time-
varying unobserved variables are related to both geriatric care and physician visits. We 
estimated IV models using two-stage residual inclusion (2SRI) [106]. In 2SRI, both the 
observed value of any geriatric care and the predicted residual from logit model of any 
geriatric care were included in the OLS model of physician visits. Instruments were 
county geriatrician supply and differential distance to geriatric care (distance from 
beneficiary home ZIP code to nearest geriatrician minus distance from home ZIP to 
nearest FM/IM physician or specialist). Data for the instruments came from an analytic 
file created using data from the American Medical Association Physician Masterfile and 
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the American Board of Medical Specialties. Tests of exogeneity suggested that any 
geriatric care was not exogenous in either sample (p<0.05) [107]. F-tests indicated that 
the instruments were strong (F test statistic>10) [108]. However, we do not present IV 
results as the preferred approach because of questions regarding the validity of the 
instruments. Lagrange Multiplier tests of overidentification rejected the null hypothesis 
that the instruments were jointly validly excluded from models of ED use. Correlation 
between control variables and instruments also suggested that the instruments may not 
have been validly excluded. 
6.4. Results 
 
6.4.1. Descriptive statistics  
Both samples had a high proportion of females, whites, beneficiaries aged 80 or 
older, and metropolitan area residents (Table 6.2). NH dwellers had a median of six 
comorbidities compared to four for community dwellers. NH residents had more FM/IM 
visits and fewer specialist visits than community residents.  
A very small share of beneficiaries in either sample used geriatric care during the 
study period. Geriatrician use was much higher in the NH sample than in the community 
sample, and use of geriatric care was heavier in the NH setting. Among all NH 
observations with geriatric care during the study period, 59.6% had ≥3 visits in six 
months (2.8% of 4.7%). In contrast, 38.5% of community observations with geriatric care 
had ≥3 visits (0.5% of 1.3%).  
6.4.2. Main results 
Results for the community sample from multivariate logistic regression showed 
that both the binary and ordered measures of geriatric care a six month period were 
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negatively related to FM/IM visits in the following six months (Table 6.3). The 
associations of geriatric care with specialist visits were also negative but were smaller 
than the associations with FM/IM visits. For both dependent variables, FE results were 
smaller than multivariate logistic regression results. Any geriatric care was associated 
with a 13.7% reduction in FM/IM visits (decrease of 0.396 visits compared to sample 
average of 2.9 visits) (Figure 6.1.a). The effect of ≥3 geriatrician visits was statistically 
different from the effect of 1 visit but not 2 visits. Any geriatric care was associated with 
a much smaller reduction in the predicted number of specialist visits than FM/IM visits 
(3.3% versus 13.7%). The association of geriatric care with reduced specialist visits by 
community residents was found for people with 1 or 2 geriatrician visits but not ≥3 
geriatrician visits. 
For the NH sample, multivariate logistic regression suggested negative 
associations between geriatric care and FM/IM visits as well as geriatric care and 
specialist visits (Table 6.4). FE results were smaller than multivariate logistic regression 
results. Any geriatric care was associated with a 13.8% reduction in FM/IM visits (Figure 
6.1.b). The association of ≥3 geriatrician visits with FM/IM visits was not statistically 
different from the association of 1 or 2 visits. Any geriatric care was associated with a 
10.8% reduction in specialist visits. The reduction in specialist visits associated with 
geriatric care was concentrated among NH residents with ≥3 geriatrician visits. Estimates 
from control variables provided additional evidence that geriatric care was more 
important in predicting FM/IM visits than in predicting specialist visits for both samples 
(Appendix Tables 12 and 13).  
6.4.3. Alternative estimations 
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 Estimations using alternative dependent variables, measures of geriatric care, and 
samples supported our main conclusions. Specialist visits had no meaningful effect on the 
relationship between geriatric care and FM/IM visits for either sample, but FM/IM visits 
impacted the relationship between geriatric care and specialty care. For community 
dwellers, the reduction in specialist visits associated with geriatric care was small and 
insignificant for beneficiaries with zero FM/IM visits; beneficiaries who had three 
FM/IM visits (approximately the sample mean) had a 3.2% reduction in specialist visits. 
For NH dwellers, the reduction in specialist visits associated with geriatric care was 
larger for beneficiaries with zero FM/IM visits than those with six FM/IM visits, which 
was approximately the sample mean (16.5% compared to 10.6%).  
IV results were implausible, suggesting that having any geriatric care led to 
increases in the number of FM/IM visits for both samples and specialist visits for the 
community sample (Appendix Table 14). The IV estimates are relative to mean FM/IM 
and specialist visits for the marginal subgroup of beneficiaries (i.e., those who would 
have received geriatric care because of an increase in geriatrician availability as measured 
by the supply and distance instruments). Even though those means were unknown 
because the marginal subgroup could not be identified, the results were highly 
questionable. Compared to the means for the entire samples, IV results suggested a 150% 
(NH) to 240% (community) increase in FM/IM visits and a 110% increase in specialist 
visits for the community sample. Because we found evidence that the instruments were 
not validly excluded from the models of FM/IM and specialty visits, we chose FE as the 
preferred specification. 
6.5. Discussion 
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In this study, we used Medicare claims data for elderly beneficiaries with a 
hospitalization for ACS and subsequent diagnosis of a geriatric condition to examine the 
relationships between geriatric care and other physician visits. For both samples, geriatric 
care appeared to substitute for FM/IM visits, and the magnitude of the association of 
geriatric care with specialist visits was smaller than for FM/IM visits. The association of 
geriatric care with specialist visits was larger at lower levels of geriatric care for 
community dwellers and at higher levels of geriatric care for NH dwellers.   
We found support for our hypothesis that geriatric care is a substitute for FM/IM 
care from both samples. For community residents, the negative association of geriatric 
care with FM/IM care was larger at higher levels of geriatric care. For NH residents, 
reductions in FM/IM visits were statistically equivalent for all levels of geriatric care. 
Taken together, these results indicate that geriatric care tended to eliminate the need for 
FM/IM care rather than to identify previously unmet health care needs that were 
subsequently addressed by an FM/IM physician. The gradient in the geriatric care-FM/IM 
care relationship for community residents and lack thereof for NH residents suggests that 
permanent replacement of FM/IM care with geriatric care was more common among NH 
residents than community residents. In other words, geriatric primary care was more 
common among NH residents than geriatric consultative care, while community residents 
tended to receive both consultative and primary care from geriatricians.  
For both samples, the relationship between geriatric care and specialty care 
depended on the dose of geriatric care and the number of FM/IM visits received in the 
same period as the geriatric care. Geriatric care was associated with a small reduction in 
specialist visits by community dwellers, but this reduction was statistically significant 
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only for beneficiaries who had few (1 or 2) geriatrician visits or who had FM/IM visits in 
conjunction with geriatric care. The small degree of substitution between geriatric and 
specialty care likely occurs when FM/IM physicians refer patients to geriatric care for 
problems that might have other otherwise lead to referral to a specialist (e.g., referral to a 
geriatrician for cognitive impairment in lieu of referral to a neurologist). Geriatric care 
was neither a substitute for nor complementary to specialty care when a community 
resident had several (≥3) geriatrician visits. For that group, a reduced need for specialist 
visits due to geriatricians’ specialized experience may have been offset by demand for 
specialty care induced by geriatric care (e.g., geriatricians may be more likely than 
FM/IM physicians to perceive aging-related conditions as being treatable problems 
instead of inevitable consequences of aging). 
Results supported our hypothesis that geriatric care is negatively associated with 
specialist care for NH residents. Compared to NH residents who had no geriatric care, the 
largest reduction in specialist visits was associated with having several (≥3) geriatrician 
visits or having geriatric care but no FM/IM care; a smaller reduction was associated with 
consuming both geriatric care and FM/IM care. In other words, the larger the role of a 
geriatrician in a NH resident’s health care, the larger the decrease in specialty care. 
Overall, results for both dependent variables suggest that NH residents and their families 
prefer to have a single physician provide as much of the patient’s care as possible. 
Effects of geriatric care estimated by FE models were substantially smaller than 
effects estimated by multivariate logistic regression models. Smaller FE estimates 
suggest that unobserved, time-invariant individual-level variables caused upward bias in 
the multivariate estimates. For example, beneficiaries who visited geriatricians may have 
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had more extensive family and social support than other beneficiaries; if greater support 
was positively related to both geriatrician visits and other physician visits, this could be 
one reason why FE estimates were smaller. 
 Randomized controlled trials have generally found geriatric interventions that 
provide ongoing care to be more effective than those that provide consultative care [15-
23]. This suggests that substitution of geriatric care for FM/IM care, and in particular the 
focus on geriatric primary care in the NH setting, is appropriate. However, the provision 
of geriatric primary care limits the clinical impact of geriatric care; the more geriatric 
primary care that is provided, the fewer number of elders who will receive any level of 
geriatric care. The relative use of primary and consultative geriatric care is of interest 
because low geriatrician supply in the United States has been a concern for years [4, 14]. 
An estimated 36,000 geriatricians will be needed to maintain the current geriatrician to 
elderly population ratio in 2030, yet current graduation rates from geriatrics fellowship 
programs suggest that there will be 7,750 geriatricians in 2030 [35, 36]. Data from the 
present samples suggest that very few elders who may be particularly likely to benefit 
from geriatric care receive it. Only 2.4% of community residents and 7.4% of NH 
residents ever had a geriatrician visit during the study period. These figures indicate that  
geriatricians’ ability to affect health care use and outcomes for elders via clinical practice 
is very limited. The reach of geriatric care is further limited by the practice patterns we 
found for beneficiaries who used geriatric care (some geriatric primary care for 
community residents and more widespread geriatric primary care for NH residents). 
This study has some limitations. Since unobserved variables that varied over time 
at the individual level were not accounted for by the FE, our results must be interpreted 
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as evidence of an association between geriatric care and other physician visits rather than 
evidence of a causal link. Because our dataset is an unbalanced panel, we assumed that 
attrition in any period was unrelated to unobserved, time-varying variables. This issue is 
most relevant in the first period, as the 22% of the community sample and 27% of the NH 
sample that had only one observation did not contribute information toward the FE 
estimates. Results from multivariate logistic regression models estimated using only 
beneficiaries who had two or more observations were nearly identical to results estimated 
using the full samples; this provides some confidence that having an unbalanced panel 
does not pose major concerns.  
The claims data lacked some useful details (e.g., whether a gerontological nurse 
practitioner billed incident to a physician). Since physicians self-identify their specialty 
when they apply to become a Medicare provider, geriatrician specialty does not necessary 
imply that a physician has ever been or is currently certified in geriatric medicine. The 
results of this analysis cannot be generalized to beneficiaries without a history of ACS 
and geriatric conditions nor to Medicare managed care enrollees. ACS is not likely to be 
particularly relevant when considering tradeoffs between geriatric care and FM/IM care. 
However, because beneficiaries in our study were likely to need at least some cardiac 
care, we may have estimated a lower bound on the degree of substitution between 
geriatric care and specialty care. Finally, geriatricians may be more likely than other 
physicians to diagnose some geriatric conditions [21]. If beneficiaries who received their 
diagnosis from a geriatrician were systematically healthier in unobserved ways, the 
negative associations of geriatric care with other types of physician visits could be 
overestimated.  
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This analysis was the first to use data for a large, national sample of elders to 
examine whether geriatric care is typically used in conjunction with or in lieu of other 
types of physician care in non-hospital settings. We found that geriatric care was a 
substitute for FM/IM care, and permanent replacement of FM/IM care with geriatric care 
appeared to be more common among NH residents than community residents. Geriatric 
care was associated with a sizeable reduction in specialty care for NH dwellers that had a 
high dose of geriatric care and with a small reduction in specialty care for community 
dwellers that had a low dose of geriatric care. Given the lack of existing evidence on this 
topic, future studies should determine whether the results of this analysis are found for 
other samples. Since geriatric care is a substitute for FM/IM care, research is needed to 
examine the effect of geriatric care compared to FM/IM care on a variety of outcomes 
including quality of life and health care use, particularly among NH residents who have 
largely been ignored by trials of geriatric interventions. In light of increased constraints 
on geriatrician supply in the near term due to the substantial increase in the elderly 
population, future studies should determine the circumstances under which substitution of 
geriatric care for FM/IM care or specialty care is most effective. For example, given the 
very low supply of geriatric psychiatrists, are outcomes for patients who receive geriatric 
care more favorable than for those who receive psychiatric care from a traditional 
psychiatrist? If so, is the favorable effect of geriatric care for psychiatry patients larger or 
smaller than any difference in outcomes for patients with dementia who receive geriatric 
care compared to those who receive neurological care? 
 
 
 
  
 
Figure 6.1.a. Percent change in number of physician visits in six months associated 
with geriatric care, community
95% confidence intervals shown. 
Percent change calculated as change in number of physician visits (Table 6.2) divided by the sample mean 
of physician visits (Table 6.1) multiplied by
 (e.g., for FM/IM visits, 13.7% for any geriatric care reflects a decrease of 0.396 visits relative to the 
sample average of 2.9 visits). 
 
118 
 sample 
 100 
 
 
  
 
Figure 6.1.b. Percent change i
with geriatric care, NH sample
 
95% confidence intervals shown.  
Percent change calculated as change in number of physician visits (Table 6.3) divided by the sample mean 
of physician visits (Table 6.1) multiplied by 100 
(e.g., for FM/IM visits, 13.8% for any geriatric care reflects a decrease of 0.799 FM/IM visits rela
sample average of 5.8 FM/IM visits). 
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Table 6.1. Codes used to measure diagnoses, NH residence, physician visits, and physician specialty 
Item 
Data 
source Codes 
Diagnoses 
   ACS MedPAR ICD-9-CM codes 410.xx, 411.1x, and 413.9x 
   Geriatric     
   conditions 
MedPAR, 
Outpatient, 
Carrier 
ICD-9-CM codes 430.xx-432.xx, 434.xx-437.1x, 437.3x-438.xx, 290.0-290.43, 294.0-294.8, 
331.0-331.2, 331.7, 797, 300.4, 301.12, 309.0, 309.1, 311, 293.0x, 293.1x, 707.0x, 788.3, 
788.30-788.34, 788.37-788.39, 260-263.9, 783.21-783.22, 783.7x, and 276.5.707.2x-707.9x, 
800.xx--829.xx, 830.xx-839.xx, 870.xx-879.xx, 880.xx-884.xx, 890.xx-894.xx, 733.0, 780.2, 
389.xx, 369.xx, 596.51-596.52, 596.54-596.59, 599.8x, 625.6x, 788.3, 788.30-788.34, 788.37-
788.39, 260-263.9, 783.21-783.22, 783.7x, and 276.5 
NH residence   
   NH claim Carrier Place of service codes 31 and 32, HCPCS codes 99301-99318, 99379-99380, and G0066, 
BETOS code M4B  
   SNF claim MedPAR SNF indicator code 
Physician visits Carrier BETOS codes M1A, M1B, M4A, M4B, and M6 (unless one of the following HCPCS codes was 
present: 99221-99239, 99251-99255, 99261-99263, 99271-99275, 99411-99412, 95115-95117, 
or G0175) 
Physician specialty  
   FM/IM  
   physicians 
Carrier Specialty codes 01, 08, 11, 50, 84, 97 
   Specialists Carrier Specialty codes 03, 06, 07, 10, 12, 13, 16, 25, 26, 29, 34, 39, 44, 46, 66, 79, 82, 83, 86, 90-92, 
94, 98 
   Geriatricians Carrier Specialty code 38 
ACS: Acute coronary syndromes 
MedPAR: Medicare Provider Analysis and Review 
ICD-9-CM: International Statistical Classification of Diseases and Related Health Problems, Version 9, Clinical Modification 
HCPCS: Healthcare Common Procedure Coding System 
BETOS: Berenson-Eggers Type of Service  
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Table 6.2. Descriptive statistics 
  Comm.      NH** 
  
Comm.      NH** 
  First period First period 
  
All periods   All periods 
Observations 287,259 66,551  Observations 1,006,879 195,433 
  
Demographic characteristics  Geriatric care in  previous 6 months 
Age  Any geriatric care 0.013 0.047 
   66-74 0.231 0.108    
   75-79 0.235 0.156  Number of geriatrician visits 
   80-84 0.245 0.242     0 visits 0.987 0.953 
   85-89 0.178 0.255     1 visit 0.005 0.011 
   90+ 0.111 0.238     2 visits 0.003 0.008 
Male 0.378 0.286     ≥3 visits 0.005 0.028 
Nonwhite 0.103 0.116 
Dual eligible 0.171 0.350  FM/IM visits 
Median income $42,704 $43,987   #, 6 months, mean 2.9 5.8 
Metropolitan status   #, 6 months, median 2.0 5.0 
   Metropolitan area 0.686 0.731 
   Micropolitan area 0.153 0.130  Specialist visits 
   Small town 0.092 0.083   #, 6 months, mean 2.1 1.3 
   Rural area 0.069 0.056   #, 6 months, median 1.0 0.0 
**Differences between samples are statistically significant at p<0.01 for all variables 
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Table 6.3. OLS results for change in physician visits in six months, community sample 
Dependent variable FM/IM FM/IM Specialty Specialty 
Fixed effects? No Yes No Yes 
Geriatric care in previous 6 months 
Any geriatric care -1.075** -0.396** -0.229** -0.070* 
(reference: 0 visits) (-1.142,-1.009) (-0.467,-0.326) (-0.298,-0.160) (-0.133,-0.007) 
Number of geriatrician visits 
(reference: 0 visits) 
   1 visit -0.542** -0.256** -0.305** -0.087* 
(-0.645,-0.439) (-0.346,-0.165) (-0.389,-0.221) (-0.168,-0.007) 
   2 visits -1.151** -0.471** -0.356** -0.113* 
(-1.263,-1.040) (-0.581,-0.361) (-0.456,-0.255) (-0.211,-0.014) 
   ≥3 visits -1.486** -0.562** -0.087 -0.005 
(-1.583,-1.389) (-0.667,-0.458) (-0.206,0.032) (-0.099,0.088) 
Control variables 
Age (omitted: 66-74) 
    75-79 -0.006 -0.010 -0.071** -0.043* 
(-0.033,0.020) (-0.047,0.027) (-0.098,-0.044) (-0.076,-0.010) 
    80-84 0.012 -0.002 -0.251** -0.109** 
(-0.016,0.040) (-0.055,0.050) (-0.278,-0.223) (-0.156,-0.062) 
    85-89 -0.023 -0.042 -0.543** -0.142** 
(-0.053,0.007) (-0.110,0.025) (-0.573,-0.514) (-0.202,-0.082) 
    90+ -0.226** -0.070 -0.994** -0.065 
(-0.261,-0.192) (-0.157,0.017) (-1.026,-0.962) (-0.143,0.012) 
Male -0.191** N/A 0.376** N/A 
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Dependent variable FM/IM FM/IM Specialty Specialty 
Fixed effects? No Yes No Yes 
(-0.213,-0.170) (0.355,0.398) 
Nonwhite 0.035 N/A -0.114** N/A 
(-0.000,0.070) (-0.147,-0.081) 
Dual eligible -0.219** -0.592** -0.517** -0.463** 
(-0.244,-0.193) (-0.624,-0.559) (-0.538,-0.495) (-0.491,-0.434) 
ZIP income quartile (omitted: First quartile) 
    Second 0.070** -0.006 0.066** 0.059 
(0.042,0.098) (-0.088,0.076) (0.042,0.090) (-0.014,0.133) 
    Third 0.120** 0.070 0.126** 0.073 
(0.090,0.149) (-0.015,0.156) (0.099,0.153) (-0.003,0.149) 
    Fourth 0.062** 0.218** 0.461** 0.097* 
(0.031,0.093) (0.125,0.310) (0.430,0.492) (0.014,0.179) 
Metropolitan status (omitted: Metropolitan area) 
    Micropolitan area -0.017 0.116* -0.513** -0.169** 
(-0.045,0.011) (0.012,0.219) (-0.538,-0.489) (-0.261,-0.077) 
    Small town -0.265** -0.019 -0.722** -0.217** 
(-0.301,-0.228) (-0.144,0.106) (-0.749,-0.696) (-0.328,-0.106) 
    Rural area -0.382** -0.007 -0.816** -0.238** 
(-0.428,-0.336) (-0.148,0.133) (-0.845,-0.787) (-0.363,-0.113) 
Observations 1,006,879 1,006,879 1,006,879 1,006,879 
** p<0.01, * p<0.05 
95% confidence intervals in parentheses.  
Month indicators, time trends, and comorbidities omitted. 
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Table 6.4. OLS results for change in physician visits in six months, NH sample 
Dependent variable FM/IM FM/IM Specialty Specialty 
Fixed effects? No Yes No Yes 
Geriatric care in previous 6 months 
Any geriatric care -1.938** -0.799** -0.316** -0.140** 
(reference: 0 visits) (-2.098,-1.778) (-0.968,-0.631) (-0.380,-0.253) (-0.230,-0.051) 
Number of geriatrician visits 
(reference: 0 visits) 
   1 visit -0.849** -0.767** -0.188** -0.016 
(-1.110,-0.589) (-1.017,-0.516) (-0.322,-0.054) (-0.150,0.117) 
   2 visits -1.145** -0.605** -0.339** -0.111 
(-1.440,-0.850) (-0.895,-0.315) (-0.459,-0.220) (-0.265,0.044) 
   ≥3 visits -2.612** -0.898** -0.361** -0.235** 
(-2.816,-2.408) (-1.110,-0.687) (-0.436,-0.286) (-0.348,-0.122) 
Control variables 
Age (omitted: 66-74) 
    75-79 -0.132 -0.289* -0.124** -0.266** 
(-0.284,0.020) (-0.527,-0.050) (-0.214,-0.033) (-0.393,-0.139) 
    80-84 -0.247** -0.466** -0.230** -0.372** 
(-0.392,-0.101) (-0.772,-0.159) (-0.322,-0.139) (-0.535,-0.209) 
    85-89 -0.270** -0.565** -0.396** -0.393** 
(-0.415,-0.124) (-0.922,-0.209) (-0.483,-0.309) (-0.583,-0.204) 
    90+ -0.503** -0.674** -0.589** -0.391** 
(-0.650,-0.355) (-1.084,-0.264) (-0.676,-0.502) (-0.609,-0.173) 
Male -0.192** 0.154** 
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Dependent variable FM/IM FM/IM Specialty Specialty 
Fixed effects? No Yes No Yes 
(-0.280,-0.104) (0.104,0.205) 
Nonwhite 0.156* 0.148** 
(0.023,0.290) (0.068,0.227) 
Dual eligible -0.242** -0.793** -0.245** -0.332** 
(-0.319,-0.165) (-0.922,-0.664) (-0.284,-0.206) (-0.401,-0.263) 
ZIP income quartile (omitted: First quartile)  
    Second 0.088 0.200 -0.008 0.092 
(-0.012,0.188) (-0.075,0.474) (-0.061,0.044) (-0.054,0.239) 
    Third 0.265** 0.301* -0.039 0.019 
(0.155,0.374) (0.017,0.586) (-0.097,0.018) (-0.133,0.170) 
    Fourth 0.453** 0.212 0.243** 0.043 
(0.334,0.572) (-0.101,0.525) (0.174,0.313) (-0.123,0.210) 
Metropolitan status (omitted: Metropolitan area) 
    Micropolitan area -1.130** -0.057 -0.490** -0.164 
(-1.230,-1.031) (-0.466,0.353) (-0.540,-0.441) (-0.382,0.054) 
    Small town -1.298** 0.062 -0.578** 0.095 
(-1.421,-1.175) (-0.410,0.534) (-0.639,-0.518) (-0.156,0.346) 
    Rural area -1.407** 0.371 -0.678** -0.022 
(-1.549,-1.265) (-0.170,0.912) (-0.736,-0.620) (-0.310,0.266) 
Observations 195,433 195,433 195,433 195,433 
** p<0.01, * p<0.05 
95% confidence intervals in parentheses.  
Month indicators, time trends, and comorbidities omitted. 
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7. DISCUSSION 
 
7.1. Summary of findings 
 
7.1.1. Study 1: Use of geriatric care in the United States 
 In Study 1, we sought to determine the frequency and location of geriatric care, 
examine patient characteristics associated with use of geriatric care, and describe the use of 
geriatric care over time. We conducted several bivariate analyses in order to characterize 
those issues. We found that only 3.5% of the sample had any geriatrician visits in one year. 
The use of geriatric care was approximately evenly split between heavy users (4 or more 
visits in one year) and light users (1 to 3 visits in one year). Beneficiaries living in a 
metropolitan area, those with dementia or depression, and those who had any nursing home 
physician visits were substantially more likely to use geriatric care than other beneficiaries. 
Most beneficiaries with at least one geriatrician visit in a nursing home had the majority of 
their nursing home physician visits provided by geriatricians. Use of geriatric care by patients 
with dementia and congestive heart failure was higher; other results for subsamples defined 
by those diagnoses were similar to the full sample. We concluded that an enormous increase 
in the supply of geriatricians would be required for clinical geriatric care to have a sizeable 
effect. Because such a large increase in supply is unlikely, teaching, research, and 
advocacy/policymaking are the pathways through which geriatric medicine may be able to 
have a broad impact on the health of older adults. 
7.1.2. Study 2: The association of geriatric care and emergency department use  
 In Study 2, we assessed whether geriatric care was associated with ED use. We 
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examined whether community and long-term nursing home residents who used geriatric care 
in a six month period were less likely to have ED use in the following month than those who 
did not use geriatric care. We used individual FE to account for unobserved heterogeneity 
and measured geriatric care was measured as number of visits and share of total visits to 
geriatricians. Geriatric care was associated with reductions in ED use of 7.5% to 18.8%. 
Reductions associated with geriatric consultative care were equivalent to reductions 
associated with geriatric primary care. Results for the two samples were similar. We 
concluded that studies should continue to examine whether differences exist in the effects of 
geriatric primary and consultative care as well as whether the effects of geriatric care vary 
based on setting of care. More generally, researchers need to analyze the effect of geriatric 
care in other samples and on other outcomes such as quality of life, functional status, and 
health care expenditures. 
7.1.3. Study 3: Is geriatric care a substitute or complement for other physician care? 
 In Study 3, we sought to determine whether geriatric care was used more often in 
combination with or in lieu of FM/IM care and specialty care. We estimated the association 
of geriatric care received during a six month period on the number of FM/IM and specialist 
visits in the following six months. We found that geriatric care was associated with 
reductions in FM/IM care of 8.8% to 19.4%. The magnitude of the reduction in specialist 
visits associated with geriatric care was smaller than the reduction in FM/IM visits. 
Reduction in specialist visits was larger at lower levels of geriatric care for community 
dwellers and at higher levels of geriatric care for NH dwellers. We concluded that geriatric 
care appears to be used in place of care from FM/IM physicians and in certain instances, 
geriatric care may also reduce subsequent use of specialty care. Since geriatric care seems to 
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substitute for FM/IM care, future studies should determine the circumstances under which 
substitution of geriatric care for FM/IM care or specialty care is most effective. 
7.2. Limitations 
 
7.2.1. Claims data 
 
This dissertation has several limitations. The claims data lack some variables that 
would be useful as outcome measures and control variables, including detailed measures of 
cognitive and functional status, socioeconomic status, and family and social support. The 
claims data do not indicate nurse practitioner and physician assistant specialty, whether a 
gerontological nurse practitioner or other mid-level provider bills incident to a physician, or 
whether a long-term nursing home resident receives care from the facility’s medical director. 
More generally, using claims data, we cannot capture any services that were provided but 
were not billed. For example, if a FM/IM physician is in a group practice with a geriatrician, 
the FM/IM physician may have informal communication with the geriatrician which affects 
the care the physician provides.  
Physician specialty was self-designated, and we considered physicians with at least 
two visits in a year coded as GM to be a geriatrician for all visits in that year. As a result, we 
many have misclassified some visits to non-geriatricians as geriatric care and vice versa. In 
addition, some FM/IM physicians have extensive experience working with elders with 
geriatric conditions. If we could compare only geriatricians with active certification in GM to 
physicians without extensive experience working with patients with geriatric conditions, we 
might find an even larger reduction in ED use associated with geriatric care (i.e., the results 
we present may be a lower bound of the association of geriatric care with ED use). More 
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generally, the mechanisms by which geriatric care may reduce ED use are not clear. We 
could not distinguish between a training effect and an experience effect.  
7.2.2. Selection 
Geriatricians may be more likely than other physicians to diagnose some geriatric 
comorbidities such as dementia, depression, and incontinence [21]. If beneficiaries who 
receive their diagnosis from a geriatrician have less severe comorbidities (i.e., are 
systematically healthier in unobserved ways), this could lead to overestimates of the 
favorable effects of geriatric care on outcomes. Although estimating models with individual 
FE controls for differences in unobserved variables at baseline (including health status), any 
changes over time that were unobserved are not accounted for. It is possible that time-
varying unobserved variables were related to the use of geriatric care as well as ED use and 
other physician visits, so our results must be interpreted as evidence of associations rather 
than evidence of causal links. Additionally, because we used FE on an unbalanced panel, we 
assumed that attrition in any period was unrelated to unobserved, time-varying variables. We 
used IV methods to try to address the issue of time-varying unobserved variables but were 
not confident that our instruments were valid. 
7.2.3. External generalizability 
Finally, the results of this analysis cannot be generalized to beneficiaries without a 
history of ACS and geriatric comorbidities nor to those who enrolled in Medicare managed 
care. Since geriatric care is rare, the data we used were advantageous because of the large 
initial sample size. Although ACS is not a condition for which geriatric care would be 
expected to confer benefits relative to care from other physicians, beneficiaries who have had 
ACS may have poorer functional status and overall health status than the general elderly 
  
130 
 
 
population. In combination with the diagnosis of a geriatric condition, these people may have 
been particularly good candidates for geriatric care. Geriatric care was more common among 
beneficiaries whose geriatric condition was diagnosed closer in time to the ACS 
hospitalization, which suggests that cardiac care was not “crowding out” geriatric care.  
7.3. Contributions of this study 
 
This dissertation contributes to the literature in a number of ways. Using data from a 
large, geographically diverse sample of elderly Medicare beneficiaries with a history of ACS 
and subsequent diagnosis of a geriatric condition, we investigated a number of issues that had 
not been previously explored. We found no existing studies that examined patient-level 
trends in the use of geriatric care (Study 1) or considered whether geriatric care is more often 
positively or negatively associated with other types of physician care (Study 3). Although the 
relationship between geriatric care and ED use by older adults has been studied in RCTs, we 
did not find any studies that attempted to replicate these findings using real-world data. 
Further, we did not find any studies that compared the effect of geriatric care for long-term 
NH residents to the effect for community residents (Study 2).  
7.4. Policy implications and future research  
 
Information about the use and effects of geriatric care by this important patient 
population should aid policymakers, health professionals, and researchers as they seek to 
determine the most effective ways to use the existing supply of geriatricians and whether 
additional resources for geriatric training may be worthwhile. More generally, this research 
has implications for the role of geriatricians in models of care for elders with geriatric 
conditions. Our results showed that geriatric care is used by very few elders who are likely 
benefit from such care. Among those who receive geriatric care, geriatric care tends to 
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substitute for care from FM/IM physicians. Primary care was the dominant model of geriatric 
care for users of geriatric care residing in NHs. RCTs have generally shown that geriatric 
interventions that provide ongoing care are more effective than those that provide 
consultative care. This suggests that substitution of geriatric care for FM/IM care, and in 
particular the focus on geriatric primary care in the NH setting, is appropriate. However, the 
provision of geriatric primary care limits the clinical impact of geriatric care; the more 
geriatric primary care that is provided, the fewer the number of elders who receive any level 
of geriatric care. The results of Study 2 suggest that geriatric consultative care may be no less 
effective than geriatric primary care in preventing ED use by both community and NH 
residents. If geriatric care can be effectively provided in communities and nursing homes as 
consultative care, then the existing supply of geriatricians could be more broadly spread 
across the elderly population. More generally, Study 2 suggests that increasing the supply of 
geriatricians may lead to improved health outcomes for elderly Medicare beneficiaries with 
geriatric conditions. 
Because of the lack of existing literature on the topic, additional studies are needed to 
further elucidate the use and effects of geriatric care in real-world clinical settings. 
Researchers should examine additional outcomes and other samples. This is particularly true 
for the nursing home population which has not been addressed by the literature on geriatric 
interventions. The specific mechanisms by which geriatric care may reduce ED use are 
unknown. Researchers should continue to assess whether differences exist in the effects of 
geriatric primary and consultative care. Future studies should determine the circumstances 
under which substitution of geriatric care for FM/IM care or specialty care is most effective. 
For example, in light of the very low supply of geriatric psychiatrists, a comparison of 
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outcomes for patients with conditions such as depression who receive geriatric care to those 
who receive care from a traditional psychiatrist would be useful [134]. If an effect of geriatric 
care exists in that context, it could be compared to other situations in which geriatric care 
substitutes for specialty care (e.g., patients with dementia who receive geriatric care 
compared to those who receive neurological care). Also, beyond examining which processes 
of geriatric care play the largest role in improving outcomes (e.g., medication management 
versus coordination of care), research should examine whether quality of care differs 
between FM/IM physicians who are in group practices or other organizations that include a 
geriatrician and FM/IM physicians who do not have ready access to a geriatrician. In 
addition, little is known about care from gerontological nurse practitioners and circumstances 
under which gerontological nurse practitioners may be effective substitutes for geriatricians.  
The efficient use of the existing supply of geriatricians is a goal worth pursuing, and 
much still needs to be understood about the use and effects of geriatric care. However, 
regardless of the effects of geriatric care on health outcomes, our results suggest that the 
impact of clinical practice at the population level is very minimal. An enormous increase in 
the supply of geriatricians would be required for geriatric care to have a sizeable effect 
through clinical practice. Effects of a recent change in Medicare reimbursement for geriatric 
care on the supply of geriatricians are not likely to occur in the short-term (if any effects 
occur at all). For geriatric medicine to have a population-level impact on the health and 
health care of older adults, its focus needs to be on teaching, research, and 
advocacy/policymaking. The Patient Protection and Affordable Care Act opens some new 
avenues for this type of work. It authorizes geriatric education center grants (e.g., for 
practitioners to increase their knowledge about geriatrics), and the use of geriatric 
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assessments and comprehensive plans to coordinate care are among the payment and delivery 
reform models to be given priority by the Center for Medicare and Medicaid Innovation 
[127]. As the number of elderly Americans increases, funding for Medicare as well as 
Medicaid and Veterans Affairs will put enormous pressure on the federal budget. Finding 
ways to improve the quality of care for elders with geriatric conditions and also reduce health 
care expenditures per beneficiary is critical to ensuring the financial health of the federal 
government.  
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APPENDIX 1: DETAILS ON IV ESTIMATION 
 
Data for the instruments came from an analytic file which had data from the 
American Medical Association (AMA) Physician Masterfile and the American Board of 
Medical Specialties (ABMS). The first instrument measured geriatrician supply: a count of 
the number of geriatricians in the beneficiary’s home county per 10,000 residents aged 65 
and older. The second instrument measured differential distance to geriatric care: the 
difference between the distance from the beneficiary’s home ZIP code to the ZIP code of the 
nearest geriatrician and the distance from home ZIP code to the ZIP code nearest FM/IM 
physician or specialist. Distance was measured as the number of miles between the centroid 
of the beneficiary’s home ZIP code and the centroid of the physician ZIP code using the 
zipcitydistance function in SAS 9.1.3. We hypothesized that supply would be positively 
associated with use of geriatric care since awareness of geriatric care is likely to be higher 
among beneficiaries who live in an area with higher supply. We hypothesized that 
differential distance would be negatively related to use of geriatric care since it is an 
indicator of transportation costs.  
The instruments were valid only if there is was no direct effect of geriatrician supply 
and differential distance to geriatric care on outcomes and the instruments were uncorrelated 
with unobservable variables that affect those outcomes. Physician supply and differential 
distance have been used as instruments for the receipt of cardiac care [94, 95]. Some research 
suggests that primary care provider supply is correlated with area-level health outcomes and 
that physician density is endogenous in models of area-level health [96-99]. A recent paper 
found a connection between area-level primary care physician supply and individual-level 
outcomes [100]. To address concerns about the supply instrument, we used an alternative 
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measure of supply that measured the availability of geriatricians relative to other types of 
physicians rather than indicating the actual availability of geriatricians: the ratio of county 
geriatrician supply to county FM/IM and specialist supply.  
If the marginal subpopulations had rates of ED use similar to the full samples, then 
the effects estimated by IV models suggest decreases of 92.5% (community, 7.4 percentage 
points compared to 8.0) and 122.9% (NH, 11.7 percentage points compared to 9.6) 
(Appendix Table 6). IV results using an alternative supply instrument (GM supply relative to 
FM/IM and specialist supply) in lieu of actual GM supply as an instrument were similar. 
However, we did not present results from IV regression as the preferred approach for either 
model because of questions regarding the validity of our instruments. To try to discern 
whether the instruments were validly excluded from the ED use model, we compared two 
groups: beneficiaries who lived in an area where geriatrician supply was at or above the 
median for all beneficiaries, and those who lived in an area where supply was below the 
median [101]. This comparison suggested that the distribution of observable variables was 
not independent of geriatrician supply (i.e., the instruments did not appear to mimic a natural 
experiment for geriatric care). For example, geriatrician supply was positively correlated 
with ZIP code median income and negatively correlated with dual eligibility. Since 
unobserved socioeconomic status is likely to be associated with both geriatric care and ED 
use, differences in income and dual eligibility are problematic.  
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APPENDIX 2: ADDITIONAL DETAILS ON IV ESTIMATION 
 
In addition to using a bivariate probit model to estimate IV regression for any 
geriatric care, we estimated the effects of all three measures of geriatric care with IV 
regression. Depending on whether the measure of geriatric care was binary, ordered, or 
categorical, the first stage equation that predicted geriatric care was estimated using a logit, 
ordered logit, or multinomial logit model with standard errors clustered at the beneficiary 
level. Since geriatric care was measured using a six month lag in the second stage equation, 
the unit of observation in the first stage equation was a six month period.  
We used two-stage residual inclusion (2SRI) in which both the observed value of the 
endogenous variable and the predicted residual from the first stage equation are included in 
the second stage equation [106]. Bias-corrected confidence intervals for changes in the 
predicted probability of the dependent variable were generated by bootstrapping 250 random 
samples drawn at the beneficiary level with replacement. Further details of the 2SRI 
estimation are provided in Chapter 3.6.2. 
The IV results for the binary measures of geriatric care estimated by 2SRI were larger 
than but still somewhat similar to results estimated by bivariate probit (Appendix Tables 6 
and 7). Results from both 2SRI and bivariate probit were extremely large relative to the 
means of ED use for the entire sample. This could have been because the marginal 
subsamples had much higher rates of ED use than the full samples, although there is no 
reason to expect this. The very rare nature of geriatric care could have presented problems in 
the estimation. Another explanation is that perhaps the instruments were not validly excluded 
from the outcome models.  
  
137 
 
 
Even more puzzling is that 2SRI estimates for the effect of the ordered and 
categorical measures of geriatric care on ED use were completely unlike the 2SRI effects 
estimated for the binary measures; the signs of the effects were opposite, and the magnitudes 
different substantially. This may have been because there was a problem with the way the 
instruments were operating in 2SRI when the first stage was an ordered or multinomial logit. 
For both samples, the estimated effect of GM plurality had the opposite sign and a 
substantially different size in terms of absolute value compared to the estimated effect of GM 
consultation. In contrast, in the FE models for ED use, the effects estimated for GM plurality 
and GM consultation were very similar. In sum, it is not clear what was going on in the IV 
models that produced such wild estimates, but most of the IV results are implausible (both 
from bivariate probit and 2SRI). 
  
  
138 
 
 
APPENDIX 3: ASSOCIATION OF GERIATRIC CARE WITH 
 IN-HOSPITAL DEATH 
 
Methods 
 An analysis of in-hospital death was conducted using data from the month in which 
death occurred. MedPAR and Outpatient claims identified in-hospital death (including death 
in an ED) [135]. Sample sizes for in-hospital death were 36,796 (NH) and 72,244 
(community). We used three-digit ZIP code FE to control for area-level factors that may have 
affected the likelihood of in-hospital death (e.g., norms for aggressiveness of end of life care, 
socioeconomic status). FE models were estimated with LPMs because of perfect prediction. 
F tests of joint insignificance of the FE were rejected for both samples (p<0.000), and 
Hausman tests indicated that estimates from OLS models were inconsistent (p<0.000). 
Results 
 The rate of any geriatric care was very low for both samples, although it was nearly 
three times higher for the NH sample than for the community sample. In-hospital death was 
substantially higher among community dwellers (42.0% community vs. 27.7% NH) 
(Appendix Table 8). In the naïve models, geriatric care was associated with a reduced 
likelihood of in-hospital death (Appendix Table 9). Compared to in-hospital death rates of 
42.0% and 27.7%, the effects of 5.7 and 2.3 percentage points reflected reductions in the 
predicted probability of in-hospital death of 13.6% (community) and 8.3% (NH). In general, 
the FE results showed larger effects of geriatric care on in-hospital death for community 
dwellers than for NH dwellers, and effects for community dwellers were more often 
statistically significant (Appendix Figure 1). In the FE model for community dwellers, GM 
plurality and GM consultation were associated with reductions of 10.0% and 11.7% in the 
predicted probability of in-hospital death compared to FM/IM plurality. For NH dwellers, 
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neither of those two measures had statistically significant effects. For both samples, specialist 
plurality was associated with a substantial increase in the likelihood of in-hospital death 
(9.3% community, 9.7% NH) compared to FM/IM plurality. The associations of geriatric 
care with in-hospital death were smaller (in absolute value) than many of the demographic 
characteristics (e.g., advanced age). 
Effects of geriatric care estimated by IV models of in-hospital death were 
substantially larger in absolute value than effects estimated by FE, and the signs of the effects 
estimated by IV were different from the signs estimated by FE. IV models indicated that 
geriatric care may increase the likelihood of in-hospital death. The effects of 29.3 
(community) and 32.3 percentage points (NH) suggested increases of 69.8% (community) 
and 116.6% (NH) compared to the prevalence of in-hospital death in the full sample.  
Results from three and nine month measures of geriatric care produced slightly 
different results from six month measures, but the differences were small enough that the 
interpretation would not have differed. Using the alternative measure of NH residence led to 
estimates that were very similar to the original estimates.  
Discussion 
The effects of geriatric care on in-hospital death were larger and more often 
statistically significant for community dwellers than NH dwellers. The largest effects on in-
hospital death were found for beneficiaries who had a single visit. Geriatric consultation was 
found to be as effective as GM plurality in both samples. Most measures of geriatric care had 
very similar effect sizes in FE models compared to naive models. This may have been 
because area FE did not control for unobserved person- or facility-level factors. In other 
words, unobserved person- or facility-level heterogeneity affecting both geriatric care and in-
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hospital death was likely to have been a big problem. For example, NHs may have a 
particular protocol for palliative and end of life care that affected whether their residents are 
likely to die in a hospital.  
The association of a single geriatrician visit with in-hospital death was statistically 
significant for both samples. Although the effect of 1 visit was not statistically different from 
the effect of ≥3 visits, the estimated coefficient for 1 visit was larger than all other measures 
of geriatric care in the in-hospital death models. Unobserved individual-level variables could 
explain the link between 1 visit and a sizeable reduction in the predicted probability of in-
hospital death. For example, beneficiaries who visited geriatricians near the end of life may 
have been less likely to seek aggressive medical care than otherwise similar beneficiaries in 
their geographic area. This result suggests that a geriatrician visit may be beneficial even if a 
person is near death. 
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Appendix Table 1. Frequency and location of physician visits during first year following initial geriatric diagnosis,  
by frequency of geriatrician visits 
(For inclusion in an online appendix) 
Geriatrician visits People, Dementia %, Dementia Geriatrician visits People, CHF  %, CHF 
All settings 
0 41,218 93.3 0 88,867 95.6 
1 696 1.6 1 951 1.0 
2-3 752 1.7 2-3 1,059 1.1 
4-6 598 1.4 4-6 794 0.9 
≥7 905 2.1 ≥7 1,284 1.4 
≥1 2,951 6.7 ≥1 4,088 4.4 
Office, nursing home, home 
0 41,704 94.4 0 89,706 96.5 
1 583 1.3 1 749 0.8 
2-3 653 1.5 2-3 848 0.9 
4-6 528 1.2 4-6 680 0.7 
≥7 701 1.6 ≥7 972 1.1 
≥1 2,465 5.6 ≥1 3,249 3.5 
Hospital, emergency department 
0 43,196 97.8 0 91,354 98.3 
1 298 0.7 1 480 0.5 
2-3 265 1.0 2-3 463 0.5 
4-6 190 0.4 4-6 293 0.3 
≥7 220 0.5 ≥7 365 0.4 
≥1 973 2.2 ≥1 1,601 1.7 
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Appendix Table 2. Characteristics and comorbidities associated with geriatric care in first year following initial geriatric 
diagnosis, dementia subsample 
(For inclusion in an online appendix) 
  0 visits, % ≥1 visits, % 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
Sample 41,218 2,951 
Female 67.3 71.3 1.21** (1.11,1.31) 1.05 (0.96,1.15) 
Nonwhite 13.0 15.1 1.19** (1.07,1.32) 1.25** (1.12,1.41) 
Dual eligible 27.2 25.6 0.92* (0.84,1.00) 0.89* (0.81,0.98) 
Age 
   75 or younger 14.9 12.1 
   76-80 20.8 19.7 0.93 (0.85,1.03) 1.13 (0.99,1.30) 
   81-85 27.8 28.1 1.01 (0.93,1.10) 1.17* (1.02,1.33) 
   86 or older 36.5 40.0 1.16** (1.08,1.25) 1.25** (1.09,1.42) 
Income 
   1st quartile 25.6 17.3 
   2nd quartile 25.4 19.7 0.72** (0.66,0.79) 1.05 (0.93,1.20) 
   3rd quartile 24.8 27.5 1.15** (1.06,1.25) 1.23** (1.08,1.39) 
   4th quartile 24.2 35.6 1.73** (1.60,1.87) 1.47** (1.30,1.66) 
Metropolitan status  
   Metropolitan area 70.1 88.0 
   Micropolitan area 14.3 6.9 0.44** (0.38,0.51) 0.47** (0.40,0.55) 
   Small town 9.1 3.3 0.34** (0.27,0.41) 0.36** (0.29,0.45) 
   Rural area 6.5 1.9 0.27** (0.21,0.36) 0.30** (0.23,0.40) 
Geriatric conditions 
   Stroke 34.5 37.9 1.16** (1.07,1.25) 1.08 (1.00,1.17) 
   Dementia 100.0 100.0 1.00 (1.00,1.00) 1.00 (1.00,1.00) 
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  0 visits, % ≥1 visits, % 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
   Osteoporosis 16.2 22.5 1.50** (1.37,1.64) 1.37** (1.24,1.51) 
   Urinary incontinence 9.6 13.1 1.42** (1.27,1.59) 1.41** (1.26,1.58) 
   Depression 26.7 37.6 1.65** (1.53,1.79) 1.55** (1.43,1.68) 
   Dehydration 20.9 23.7 1.18** (1.08,1.29) 1.02 (0.93,1.12) 
   Hearing impairment 4.9 5.1 1.05 (0.88,1.24) 1.02 (0.86,1.21) 
   Syncope 15.1 17.0 1.16** (1.05,1.28) 1.10 (0.99,1.22) 
   Fracture 16.2 21.0 1.38** (1.26,1.51) 1.23** (1.12,1.35) 
   Pressure 6.3 10.1 1.68** (1.48,1.90) 1.41** (1.23,1.61) 
   Weight loss/failure to thrive 11.5 19.3 1.84** (1.67,2.02) 1.62** (1.46,1.79) 
   Vision impairment 1.6 2.0 1.26 (0.96,1.64) 1.22 (0.93,1.59) 
   Laceration 4.7 6.5 1.40** (1.20,1.63) 1.21* (1.03,1.41) 
   Delirium 4.3 6.8 1.65** (1.42,1.91) 1.47** (1.26,1.72) 
   Dislocation 0.8 1.0 1.23 (0.84,1.81) 1.21 (0.82,1.79) 
Comorbidities 
   Hypertension 89.3 92.4 1.45** (1.26,1.66) 1.27** (1.10,1.47) 
   CHF 50.3 54.6 1.19** (1.10,1.28) 1.11* (1.02,1.21) 
   Diabetes 38.7 39.1 1.02 (0.94,1.10) 0.95 (0.86,1.04) 
   Deficiency anemia 45.3 55.2 1.49** (1.38,1.60) 1.23** (1.13,1.33) 
   Chronic obstructive pulmonary  
   disease 33.2 32.7 0.98 (0.90,1.06) 0.94 (0.86,1.02) 
   Peripheral vascular disease 34.3 37.9 1.17** (1.08,1.26) 0.95 (0.88,1.03) 
   Hypothyroidism 27.4 30.6 1.17** (1.08,1.27) 1.04 (0.95,1.13) 
   Valvular disease 19.8 20.8 1.06 (0.97,1.17) 0.98 (0.89,1.07) 
   Other neurological 21.9 24.9 1.18** (1.08,1.29) 1.06 (0.96,1.16) 
   Diabetes, with complications 15.2 17.3 1.16** (1.05,1.28) 1.14* (1.01,1.29) 
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  0 visits, % ≥1 visits, % 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
   Renal failure 13.9 16.0 1.18** (1.06,1.31) 1.16* (1.03,1.30) 
   Tumor, no metastasis 9.5 9.6 1.01 (0.89,1.15) 0.98 (0.85,1.12) 
   Electrolyte disorder 19.4 22.2 1.19** (1.08,1.30) 0.99 (0.90,1.09) 
   Hypertension, with complications 19.4 18.8 0.96 (0.88,1.06) 0.80** (0.72,0.89) 
   Paralysis 2.6 3.5 1.36** (1.11,1.68) 1.20 (0.97,1.49) 
   Psychoses 19.3 23.3 1.27** (1.16,1.39) 1.05 (0.95,1.15) 
   Coagulation deficiency 5.2 5.6 1.09 (0.92,1.28) 0.95 (0.80,1.12) 
   Rheumatoid arthritis 4.2 4.7 1.14 (0.95,1.36) 1.00 (0.84,1.20) 
   Obesity 2.2 2.2 1.01 (0.79,1.30) 0.99 (0.76,1.28) 
   Pulmonary circulation disorder 3.1 3.3 1.09 (0.88,1.34) 1.01 (0.81,1.25) 
   Blood loss anemia 3.3 3.6 1.11 (0.91,1.36) 0.93 (0.76,1.14) 
   Metastatic cancer 0.9 1.2 1.29 (0.91,1.82) 1.24 (0.86,1.80) 
   Lymphoma 0.8 0.9 1.21 (0.81,1.79) 1.02 (0.68,1.53) 
   Liver disease 0.9 1.3 1.47* (1.06,2.05) 1.43* (1.02,2.02) 
   Alcohol abuse 1.1 1.1 1.03 (0.72,1.48) 0.98 (0.68,1.42) 
   Drug abuse 0.4 0.6 1.55 (0.95,2.52) 1.40 (0.86,2.29) 
   AIDS 0.0 0.1 3.99* (1.31,12.14) 4.39* (1.19,16.10) 
   Ulcer 0.2 0.2 1.11 (0.45,2.76) 0.94 (0.37,2.39) 
Constant         0.026** (0.02,0.03) 
**p<0.01, *p<0.05 
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Appendix Table 3. Characteristics and comorbidities associated with geriatric care in first year following initial geriatric 
diagnosis, CHF subsample 
(For inclusion in an online appendix) 
  0 visits, % ≥1 visits, % 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
Sample 88,867 4,088 
Female 34.0 29.6 1.22** (1.14,1.31) 1.06 (0.99,1.15) 
Nonwhite 11.7 14.7 1.30** (1.19,1.42) 1.28** (1.16,1.42) 
Dual eligible 24.4 24.1 0.98 (0.91,1.06) 0.91* (0.84,0.99) 
Age 
   75 or younger 23.8 17.8 
   76-80 22.5 20.7 0.90** (0.83,0.97) 1.17** (1.05,1.30) 
   81-85 24.7 25.9 1.07 (0.99,1.14) 1.27** (1.15,1.41) 
   86 or older 29.0 35.6 1.35** (1.26,1.44) 1.44** (1.30,1.59) 
Income 
   1st quartile 25.3 18.2 
   2nd quartile 25.3 18.8 0.69** (0.63,0.74) 0.97 (0.87,1.07) 
   3rd quartile 24.9 26.9 1.11** (1.04,1.19) 1.14* (1.02,1.26) 
   4th quartile 24.5 36.1 1.74** (1.63,1.86) 1.33** (1.20,1.48) 
Metropolitan status 
   Metropolitan area 68.2 87.2 
   Micropolitan area 15.5 7.5 0.44** (0.39,0.49) 0.47** (0.41,0.53) 
   Small town 9.4 3.1 0.31** (0.26,0.37) 0.33** (0.27,0.39) 
   Rural area 6.9 2.2 0.30** (0.25,0.37) 0.32** (0.26,0.40) 
Geriatric conditions 
   Stroke 29.5 34.5 1.26** (1.18,1.35) 1.13** (1.06,1.22) 
   Dementia 23.3 39.4 2.13** (2.00,2.28) 1.69** (1.57,1.82) 
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  0 visits, % ≥1 visits, % 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
   Osteoporosis 19.4 23.3 1.26** (1.17,1.35) 1.29** (1.19,1.40) 
   Urinary incontinence 9.6 12.0 1.29** (1.17,1.42) 1.31** (1.18,1.44) 
   Depression 20.9 33.0 1.87** (1.74,2.00) 1.69** (1.58,1.82) 
   Dehydration 23.8 26.9 1.18** (1.10,1.26) 1.08* (1.01,1.17) 
   Hearing impairment 6.5 6.2 0.94 (0.82,1.07) 1.01 (0.88,1.15) 
   Syncope 18.6 19.0 1.02 (0.94,1.11) 1.09* (1.01,1.19) 
   Fracture 19.0 24.2 1.36** (1.27,1.47) 1.35** (1.25,1.46) 
   Pressure 6.0 11.2 1.96** (1.77,2.17) 1.55** (1.39,1.73) 
   Weight loss/failure to thrive 10.3 16.1 1.68** (1.54,1.83) 1.47** (1.35,1.61) 
   Vision impairment 1.9 2.0 1.07 (0.86,1.34) 1.08 (0.86,1.36) 
   Laceration 6.0 7.4 1.24** (1.10,1.40) 1.16* (1.03,1.32) 
   Delirium 2.2 4.8 2.22** (1.91,2.58) 1.49** (1.27,1.75) 
   Dislocation 1.7 1.1 0.67** (0.50,0.90) 0.84 (0.62,1.14) 
Comorbidities 
   Hypertension 91.7 94.5 1.56** (1.36,1.79) 1.34** (1.16,1.54) 
   CHF 100.0 100.0 1.00 (1.00,1.00) 1.00 (1.00,1.00) 
   Diabetes 48.5 48.4 0.99 (0.93,1.06) 0.95 (0.88,1.03) 
   Deficiency anemia 50.8 61.2 1.53** (1.43,1.63) 1.20** (1.12,1.28) 
   Chronic obstructive pulmonary  
   disease 45.8 44.8 0.96 (0.90,1.03) 0.98 (0.92,1.05) 
   Peripheral vascular disease 35.8 42.0 1.30** (1.22,1.39) 1.06 (1.00,1.14) 
   Hypothyroidism 28.9 33.0 1.21** (1.13,1.30) 1.08* (1.01,1.16) 
   Valvular disease 32.2 32.6 1.02 (0.95,1.09) 0.99 (0.92,1.06) 
   Other neurological 13.3 19.2 1.55** (1.43,1.68) 1.15** (1.06,1.26) 
   Diabetes, with complications 22.1 24.7 1.16** (1.07,1.24) 1.16** (1.06,1.27) 
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  0 visits, % ≥1 visits, % 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
   Renal failure 23.1 26.1 1.17** (1.09,1.26) 1.18** (1.09,1.28) 
   Tumor, no metastasis 11.7 11.7 1.00 (0.91,1.11) 1.03 (0.93,1.15) 
   Electrolyte disorder 23.1 28.6 1.33** (1.24,1.43) 1.11** (1.03,1.20) 
   Hypertension, with complications 28.0 27.7 0.99 (0.92,1.06) 0.86** (0.79,0.93) 
   Paralysis 2.2 3.0 1.37** (1.14,1.65) 1.10 (0.90,1.33) 
   Psychoses 9.6 17.5 2.00** (1.84,2.18) 1.24** (1.13,1.36) 
   Coagulation deficiency 7.6 9.6 1.30** (1.16,1.44) 1.18** (1.06,1.32) 
   Rheumatoid arthritis 6.3 7.3 1.18** (1.04,1.33) 1.10 (0.97,1.25) 
   Obesity 4.8 4.9 1.01 (0.87,1.17) 1.12 (0.96,1.30) 
   Pulmonary circulation disorder 5.7 6.5 1.16* (1.02,1.31) 1.15* (1.00,1.31) 
   Blood loss anemia 4.4 4.8 1.10 (0.95,1.27) 0.95 (0.82,1.11) 
   Metastatic cancer 1.5 1.5 0.98 (0.75,1.27) 0.97 (0.74,1.28) 
   Lymphoma 1.2 1.5 1.22 (0.94,1.58) 1.16 (0.89,1.52) 
   Liver disease 1.4 1.8 1.28* (1.01,1.63) 1.19 (0.93,1.53) 
   Alcohol abuse 0.9 1.3 1.50** (1.13,1.98) 1.41* (1.05,1.89) 
   Drug abuse 0.4 0.7 1.93** (1.31,2.84) 1.60* (1.07,2.40) 
   AIDS 0.0 0.1 3.53** (1.49,8.37) 2.70* (1.05,6.90) 
   Ulcer 0.2 0.1 0.71 (0.29,1.72) 0.64 (0.26,1.60) 
Constant         0.01** (0.01,0.01) 
**p<0.01, *p<0.05  
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Appendix Table 4. Comorbidity prevalence, first month of study period  
Comm. NH**  Comm. NH** 
Stroke 0.204 0.332 Peripheral vascular 0.180 0.347 
Osteoporosis 0.162 0.159 Hypothyroidism 0.180 0.249 
Dehydration 0.152 0.143 Valvular disease 0.156 0.193 
Dementia 0.132 0.443 Complicated diabetes 0.109 0.167 
Fracture 0.127 0.165 Tumor, no metastasis 0.106 0.091 
Syncope 0.125 0.063 Renal failure 0.105 0.170 
Depression 0.116 0.163 Complicated hypertension 0.090 0.091 
Urinary incontinence 0.071 0.078 Electrolyte disorder 0.082 0.107 
Weight loss 0.069 0.062 Other neurological 0.073 0.185 
Hearing impairment 0.055 0.039 Rheumatoid arthritis 0.044 0.046 
Laceration 0.035 0.031 Coagulation deficiency 0.025 0.024 
Pressure ulcer 0.027 0.071 Psychoses 0.022 0.092 
Dislocation 0.019 0.004 Obesity 0.020 0.029 
Vision impairment 0.012 0.018 Metastatic cancer 0.020 0.017 
Delirium 0.010 0.022 Pulmonary circ. disorder 0.015 0.018 
Failure to thrive 0.007 0.018 Paralysis 0.013 0.035 
Hypertension 0.767 0.844 Blood loss anemia 0.013 0.014 
Diabetes 0.344 0.429 Lymphoma 0.011 0.010 
Congestive heart failure 0.341 0.602 Liver disease 0.008 0.010 
Deficiency anemia 0.267 0.471 Alcohol abuse 0.006 0.009 
Chronic obstructive pulmonary disease 0.267 0.367    
**Differences between samples are statistically significant at p<0.01 for all comorbidities  
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Appendix Table 5. Change in predicted probability of ED use in one month associated with month, time, and comorbidities  
Sample Comm. Comm. NH NH 
Model Logit LPM Logit LPM 
FE? No Yes No Yes 
Month (omitted: December) 
    January 0.002** 0.000 0.005** 0.005** 
(0.001, 0.002) (-0.001,0.001) (0.003, 0.006) (0.002,0.007) 
    February 0.002** 0.001 -0.002** -0.003 
(0.001, 0.003) (-0.000,0.002) (-0.004, -0.001) (-0.005,0.000) 
    March -0.001 -0.002** -0.006** -0.006** 
(-0.001, -0.000) (-0.003,-0.000) (-0.008, -0.004) (-0.008,-0.003) 
    April -0.003** -0.004** -0.010** -0.010** 
(-0.004, -0.002) (-0.005,-0.003) (-0.012, -0.009) (-0.013,-0.008) 
    May -0.003** -0.004** -0.009** -0.009** 
(-0.004, -0.003) (-0.005,-0.003) (-0.011, -0.008) (-0.012,-0.006) 
    June -0.004** -0.004** -0.013** -0.013** 
(-0.004, -0.003) (-0.006,-0.003) (-0.014, -0.012) (-0.016,-0.010) 
    July -0.006** -0.007** -0.014** -0.015** 
(-0.006, -0.005) (-0.008,-0.006) (-0.016, -0.014) (-0.018,-0.012) 
    August -0.005** -0.007** -0.014** -0.014** 
(-0.006, -0.005) (-0.008,-0.005) (-0.016, -0.013) (-0.017,-0.012) 
    September -0.005** -0.006** -0.010** -0.011** 
(-0.005, -0.004) (-0.007,-0.005) (-0.012, -0.009) (-0.013,-0.008) 
    October -0.006** -0.007** -0.012** -0.013** 
(-0.007, -0.005) (-0.008,-0.006) (-0.014, -0.011) (-0.015,-0.010) 
    November -0.005** -0.005** -0.012** -0.013** 
(-0.005, -0.005) (-0.006,-0.004) (-0.012, -0.010) (-0.015,-0.010) 
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Sample Comm. Comm. NH NH 
Model Logit LPM Logit LPM 
FE? No Yes No Yes 
Month in study 0.001** 0.002** -0.002** -0.001** 
(0.001, 0.001) (0.002,0.002) (-0.002, -0.002) (-0.001,-0.001) 
Month in study squared -0.000** -0.000** 0.000** 0.000** 
(-0.000, -0.000) (-0.000,-0.000) (0.000, 0.000) (-0.000,0.000) 
Stroke 0.015** 0.035** 0.010** 0.033** 
(0.014, 0.015) (0.033,0.037) (0.009, 0.011) (0.028,0.037) 
Dementia 0.020** 0.031** 0.007** 0.027** 
(0.019, 0.021) (0.029,0.033) (0.007, 0.009) (0.023,0.031) 
Osteoporosis 0.004** 0.019** 0.010** 0.022** 
(0.003, 0.005) (0.017,0.021) (0.008, 0.011) (0.017,0.027) 
Urinary incontinence 0.009** 0.005** 0.008** 0.003 
(0.008, 0.010) (0.002,0.008) (0.005, 0.011) (-0.003,0.009) 
Depression 0.091** 0.095** 0.042** 0.057** 
(0.090, 0.092) (0.094,0.097) (0.039, 0.044) (0.055,0.059) 
Dehydration 0.153** 0.208** 0.173** 0.231** 
(0.149, 0.156) (0.206,0.210) (0.169, 0.176) (0.228,0.235) 
Hearing impairment 0.004** 0.009** 0.001 0.008* 
(0.003, 0.005) (0.005,0.012) (-0.001, 0.002) (0.000,0.016) 
Syncope 0.158** 0.175** 0.123** 0.158** 
(0.157, 0.160) (0.173,0.176) (0.121, 0.128) (0.154,0.163) 
Fracture 0.091** 0.097** 0.076** 0.091** 
(0.090, 0.093) (0.096,0.099) (0.075, 0.079) (0.088,0.094) 
Pressure 0.025** 0.050** 0.023** 0.046** 
(0.023, 0.027) (0.047,0.054) (0.021, 0.026) (0.042,0.050) 
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Sample Comm. Comm. NH NH 
Model Logit LPM Logit LPM 
FE? No Yes No Yes 
Weight loss 0.037** 0.043** 0.025** 0.041** 
(0.035, 0.038) (0.041,0.046) (0.024, 0.029) (0.036,0.045) 
Vision impairment 0.013** 0.032** 0.007* 0.032** 
(0.011, 0.015) (0.026,0.039) (0.002, 0.012) (0.020,0.045) 
Failure to thrive 0.059** 0.112** 0.031** 0.050** 
(0.054, 0.069) (0.104,0.120) (0.023, 0.035) (0.042,0.059) 
Laceration 0.129** 0.144** 0.104** 0.130** 
(0.126, 0.133) (0.141,0.147) (0.096, 0.113) (0.125,0.136) 
Delirium 0.109** 0.161** 0.136** 0.177** 
(0.102, 0.111) (0.154,0.168) (0.130, 0.142) (0.169,0.185) 
Dislocation 0.037** 0.036** 0.078** 0.097** 
(0.034, 0.042) (0.032,0.039) (0.075, 0.088) (0.080,0.113) 
Hypertension 0.022** 0.041** 0.022** 0.046** 
(0.022, 0.023) (0.039,0.042) (0.020, 0.024) (0.041,0.052) 
Congestive heart failure 0.018** 0.037** 0.013** 0.035** 
(0.018, 0.019) (0.035,0.038) (0.011, 0.014) (0.031,0.039) 
Diabetes 0.002** 0.008** 0.003** 0.012** 
(0.002, 0.004) (0.006,0.010) (0.002, 0.004) (0.007,0.018) 
Deficiency anemia 0.003** 0.009** 0.000 0.006** 
(0.003, 0.004) (0.007,0.010) (-0.001, 0.001) (0.003,0.010) 
COPD 0.021** 0.031** 0.019** 0.038** 
(0.020, 0.022) (0.030,0.033) (0.018, 0.020) (0.033,0.042) 
Peripheral vascular disease 0.004** 0.012** -0.004** 0.001 
(0.004, 0.005) (0.010,0.013) (-0.005, -0.003) (-0.002,0.004) 
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Sample Comm. Comm. NH NH 
Model Logit LPM Logit LPM 
FE? No Yes No Yes 
Hypothyroidism 0.002** 0.012** 0.003** 0.017** 
(0.001, 0.003) (0.010,0.014) (0.002, 0.005) (0.012,0.022) 
Valvular disease 0.008** 0.026** 0.015** 0.047** 
(0.007, 0.008) (0.024,0.027) (0.014, 0.017) (0.042,0.052) 
Other neurological 0.021** 0.036** 0.019** 0.042** 
(0.020, 0.021) (0.034,0.039) (0.018, 0.022) (0.037,0.046) 
Diabetes w/complications 0.006** 0.015** 0.007** 0.008** 
(0.005, 0.006) (0.013,0.017) (0.006, 0.008) (0.003,0.013) 
Renal failure 0.003** 0.028** 0.009** 0.045** 
(0.002, 0.004) (0.027,0.030) (0.007, 0.010) (0.041,0.048) 
Tumor, no metastasis 0.003** 0.009** 0.006** 0.014** 
(0.002, 0.004) (0.007,0.012) (0.004, 0.008) (0.007,0.022) 
Electrolyte disorder 0.116** 0.181** 0.099** 0.148** 
(0.114, 0.117) (0.179,0.183) (0.096, 0.101) (0.145,0.151) 
Hypertension 
w/complications 0.062** 0.099** 0.084** 0.140** 
(0.060, 0.064) (0.098,0.101) (0.081, 0.088) (0.136,0.143) 
Paralysis 0.008** 0.042** 0.007** 0.032** 
(0.007, 0.009) (0.037,0.047) (0.005, 0.008) (0.023,0.042) 
Psychoses 0.048** 0.069** 0.036** 0.059** 
(0.046, 0.050) (0.066,0.071) (0.034, 0.038) (0.056,0.062) 
Coagulation deficiency 0.036** 0.068** 0.040** 0.071** 
(0.033, 0.039) (0.066,0.071) (0.036, 0.047) (0.065,0.076) 
Rheumatoid arthritis 0.006** 0.008** 0.009** 0.012* 
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Sample Comm. Comm. NH NH 
Model Logit LPM Logit LPM 
FE? No Yes No Yes 
(0.005, 0.006) (0.004,0.011) (0.006, 0.011) (0.001,0.022) 
Obesity 0.010** 0.023** 0.009** 0.026** 
(0.009, 0.012) (0.020,0.026) (0.002, 0.011) (0.016,0.036) 
Pulmonary circulation 
disorder 0.076** 0.119** 0.079** 0.123** 
(0.072, 0.080) (0.116,0.122) (0.072, 0.084) (0.115,0.130) 
Blood loss anemia 0.066** 0.110** 0.074** 0.119** 
(0.061, 0.069) (0.106,0.114) (0.069, 0.080) (0.111,0.126) 
Metastatic cancer 0.021** 0.054** 0.017** 0.064** 
(0.020, 0.022) (0.049,0.058) (0.010, 0.021) (0.050,0.078) 
Lymphoma 0.006** 0.017** 0.001 0.041** 
(0.004, 0.007) (0.010,0.025) (-0.004, 0.006) (0.016,0.067) 
Liver disease 0.010** 0.029** 0.004 0.009 
(0.007, 0.012) (0.023,0.035) (-0.000, 0.009) (-0.008,0.025) 
Alcohol abuse 0.022** 0.057** 0.012** 0.027* 
(0.021, 0.026) (0.050,0.065) (0.008, 0.015) (0.005,0.049) 
    
Observations 5,277,762 5,277,762 1,005,122 1,005,122 
** p<0.01, * p<0.05 
95% confidence intervals in parentheses.  
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Appendix Table 6. Comparison of IV and FE estimates  
Sample Comm. Comm. Comm. NH NH NH 
Dependent variable ED use ED use Geriatric care ED use ED use Geriatric care 
Model LPM, FE IV IV LPM, FE IV IV 
Geriatric care in previous 6 months 
Any geriatric care 
(reference: 0 visits) -0.009** -0.074** -0.117** 
(-0.012,-0.006) (-0.077, -0.071) (-0.121, -0.112) 
Instrumental variables 
Geriatrician supply 0.001** 0.004** 
(0.001, 0.001) (0.003, 0.006) 
Differential distance to 
geriatrician -0.000** -0.001** 
(-0.000, -0.000) (-0.002, -0.000) 
Control variables 
Age (omitted: 66-74) 
    75-79 -0.001 -0.001 0.002** -0.003 -0.006** 0.003 
(-0.003,0.000) (-0.002, 0.000) (0.001, 0.004) (-0.010,0.003) (-0.009, -0.001) (-0.004, 0.009) 
    80-84 0.000 0.003** 0.004** -0.006 -0.007** 0.005 
(-0.003,0.002) (0.002, 0.004) (0.003, 0.005) (-0.014,0.002) (-0.011, -0.002) (-0.001, 0.012) 
    85-89 0.001 0.007** 0.008** -0.004 -0.009** 0.002 
(-0.002,0.004) (0.006, 0.008) (0.007, 0.010) (-0.013,0.006) (-0.013, -0.006) (-0.003, 0.008) 
    90+ 0.007** 0.012** 0.010** 0.002 -0.008** 0.008* 
(0.003,0.011) (0.010, 0.013) (0.008, 0.012) (-0.009,0.013) (-0.011, -0.004) (0.004, 0.017) 
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Male N/A -0.003** -0.001 N/A 0.009** 0.002 
(-0.004, -0.002) (-0.002, 0.000) (0.006, 0.011) (-0.001, 0.006) 
Nonwhite N/A 0.004** 0.003** N/A 0.000 0.005 
(0.003, 0.005) (0.002, 0.004) (-0.005, 0.003) (-0.001, 0.010) 
Dual eligible -0.003* 0.016** -0.001 -0.010** -0.009** -0.005** 
(-0.006,-0.001) (0.015, 0.017) (-0.002, 0.000) (-0.014,-0.007) (-0.011, -0.006) (-0.010, -0.003) 
ZIP income quartile (omitted: First quartile) 
    Second -0.007** 0.000 -0.001 -0.014** -0.002 0.003 
(-0.011,-0.003) (-0.000, 0.001) (-0.002, 0.000) (-0.022,-0.006) (-0.007, 0.001) (-0.003, 0.007) 
    Third -0.011** -0.001 0.001 -0.019** -0.004 0.007* 
(-0.015,-0.007) (-0.002, 0.000) (-0.000, 0.003) (-0.027,-0.011) (-0.007, -0.000) (-0.000, 0.012) 
    Fourth -0.020** -0.004** 0.002** -0.039** -0.004 0.012** 
(-0.024,-0.015) (-0.005, -0.003) (0.000, 0.003) (-0.048,-0.030) (-0.009, 0.000) (0.004, 0.016) 
Metropolitan status (omitted: Metropolitan area) 
    Micropolitan area 0.001 0.012** -0.006** -0.003 -0.007** -0.023** 
(-0.003,0.006) (0.011, 0.013) (-0.007, -0.005) (-0.015,0.009) (-0.010, -0.003) (-0.029, -0.018) 
    Small town 0.007* 0.018** -0.008** -0.001 0.000 -0.030** 
(0.001,0.012) (0.016, 0.020) (-0.009, -0.007) (-0.014,0.013) (-0.003, 0.004) (-0.036, -0.025) 
    Rural area 0.008* 0.015** -0.008** 0.002 -0.004 -0.031** 
  (0.001,0.014) (0.013, 0.016) (-0.009, -0.007) (-0.014,0.017) (-0.007, 0.002) (-0.037, -0.024) 
 
 
 
  
  
 
 
 
156
Appendix Table 7. Comparison of 2SRI and FE estimates  
Sample Comm. Comm. NH NH 
Model FE 2SRI FE 2SRI 
Geriatric care in previous 6 months    
Any geriatric care  
(reference: 0 visits) 
-0.009** -0.090** -0.011** -0.134** 
    
Number of geriatrician visits 
(reference: 0 visits) 
   
   1 visit -0.006** 0.908** -0.003 0.858** 
   2 visits -0.012** 0.913** -0.012** 0.870** 
   ≥3 visits -0.013** 0.916** -0.018** 0.881** 
    
Physician use  
(reference: FM/IM plurality)  
  
   GM plurality -0.008** 0.749** -0.009** 0.825** 
   GM consultation -0.009** -0.236** -0.010** -0.150** 
   Specialist plurality 0.001 -0.203** 0.009** -0.103** 
** p<0.01, * p<0.05.  
Bias-corrected confidence intervals for odds ratios in 2SRI models were estimated using bootstrapping 250 random samples.  
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Appendix Figure 1. Percent change in likelihood of in
95% confidence intervals shown.  
Percent change calculated as change in predicted probability of in
Table 8) multiplied by 100. 
  
 
-hospital death associated with geriatric care  
-hospital death (Appendix Table 9) divided by the sample mean of in
 
-hospital death (Appendix 
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Appendix Table 8. Descriptive statistics for in-hospital death analysis  
Comm. NH**   Comm.  NH**         
Observations 72,244 36,796 Geriatric care during previous 6 months  
Any geriatric care 0.020 0.058 
Demographic characteristics   
Age Number of geriatrician visits   
   66-74 0.133 0.079     0 visits 0.980 0.943 
   75-79 0.179 0.127     1 visit 0.007 0.013 
   80-84 0.231 0.217     2 visits 0.005 0.009 
   85-89 0.230 0.261     ≥3 visits 0.008 0.036 
   90+ 0.226 0.315   
Male 0.432 0.320 Physician use   
Nonwhite 0.109 0.110     GM plurality 0.009 0.027 
Dual eligible 0.197 0.399     GM consultation 0.011 0.030 
ZIP median income $42,095 $44,295     Specialist plurality 0.265 0.083 
Metropolitan status     FM/IM plurality 0.715 0.859 
   Metropolitan area 0.677 0.736   
   Micropolitan area 0.158 0.128 Dependent variable   
   Small town 0.094 0.080 In-hospital death 0.420 0.277 
   Rural area 0.071 0.056   
Comorbidities, median 5 7   
**Differences between samples are statistically significant at p<0.05 for all variables except nonwhite. 
Month indicators, time trends, and comorbidities omitted. 
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Appendix Table 9. Change in predicted probability of in-hospital death 
Sample Comm. Comm. NH NH 
Model Logit LPM Logit LPM 
FE? No Yes No Yes 
Geriatric care in previous 6 months 
Any geriatric care (reference: 0 visits) 
(reference: 0 visits) -0.053** -0.057** -0.029** -0.023* 
(-0.075, -0.034) (-0.081,-0.032) (-0.039, -0.019) (-0.043,-0.003) 
 
Number of geriatrician visits (reference: 0 visits) 
   1 visit -0.067** -0.072** -0.043* -0.045* 
(-0.108, -0.038) (-0.112,-0.032) (-0.076, -0.005) (-0.084,-0.005) 
   2 visits -0.030 -0.033 0.002 0.006 
(-0.083, 0.029) (-0.082,0.016) (-0.036, 0.043) (-0.042,0.054) 
   ≥3 visits -0.056** -0.057** -0.031** -0.022 
(-0.091, -0.008) (-0.095,-0.019) (-0.055, -0.012) (-0.046,0.002) 
  
Physician use (reference: FM/IM plurality) 
   GM plurality -0.035 -0.042* -0.031* -0.025 
(-0.065, 0.001) (-0.079,-0.006) (-0.062, -0.008) (-0.053,0.002) 
   GM consultation -0.047** -0.049** -0.020 -0.016 
(-0.067, -0.016) (-0.081,-0.017) (-0.039, 0.006) (-0.043,0.010) 
   Specialist plurality 0.044** 0.039** 0.043** 0.027** 
(0.038, 0.054) (0.031,0.048) (0.024, 0.055) (0.011,0.043) 
** p<0.01, * p<0.05. 95% confidence intervals in parentheses. Demographic variables, month indicators, and comorbidities omitted. 
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Appendix Table 10. Comparison of OLS and Poisson models with FE, community sample 
Model OLS Poisson OLS Poisson 
 # FM/IM # FM/IM # Specialist # Specialist 
Interpretation  % change IRR % change IRR 
Observations 1,006,879 874,297 1,006,879 874,297 
Geriatric care in previous 6 months  
Any geriatric care -13.7** 0.876** -3.3* 0.968** 
(reference: 0 visits) (-16.1,-11.3) (0.861,0.892) (-6.3,-0.3) (0.948,0.988) 
Number of geriatrician visits 
(reference:: 0 visits)  
1 visit -8.8** 0.934** -4.1* 0.957** 
(-11.9,-5.7) (0.912,0.956) (-7.9, -0.3) (0.931,0.983) 
2 visits -16.2** 0.843** -5.4* 0.948** 
(-20.0,-12.4) (0.816,0.870) (-10.1, -0.7) (0.916,0.981) 
≥ 3 visits -19.4** 0.811** -0.2 0.997 
  (-23.0,-15.8) (0.787,0.835) (-4.7, 4.3) (0.968,1.028) 
** p<0.01, * p<0.05 
IRR: Incidence rate ratio 
% change calculated as change in number of visits (Table 6.2) divided by the sample mean (Table 6.1) multiplied by 100.  
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Appendix Table 11. Comparison of OLS and Poisson models with FE, NH sample 
Dependent variable # FM/IM # FM/IM # Specialist # Specialist 
Model OLS Poisson OLS Poisson 
Interpretation  % change IRR % change IRR 
Observations 195,433 170,763 195,433 170,763 
 
    
Geriatric care in previous 6 months     
Any geriatric care -13.8** 0.855** -10.8** 0.912** 
(reference: 0 visits) (-16.7,-10.9) (0.841,0.869) (-17.7,-3.9) (0.882,0.942) 
     
Number of geriatrician visits 
(reference:: 0 visits)     
  1 visit -13.2** 0.896** -1.2 0.996 
 (-17.5,-8.9) (0.874,0.918) (-9.1,11.5) (0.947,1.048) 
  2 visits -10.4** 0.904** -8.5 0.928* 
 (-15.4, -5.4) (0.877,0.931) (-20.4,3.4) (0.871,0.989) 
  ≥ 3 visits -15.5** 0.802** -18.1** 0.852** 
 (-19.1,-11.9) (0.785,0.820) (-26.8,-9.4) (0.817,0.890) 
** p<0.01, * p<0.05 
IRR: Incidence rate ratio 
% change calculated as change in number of visits (Table 6.3) divided by the sample mean (Table 6.1) multiplied by 100.  
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Appendix Table 12. OLS results for change in physician visits in six months, 
community sample 
Dependent 
variable FM/IM FM/IM Specialty Specialty 
FE? No Yes No Yes 
Month (omitted: December) 
    January 0.612** 0.009 0.406** -0.008 
(0.576,0.648) (-0.041,0.059) (0.372,0.440) (-0.052,0.037) 
    February 0.635** -0.185** 0.436** -0.189** 
(0.598,0.673) (-0.244,-0.126) (0.400,0.472) (-0.241,-0.136) 
    March 0.610** -0.232** 0.474** -0.176** 
(0.573,0.646) (-0.291,-0.174) (0.440,0.509) (-0.229,-0.123) 
    April 0.629** -0.080** 0.475** -0.120** 
(0.594,0.665) (-0.134,-0.026) (0.440,0.509) (-0.168,-0.071) 
    May 0.645** 0.277** 0.502** 0.130** 
(0.610,0.679) (0.233,0.321) (0.469,0.536) (0.091,0.169) 
    June 0.619** 0.538** 0.526** 0.484** 
(0.595,0.643) (0.514,0.561) (0.505,0.547) (0.462,0.505) 
    July 0.490** -0.101** 0.343** -0.069** 
(0.457,0.523) (-0.150,-0.052) (0.311,0.375) (-0.113,-0.025) 
    August 0.152** -0.430** 0.134** -0.328** 
(0.118,0.186) (-0.488,-0.373) (0.101,0.166) (-0.379,-0.277) 
    September -0.056** -0.607** 0.015 -0.441** 
(-0.090,-0.021) (-0.666,-0.548) (-0.017,0.047) (-0.494,-0.389) 
    October -0.192** -0.574** -0.116** -0.483** 
(-0.224,-0.159) (-0.627,-0.521) (-0.147,-0.085) (-0.530,-0.435) 
    November -0.269** -0.376** -0.178** -0.360** 
(-0.301,-0.238) (-0.419,-0.334) (-0.209,-0.148) (-0.398,-0.322) 
Month in study -0.326** -0.338** -0.244** -0.320** 
(-0.339,-0.313) (-0.350,-0.326) (-0.255,-0.232) (-0.331,-0.309) 
Month squared 0.007** 0.010** 0.005** 0.015** 
(0.005,0.008) (0.009,0.012) (0.003,0.006) (0.013,0.016) 
Stroke 0.098** -0.121** -0.022 -0.176** 
(0.075,0.121) (-0.149,-0.094) (-0.044,0.000) (-0.201,-0.151) 
Dementia -0.161** -0.177** -0.525** -0.282** 
(-0.184,-0.137) (-0.207,-0.147) (-0.546,-0.504) (-0.309,-0.255) 
Osteoporosis 0.184** -0.162** 0.167** -0.225** 
(0.161,0.207) (-0.192,-0.132) (0.144,0.190) (-0.252,-0.198) 
Urinary 
incontinence 0.217** -0.152** 0.602** 0.024 
(0.188,0.247) (-0.192,-0.111) (0.570,0.633) (-0.012,0.060) 
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Dependent 
variable FM/IM FM/IM Specialty Specialty 
FE? No Yes No Yes 
Depression 0.611** 0.457** -0.180** -0.033** 
(0.583,0.638) (0.436,0.478) (-0.202,-0.158) (-0.052,-0.015) 
Dehydration -0.036* 0.239** -0.326** 0.01 
(-0.063,-0.008) (0.218,0.260) (-0.351,-0.302) (-0.008,0.029) 
Hearing 
impairment 0.073** -0.302** 0.290** -0.251** 
(0.039,0.106) (-0.349,-0.256) (0.253,0.328) (-0.292,-0.209) 
Syncope 0.301** 0.269** 0.271** 0.206** 
(0.274,0.328) (0.249,0.290) (0.246,0.296) (0.188,0.225) 
Fracture 0.242** 0.354** -0.292** -0.176** 
(0.215,0.269) (0.333,0.375) (-0.315,-0.270) (-0.195,-0.158) 
Pressure 0.213** 0.529** -0.338** 0.067** 
(0.149,0.276) (0.485,0.572) (-0.392,-0.285) (0.028,0.106) 
Weight loss 0.222** 0.385** -0.043* 0.143** 
(0.186,0.258) (0.356,0.413) (-0.077,-0.010) (0.118,0.169) 
Vision 
impairment -0.161** -0.173** -0.185** -0.257** 
(-0.226,-0.096) (-0.264,-0.082) (-0.251,-0.119) (-0.338,-0.176) 
Failure to thrive 0.176** 0.479** -0.591** -0.109** 
(0.063,0.289) (0.392,0.565) (-0.669,-0.513) (-0.186,-0.032) 
Laceration 0.717** 0.515** 0.142** -0.011 
(0.658,0.777) (0.477,0.553) (0.092,0.193) (-0.045,0.023) 
Delirium 0.179** 0.324** -0.470** -0.141** 
(0.087,0.271) (0.254,0.395) (-0.535,-0.404) (-0.204,-0.078) 
Dislocation 0.095** -0.056* -0.009 -0.222** 
(0.029,0.161) (-0.108,-0.004) (-0.067,0.048) (-0.268,-0.175) 
Hypertension 0.734** 0.341** 0.323** 0.100** 
(0.707,0.761) (0.306,0.376) (0.295,0.350) (0.069,0.131) 
CHF 0.309** 0.035** 0.055** -0.012 
(0.287,0.330) (0.009,0.060) (0.035,0.076) (-0.035,0.011) 
Diabetes 0.100** -0.331** -0.131** -0.307** 
(0.077,0.122) (-0.360,-0.301) (-0.153,-0.110) (-0.333,-0.281) 
Deficiency 
anemia 0.417** 0.140** 0.501** 0.174** 
(0.396,0.438) (0.115,0.166) (0.481,0.521) (0.152,0.197) 
COPD 0.339** -0.096** 0.174** -0.085** 
(0.318,0.360) (-0.123,-0.069) (0.153,0.195) (-0.110,-0.061) 
PVD 0.216** -0.044** 0.161** -0.052** 
(0.194,0.238) (-0.071,-0.017) (0.140,0.183) (-0.076,-0.027) 
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Dependent 
variable FM/IM FM/IM Specialty Specialty 
FE? No Yes No Yes 
Hypothyroidism 0.183** -0.270** 0.155** -0.226** 
(0.161,0.205) (-0.301,-0.240) (0.134,0.177) (-0.254,-0.199) 
Valvular disease 0.136** -0.124** 0.568** 0.068** 
(0.112,0.159) (-0.153,-0.095) (0.544,0.592) (0.042,0.094) 
Other 
neurological 0.115** -0.045* 0.164** -0.052** 
(0.084,0.145) (-0.081,-0.008) (0.134,0.193) (-0.085,-0.020) 
Diabetes 
w/complications 0.166** -0.211** 0.279** -0.120** 
(0.135,0.196) (-0.246,-0.175) (0.249,0.309) (-0.152,-0.088) 
Renal failure -0.169** -0.053** 0.118** -0.014 
(-0.198,-0.140) (-0.083,-0.023) (0.090,0.147) (-0.041,0.012) 
Tumor, no 
metastasis -0.037** -0.301** 0.885** 0.337** 
(-0.065,-0.009) (-0.339,-0.263) (0.853,0.917) (0.303,0.371) 
Electrolyte 
disorder 0.437** 0.491** 0.058** 0.190** 
(0.407,0.467) (0.470,0.513) (0.030,0.086) (0.170,0.209) 
Hypertension, 
complications 0.364** 0.428** 0.535** 0.433** 
(0.338,0.390) (0.408,0.448) (0.509,0.561) (0.415,0.452) 
Paralysis -0.166** -0.037 -0.197** -0.055 
(-0.233,-0.100) (-0.117,0.043) (-0.263,-0.132) (-0.126,0.016) 
Psychoses 0.469** 0.404** 0.248** 0.134** 
(0.423,0.515) (0.368,0.440) (0.205,0.292) (0.102,0.166) 
Coagulation 
deficiency 0.710** 0.461** 0.866** 0.480** 
(0.654,0.766) (0.424,0.498) (0.805,0.927) (0.447,0.513) 
Rheumatoid 
arthritis 0.365** -0.147** 0.822** 0.053* 
(0.325,0.406) (-0.198,-0.097) (0.776,0.868) (0.008,0.098) 
Obesity 0.185** 0.028 0.075** 0.037 
(0.133,0.237) (-0.032,0.088) (0.024,0.127) (-0.017,0.090) 
Pulm. circulation 
disorder 0.614** 0.573** 0.462** 0.422** 
(0.550,0.678) (0.531,0.616) (0.402,0.523) (0.384,0.460) 
Blood loss 
anemia 0.395** 0.476** 0.290** 0.273** 
(0.327,0.463) (0.429,0.523) (0.219,0.361) (0.231,0.315) 
Metastatic -0.418** -0.179** 0.993** 0.173** 
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Dependent 
variable FM/IM FM/IM Specialty Specialty 
FE? No Yes No Yes 
cancer 
(-0.481,-0.356) (-0.249,-0.109) (0.907,1.080) (0.111,0.235) 
Lymphoma -0.056 -0.397** 1.759** 0.328** 
(-0.135,0.024) (-0.501,-0.294) (1.641,1.877) (0.236,0.420) 
Liver disease 0.135** -0.301** 0.324** -0.206** 
(0.045,0.225) (-0.404,-0.198) (0.225,0.424) (-0.298,-0.114) 
Alcohol abuse -0.276** -0.366** -0.632** -0.122* 
(-0.364,-0.188) (-0.486,-0.245) (-0.711,-0.552) (-0.230,-0.015) 
** p<0.01, * p<0.05 
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Appendix Table 13. OLS results for change in physician visits in six months, NH 
sample 
Dependent 
variable FM/IM FM/IM Specialty Specialty 
Fixed effects? No Yes No Yes 
Month (omitted: 
December)  
    January 0.753** -0.216 0.219** -0.011 
(0.609,0.897) (-0.441,0.009) (0.141,0.298) (-0.130,0.109) 
    February 0.863** -0.421** 0.196** -0.076 
(0.713,1.014) (-0.690,-0.151) (0.116,0.275) (-0.219,0.068) 
    March 0.791** -0.479** 0.234** -0.113 
(0.645,0.936) (-0.752,-0.206) (0.155,0.313) (-0.258,0.033) 
    April 0.950** -0.051 0.258** 0.123 
(0.804,1.095) (-0.307,0.205) (0.181,0.335) (-0.014,0.259) 
    May 0.916** 0.318** 0.242** 0.115* 
(0.775,1.057) (0.114,0.522) (0.168,0.316) (0.006,0.223) 
    June 0.846** 0.736** 0.222** 0.227** 
(0.740,0.952) (0.632,0.839) (0.167,0.278) (0.171,0.282) 
    July 0.695** -0.406** 0.145** -0.088 
(0.556,0.833) (-0.627,-0.185) (0.074,0.216) (-0.205,0.030) 
    August 0.205** -0.885** 0.021 -0.197** 
(0.070,0.339) (-1.149,-0.622) (-0.049,0.092) (-0.338,-0.057) 
    September -0.065 -1.110** -0.016 -0.255** 
(-0.201,0.071) (-1.382,-0.837) (-0.090,0.059) (-0.400,-0.110) 
    October -0.374** -0.971** -0.101** -0.128 
(-0.506,-0.242) (-1.221,-0.720) (-0.169,-0.032) (-0.261,0.006) 
    November -0.400** -0.738** -0.125** -0.185** 
(-0.531,-0.270) (-0.937,-0.539) (-0.191,-0.059) (-0.291,-0.079) 
Month in study -2.016** -2.313** -0.428** -0.540** 
(-2.076,-1.956) (-2.371,-2.254) (-0.459,-0.398) (-0.571,-0.509) 
Month squared 0.189** 0.222** 0.039** 0.048** 
(0.181,0.197) (0.215,0.230) (0.035,0.042) (0.044,0.053) 
Stroke 0.144** -0.294** -0.015 -0.108** 
(0.068,0.220) (-0.423,-0.164) (-0.054,0.025) (-0.177,-0.039) 
Dementia 0.053 -0.051 -0.336** -0.081* 
(-0.020,0.126) (-0.183,0.081) (-0.378,-0.295) (-0.151,-0.011) 
Osteoporosis -0.039 -0.805** -0.003 -0.226** 
(-0.122,0.044) (-0.940,-0.670) (-0.047,0.041) (-0.298,-0.154) 
Urinary 
incontinence 0.057 -0.350** 0.263** 0.017 
(-0.049,0.162) (-0.523,-0.177) (0.206,0.320) (-0.075,0.109) 
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Dependent 
variable FM/IM FM/IM Specialty Specialty 
Fixed effects? No Yes No Yes 
Depression 0.838** 0.773** 0.03 0.101** 
(0.761,0.914) (0.700,0.846) (-0.009,0.069) (0.063,0.140) 
Dehydration 0.012 0.477** -0.070** 0.063** 
(-0.081,0.104) (0.396,0.558) (-0.117,-0.023) (0.020,0.106) 
Hearing 
impairment 0.120 -0.564** 0.124** -0.172** 
(-0.030,0.271) (-0.769,-0.359) (0.044,0.204) (-0.281,-0.063) 
Syncope 0.288** 0.326** 0.263** 0.197** 
(0.173,0.403) (0.224,0.427) (0.201,0.325) (0.143,0.251) 
Fracture 0.650** 0.983** 0.205** 0.226** 
(0.561,0.739) (0.902,1.064) (0.154,0.255) (0.183,0.269) 
Pressure 1.892** 1.746** 0.134** 0.238** 
(1.731,2.053) (1.629,1.863) (0.052,0.217) (0.175,0.300) 
Weight loss 0.686** 0.764** -0.135** -0.03 
(0.558,0.815) (0.656,0.871) (-0.192,-0.077) (-0.087,0.027) 
Vision 
impairment 0.159 0.028 -0.073 -0.055 
(-0.062,0.381) (-0.327,0.382) (-0.182,0.035) (-0.244,0.134) 
Failure to thrive 1.103** 1.180** -0.312** -0.024 
(0.857,1.350) (0.954,1.407) (-0.406,-0.218) (-0.145,0.096) 
Laceration 1.464** 1.119** 0.230** 0.173** 
(1.275,1.653) (0.979,1.260) (0.135,0.325) (0.098,0.248) 
Delirium 0.889** 0.852** -0.108* 0.039 
(0.658,1.120) (0.659,1.044) (-0.209,-0.008) (-0.064,0.141) 
Dislocation -0.163 0.064 -0.051 -0.107 
(-0.484,0.157) (-0.247,0.375) (-0.251,0.149) (-0.272,0.059) 
Hypertension 0.644** 0.267** 0.189** 0.116* 
(0.516,0.772) (0.085,0.448) (0.108,0.270) (0.019,0.213) 
CHF 0.385** 0.162* 0.041 0.001 
(0.308,0.462) (0.030,0.294) (-0.000,0.083) (-0.070,0.071) 
Diabetes 0.050 -0.661** -0.043 -0.202** 
(-0.034,0.133) (-0.790,-0.532) (-0.089,0.002) (-0.270,-0.133) 
Deficiency 
anemia 0.691** 0.325** 0.246** 0.131** 
(0.621,0.762) (0.201,0.448) (0.208,0.284) (0.065,0.197) 
COPD 0.282** -0.415** 0.092** -0.067* 
(0.207,0.358) (-0.537,-0.294) (0.052,0.133) (-0.132,-0.003) 
PVD 0.253** -0.019 0.075** 0.01 
(0.181,0.325) (-0.143,0.105) (0.036,0.115) (-0.056,0.076) 
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Dependent 
variable FM/IM FM/IM Specialty Specialty 
Fixed effects? No Yes No Yes 
Hypothyroidism 0.092* -0.729** 0.028 -0.295** 
(0.014,0.169) (-0.865,-0.593) (-0.012,0.069) (-0.368,-0.223) 
Valvular disease -0.171** -0.670** 0.269** -0.057 
(-0.257,-0.085) (-0.809,-0.532) (0.222,0.316) (-0.131,0.017) 
Other 
neurological 0.222** 0.059 0.069** 0.039 
(0.134,0.309) (-0.090,0.208) (0.022,0.116) (-0.040,0.118) 
Diabetes 
w/complications 0.027 -0.490** 0.102** -0.014 
(-0.077,0.130) (-0.646,-0.333) (0.044,0.159) (-0.098,0.069) 
Renal failure -0.161** -0.297** -0.013 -0.008 
(-0.254,-0.068) (-0.426,-0.169) (-0.060,0.034) (-0.077,0.060) 
Tumor, no 
metastasis -0.059 -0.916** 0.369** -0.003 
(-0.172,0.053) (-1.084,-0.749) (0.299,0.439) (-0.092,0.087) 
Electrolyte 
disorder 0.893** 0.906** 0.112** 0.128** 
(0.797,0.990) (0.826,0.987) (0.063,0.160) (0.085,0.170) 
Hypertension, 
complications 0.461** 0.599** 0.326** 0.259** 
(0.361,0.561) (0.510,0.688) (0.270,0.382) (0.212,0.307) 
Paralysis 0.194* -0.166 0.07 -0.081 
(0.027,0.362) (-0.469,0.137) (-0.030,0.170) (-0.242,0.081) 
Psychoses 0.911** 0.951** 0.397** 0.321** 
(0.812,1.009) (0.860,1.043) (0.344,0.450) (0.272,0.370) 
Coagulation 
deficiency 0.832** 0.783** 0.328** 0.259** 
(0.655,1.009) (0.635,0.931) (0.234,0.423) (0.180,0.337) 
Rheumatoid 
arthritis 0.105 -0.681** 0.306** -0.082 
(-0.049,0.259) (-0.922,-0.439) (0.222,0.390) (-0.210,0.047) 
Obesity 0.284** -0.22 0.059 0.056 
(0.099,0.469) (-0.510,0.071) (-0.041,0.159) (-0.099,0.211) 
Pulm. circulation 
disorder 0.782** 0.865** 0.151** 0.241** 
(0.570,0.994) (0.682,1.048) (0.041,0.261) (0.143,0.338) 
Blood loss 
anemia 0.390** 0.704** 0.181** 0.208** 
(0.181,0.598) (0.517,0.890) (0.055,0.307) (0.109,0.308) 
Metastatic -0.289* -0.796** 0.205* -0.184* 
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Dependent 
variable FM/IM FM/IM Specialty Specialty 
Fixed effects? No Yes No Yes 
cancer 
(-0.543,-0.035) (-1.130,-0.462) (0.049,0.362) (-0.362,-0.006) 
Lymphoma -0.006 -1.260** 0.785** -0.244 
(-0.323,0.312) (-1.740,-0.779) (0.542,1.029) (-0.500,0.012) 
Liver disease -0.18 -0.631** 0.118 -0.03 
(-0.481,0.121) (-1.087,-0.174) (-0.085,0.322) (-0.273,0.213) 
Alcohol abuse -0.432** -0.692* -0.215* -0.370* 
(-0.704,-0.161) (-1.247,-0.136) (-0.393,-0.037) (-0.665,-0.074) 
** p<0.01, * p<0.05 
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Appendix Table 14. Effect of any geriatric care: comparison of IV and OLS FE estimates 
Dependent variable FM/IM FM/IM Specialty Specialty 
Model OLS with FE IV OLS with FE IV 
Community sample -0.396** 6.885** -0.070* 2.326** 
(-0.467,-0.326) (5.608, 8.150) (-0.133,-0.007) (1.060, 3.226) 
NH sample -0.799** 8.858** -0.140** 0.037 
  (-0.968,-0.631) (6.318, 11.232) (-0.230,-0.051) (-1.021, 1.255) 
** p<0.01, * p<0.05 
Bias-corrected confidence intervals for changes in the predicted number of physician visits were generated by bootstrapping 100 random samples drawn at the 
beneficiary level with replacement. 
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